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1 
Abstract 
 
Originally 2A was characterised in foot- and -mouth disease virus. Site directed mutagenesis 
identified a C-terminus consensus motif [D(V/I)ExNPGP] and it is proposed that 2A interacts with the 
exit tunnel of the ribosome in a way that a specific peptide bond is skipped between the last glycine of 
2A and the proline of 2B, thus providing a discontinuity in translation, resulting in release of discrete 
proteins from one single ORF. 2A was also identified in other picornaviruses, positive, single and 
double-stranded RNA insect viruses and mammalian rotaviruses. A motif present at the C-terminus of 
the 2A oligopeptide [D(V/I)ExNPGP] is very highly, though not completely conserved . The sequence 
upstream of this motif shows, however, no apparent conservation between 2As of different viruses.  
 
In this study, extensive site-directed mutagenesis were performed on several  2A sequences and a 
series of ‘hybrid’ 2As comprising different consensus motifs juxtaposed with different upstream 
contexts were created as part of a detailed analysis of the mechanism of 2A-mediated ribosome 
stalling. The results demonstrated that a minimal region of twenty to twenty-three amino acids 
interacts with the exit tunnel of the ribosome to bring about a pause in processivity, alter the peptidyl 
transferase centre geometry and restrict the ribosome A site via two distinctive stalling mechanisms.  
Other molecular analyses tested here will require further optimisations or alternative methods: a visual 
method to explore the dynamics of re-initiation of translation from proline codon, purification of the 
translation-regulating factors and structural resolution of 2A sequences. 
 
Previously, cellular 2As were identified in non-LTR retrotransposons of trypanosomes. It is reported 
here as part of two other cellular organisms Saccoglossus kowalevskii (acorn worm) and 
Branchiostoma floridae (amphioxus). In the acorn worm, the nucleotides sequences corresponding to 
2A motifs were part of the untranslated genome. In amphioxus, three 2A elements were identified in 
hypothetical proteins, and at the N-terminus of twenty non-LTR retrotransposons.  
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The 2A element is a peptide able to stall the eukaryotic ribosome during the course of its translation 
and prevent the formation of a peptide bond between a specific glycine and proline pair at the C-
terminus. Surprisingly, the ribosome having skipped the formation of this peptide bond is able to 
resume translation of the remaining RNA sequence past the C-terminal glycine of 2A. This gives rise 
to two discrete proteins from a single open reading frame (ORF). 
A model of action has previously been proposed to explain 2A-induced ribosome stalling and the 
purpose of this body of work was to further define and elaborate this model. 
 
2A was termed after the genomic region of the viruses where it was first identified; the 2A region of 
the picornaviruses foot-and-mouth disease virus (FMDV), encephalomyocarditis virus (EMCV) and 
Theiler’s murine encephalomyelitis virus (TMEV). The C-terminal consensus motif of 2A 
[D(V/I)ExNPGP] was later identified encoded by the genomes of several other single-stranded and 
double-stranded RNA viruses.  
 
 
The introduction begins with a section on the occurrence of the 2A motif in viruses. The second 
section of the introduction summarises the experimental data that lead to the elaboration of the model 
for the mechanism of action of 2A. This section is followed with a review of the elongation step on 
the ribosome and a description of four others well-studied nascent ribosome-stalling peptides.  
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1.1 Terminology and numbering of 2A 
 
 
In this thesis, for simplicity all 2A and 2A-like elements will be referred to as 2A, preceded by the 
initial of the virus in which it occurs, and if appropriate the length of the 2A sequence tested.  
e.g.: DHV20 2A the twenty-residues-long-2A sequence from Duck hepatitis virus (DHV). 
The numbering of residues follows the N- to C- numbering adopted in the literature for other 
ribosome-arresting peptides : SecM, arginine attenuator peptide (AAP), TnaC, (Ito and Nakatogawa, 
2002, Gong et al, 2007 and Vasquez-Laslop et al., 2008). In the context of 2A the numbering begins 
at the first residue of the 2A sequence.  
e.g.: 
Residue number           1        10        20        30      
                         ....|....|....|....|....|....| 
FMDV30  2A               RHKEDCAPVKQLLNFDLLKLAGDVESNPGP  
Based on sequence alignments (Luke et al., 2008) and for the purpose of site-directed mutagenesis 
(chapter 4 and 5) it has been decided to distinguish two regions in the 2A sequences: the variable 
region also called the upstream context (underlined in the example above) and the consensus motif, 
which is more conserved (in blue in the above example). 
 
Throughout this text the ribosome numbering follows E. coli numbering consistent with the ribosome-
arresting peptide literature. 
 
1.2 Occurrence of the ribosome-arrest 2A element in viruses 
 
Viruses consist of RNA or DNA genome encapsulated within a virion. They lack the translational 
machinery necessary to replicate and are obligate parasites of cellular systems. The Baltimore 
classification divides all viruses into seven categories based upon genome type and mode of 
replication (Baltimore, 1971). Positive-stranded RNA viruses, which are the classes of virus relevant 
to this thesis, have an RNA genome acting like cellular mRNAs. They are translated directly in the 
cytoplasm of the host cell. Each family of RNA viruses showcase distinctive strategies to express and 
process their proteins.  
 
The 2A-induced ribosome stalling is one of the strategies employed by several virus species from the 
families Picornaviridae, Dicistroviridae, Tetraviridae, Iflaviridae, Reoviridae and Totiviridae. The 
mechanism permits the segregation of two virally encoded proteins without the need for proteolytic 
activity.  
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1.2.1 Occurrence in Picornaviridae  
 
1.2.1.1 Picornaviruses 
 
 
‘Pico’ means small and ‘rna’ refers to the type of genome. Picornaviruses are infectious agents to 
human and animals. The classification of the Picornaviridae family has been amended extensively in 
the past four years as newly-identified viruses have been included. The picornavirus study group 
publishes online (http//www.picornaviridae.com, 2013) the most up-to-date classification. In 2013, to 
reflect the changes approved by the International Committee on Taxonomy of Viruses (Adams et al., 
2013), the Picornaviridae family is organised into the seventeen genera presented in table 1.1.  
 
 
Their genome is 7500 to 8500 nucleotides (nts) long and organised in a single ORF encoding a 
polyprotein (figure 1.1). This single precursor is sequentially processed into final-mature proteins, 
twelve in the case of FMDV. The 5’ end of the picornavirus RNA is the Leader region and comprises 
600 to 1100 nts (Palmenberg, 1990). The ORF has three distinct regions called P1, P2 and P3. The 
underlying rationale for this subdivision lies in the structural or enzymatic functions of the viral 
proteins encoded. The ORF constitutes 85 to 90 % of the coding capacity, and the remaining 10 to 15 
% are shared between the 3’ and the 5’ region (Palmenberg et al., 2009). The 3’ region is between 40 
to 120 nts long (Palmenberg, 1990).  
 
The unprocessed polyprotein would be a large protein of about 250 kDa, but is not observed in 
cultures. It is processed sequentially into precursors and then individual viral proteins by a proteolytic 
cascade involving a primary and secondary series of events (Palmenberg, 1992). The primary 
processing releases the structural from the replication precursors. The purpose of the secondary 
processing, performed by the virally encoded 3C protease (3C
pro
) is to cleave each individual protein 
unit from the precursors.  
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Table 1.1: The picornaviruses genera, species and serotypes 
(From Fernandez- Miragall et al., 2009, Adams et al., 2013 and http//www.picornaviridae.com, 2013) 
Picornaviruses using the 2A-induced ribosome stalling mechanism during the course of their polyprotein processing are 
highlighted in red showing the serotypes relevant to this thesis. 
 
genus species relevant serotypes  
Aphthovirus Foot-and-mouth disease virus 
 
Bovine rhinitis A virus 
Bovine rhinitis B virus 
Equine rhinitis A virus 
Foot-and-mouth disease virus O, A, C, Asia 
1, SAT 1, SAT 2 and SAT 3 
Bovine rhinitis A virus 1and 2 
Bovine rhinitis B virus 1  
Equine rhinitis A virus 1 
Aquamavirus Aquamavirus A Aquamavirus A 
Avihepatovirus Duck hepatitis A virus Duck hepatitis A virus 1 to 3 
Cardiovirus Encephalomyocarditis virus 
 
Theilovirus 
Encephalomyocarditis virus 1 
Encephalomyocarditis virus 2 
Theiler’s murine encephalomyelitis virus 
Vilyuisk human encephalomyelitis virus 
Thera virus  
Saffold virus 1 to 9 
Cosavirus Cosavirus A, B, C and D  
Dicipivirus Cadicivirus A  
Enterovirus Enterovirus A, B, C, D, E, F, G, H, J 
Rhinovirus A, B, C 
 
Erbovirus Equine rhinitis B virus Equine rhinitis B virus 1 to 3 
Hepatovirus Hepatitis A virus  
Kobuvirus Aichi virus A, B, C  
Megrivirus Melegrivirus A  
Parechovirus Human parechovirus Human parechovirus 1 to 14 
Ljungan virus Ljungan virus 1 to 4 
Salivirus Salivirus A  
Sapelovirus Porcine sapelovirus 
Simian sapelovirus 
Avian sapelovirus 
 
Senecavirus Seneca Valley virus Seneca Valley virus 1 
Teschovirus Porcine teschovirus Porcine teschovirus 1 to 11 
Tremovirus Avian encephalomyelitis virus  
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In the 5’ region, the RNA has a VPg protein capping the 5’end (figure 1.1) attached to the 5’ uridylyl 
nucleotide of the RNA through a tyrosine residue to form a phosphodiester bond (Forss and Schaller, 
1982 and Steil et al., 2010). Other key features of the 5’ region are the presence of a cloverleaf 
structure and an internal ribosome entry site (IRES). This structural element is the key factor 
controlling the viral-RNA translation by its ability to recruit cellular ribosomes (Kolupaeva et al., 
1998).  
From the coding region, region P1 yields all the proteins (VP1, VP2, VP3 and VP4) required for the 
virion formation. The middle part of the picornaviral RNA yields peptides 2A, 2B and 2C. The P3 
region yields four final proteins via a series of active intermediates 3AB, 3B 
VPg
, 3CD
pro
, 3C
pro
 and the 
polymerase 3D
pol
 (Palmenberg, 1990). Picornavirus non-structural proteins are involved in viral 
genome replication, cellular shut-down and cellular membranes shuffle. 2A protein is highly variable 
amongst Picornaviridae and is involved in primary processing of the viral polyprotein. 2B protein is a 
transmembrane protein able to form pores, alter membranes permeability and therefore disturb 
calcium homeostasis (Sandoval and Carrasco, 1997). In Enterovirus 2B disrupts membrane 
permeability in the endoplasmic reticulum and Golgi apparatus (Sanchez-Martinez et al., 2012). It is 
not established at present if all the picornaviruses 2B functions similarly. 2C has ATPase/GTPase 
activity and is an essential element of the replication process (Rodriguez and Carrasco, 1993). The 2C 
and the precursor 2BC bind viral RNA to cellular vesicles. 2C has been shown to participate in the 
encapsidation step of the viral genome (Vance et al., 1997). 3A disrupts the traffic between 
endoplasmic reticulum and Golgi apparatus thereby inhibiting host cellular responses such as 
production of interferon, interleukins and cytokins mainly by releasing intracellular calcium (Dodd et 
al., 2001). The host range is defined essentially by 3A (Lama et al., 1998). 3B or VPg is covalently 
bound to the next viral RNA and is a primer for initiation of replication (Schein et al., 2006). 3C
pro
 is a 
chymotrypsin like protease responsible for most of the polyprotein cleavage (Palmenberg, 1992). 3C 
also takes part outside of the viral protein processing to cellular disruption by cleaving eIF4A, eIF4GI 
and II, PABP, and degrading p53, thereby controlling cell apoptosis (Blair et al., 1998, Belsham et al., 
2000, Barco et al., 2000, Weidman et al., 2001). 3D
pol
 is a RNA-dependent RNA polymerase, which 
shows much specificity to each virus type and is the crucial element in viral replication, the enzyme 
lacks proof-reading and frequent errors induced during replication allow the virus flexible adaptation 
(Kerkvliet et al., 2010). The cleavage intermediates 2BC, 3AB and 3CD
pro
 have additional functions. 
2BC creates small cellular vesicles, 3AB induce 3D
pol 
activity and 3CD
pro
 participate in polyprotein 
processing and enhances replication by binding the cloverleaf structure at the 5’UTR (Chase and 
Semler, 2012). 
The last region of the viral RNA, the 3’ region is similar to eukaryotic mRNA as it hosts a poly(A) 
tail, thought to be involved on the stability of the RNA translation through forming a loop back, 
binding to the ribosomal initiation complex (Steil et al., 2010). 
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Figure 1.1: The generic genomic organisation of Picornaviridae 
The positive-sense RNA genome has a small protein VPg at the 5’ end (encoded by 3B). The 5’ UTR contains an internal 
ribosome entry site (IRES). The 3’ end has a poly (A) tail. 3Cpro carries out most of the proteolytic processing. The genome 
is organised in three regions P1, 2 and 3. The schema indicates the peptides encoded by each region (written in white). 
 
 
1.2.1.2 The 2A product in Picornaviridae 
 
Picornaviral RNA is translated once the IRES has successfully recruited a ribosome. Eukaryotic 
initiation factor 4 (eIF4) is a principal target for most picornaviruses. The genus Enterovirus uses the 
2A protease (2A
pro
) to cleave eIF4 (Novoa and Carrasco, 1999). Members of the Aphthovirus and 
Cardiovirus genera shut cellular-mRNA translation down by the activity of their leader protein. For 
apthoviruses, the leader protein is a protease L
pro 
which is able to cleave eIF4G (Gradi et al., 2004). 
For cardioviruses, there is no proteolysis but dephosphorylation of eIF4E, in which case mRNA cap 
recognition is inhibited (Jen and Thach, 1982). The cleavage of eIF4 family serves the purpose of 
releasing the central component eIF4G most useful for virus translation as it assists in recruitment of 
43S ribosome subunit by IRESes type I and II (Daijogo and Semler, 2011). Hepatitis A virus however 
has a type III IRES and can recruit 43S subunit without the need for eIF4G. This virus does not inhibit 
host-cellular translation (Cohen et al., 2002). 
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Regions of the picornavirus ORF encodes for proteins with similar functions across genera. The 2A 
locus however is an exception. For the genus Hepatovirus, the 2A protein is cleaved from VP4 late in 
the replication. The primary processing is performed by 3C
pro
 (the only protease this genus encodes) 
at the 2A/2B junction. Cohen and colleagues (2002) performed serial N- and C-terminal deletions of 
the 2A sequence. It was found that 40 % of the N-terminal sequence was necessary for infectivity 
whereas the C-terminal (the remaining 60 %) of the sequence was required for adequate cleavage of 
VP1/2A by an elusive cellular protease. For this genus, the 2A product is involved in virion assembly 
and maturation.  
Human parechovirus bioinformatics analyses showed that the 2A product is related to the cellular 
protein H-rev107 involved in cell-growth regulation. The conserved features of this protein are a long 
hydrophobic domain and an Asn-Cys-Glu motif (Hughes and Stanway, 2000). The 2A from Human 
parechovirus was then called ‘H-box 2A’ and is also identified in Kobuvirus, Megrivirus and 
Tremovirus (http//www.picornaviridae.com, 2013). For this category of 2A, 3C
pro
 acts between the 
VP1 and 2A. 
InEnterovirus, the 2A product is a protease. The primary cleavage has two events, the self-processing 
cleavage by 2A
pro
 at its C-terminus and the release of the 3ABC precursor by 3C
pro
. Apart from 
performing the primary processing of the picornavirus polyprotein, 2A
pro
 also cleaves eIF4 (inhibition 
of cap-dependent translation) and nucleoporins (inhibition of mRNA transport to cytoplasm) 
(Redondo et al., 2011). Sapelovirus also has this type of 2A protein.  
The 2A product for Dicipivirus and Salivirus has not been characterised to date.  
Finally, 2A for Aphthovirus and Cardiovirus, as well as other genera (Aquamavirus, Avihepatovirus, 
Erbovirus, Senecavirus, Teschovirus and the species Ljungan virus from genus Parechovirus) 
highlighted in red in the table 1.1, is characterised by the C-terminally conserved motif 
[D(V/I)ExNPGP] and is the focus of this thesis. The primary processing involves a scission at the 
2A/2B junction, by ribosome- stalling and re-initiation of translation (Luke et al., 2008). 
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Table 1.2: Viruses employing 2A-induced ribosome stalling.  
Family Genus Species reference virus for 2A studies  
Picornaviridae Aphthovirus Foot-and-mouth disease virus 
 
Bovine rhinitis A virus 
Bovine rhinitis B virus 
Equine rhinitis A virus 
FMDV-O1K (X00871) 
 
 Aquamavirus Aquamavirus A  
 Avihepatovirus Duck hepatitis A virus Duck hepatitis virus 1 (DQ219396)  
 Cardiovirus Encephalomyocarditis virus 
 
 
Theilovirus 
Encephalomyocarditis virus (Ruckert) 
(M81861)  
Mengovirus (DQ294633) 
Theiler’s murine encephalomyelitis virus 
(NGS910_AB) 
 Erbovirus Equine rhinitis B virus  
 Parechovirus Ljungan virus  
 Senecavirus Seneca Valley virus  
 Teschovirus Porcine teschovirus  
Dicistroviridae Aparavirus Acute bee paralysis virus Acute bee paralysis virus (AF150629) 
  Israeli acute paralysis virus  
  Kashmir bee virus  
 Cripavirus Cricket paralysis virus Cricket paralysis virus (AF218039) 
  Drosophila C virus  
Iflaviridae Iflavirus Ectropis oblique picorna-like virus  
  Infectious flacherie virus Infectious flacherie virus (AB000906) 
  Perina nuda picorna-like virus  
Tetraviridae Permutotetravirus Thosea asigna virus Thosea asigna virus (AF062037) 
  Euprosterna eleasa virus  
 Cormotetravirus  Providence virus Providence virus (AF548354) 
    
Reoviridae Rotavirus Human rotavirus C  
  Porcine rotavirus C Porcine rotavirus C (Cowden) (M69115) 
  Bovine rotavirus C  
  Non A,B,C novel adult diarrhea 
virus 
novel adult diarrhea virus (AY632079) 
 Cypovirus Bombyx mori cypovirus 1 Bombyx mori cypovirus 1(AF433660) 
  Lymantria dispar cypovirus 1  
  Dendrolimus punctatus cypovirus 1  
  Operophtera brumata cypovirus 18  
Totiviridae Giardavirus Penaeid shrimp infectious 
myonecrosis virus 
Penaeid shrimp infectious myonecrosis 
virus (AF323747) 
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1.2.2 Occurrence of the ribosome-stalling 2A sequence in other RNA viruses 
 
Worldwide efforts in genome sequencing provided an unprecedented opportunity to compare and 
align viral genomes. Using local alignment algorithms programmed with the [D(V/I)ExNPGP] 
consensus motif previously identified in Picornaviridae, revealed that outside aphthoviruses and 
cardioviruses other mammalian and insect RNA viruses contained the 2A motif (Luke et al., 2008). 
The classification for these viruses is provided in table 1.2. The 2A elements were cloned and tested 
in the generic expression-system (figure 1.6). They were able to separate a single ORF into two 
discrete products with varying efficiencies (summarised in table 1.3) (Luke et al., 2008). A nucleotide 
sequence coding for 2A was discovered in the genomes of positive single stranded RNA virus 
families: Dicistroviridae, Iflaviridae and Tetraviridae. Figure 1.2 provides the position of 2A in 
relation to these virus genomes.  
The virus classifications reported throughout this section follows the latest taxonomy released by the 
International Committee on Taxonomy of Viruses in 2012 (http//www.ictv.org). 
 
The Dicistroviridae family consists of two genera: Aparavirus and Cripavirus infecting invertebrates 
such as bees and cricket worldwide (De Miranda et al., 2010).  
The generic dicistrovirus genome is organised in two non-overlapping ORFs encoding for two distinct 
polyproteins. The structural proteins (products of the ORF2) of insect picorna-like viruses have many 
common features with picornaviruses. However, dicistroviruses are distinguished by the position of 
their structural protein-coding sequences at the 3’ rather than the 5’ end as for picornaviruses and 
iflaviruses. Dicistroviruses also have an IRES preceding each ORF (De Miranda et al., 2010). Three 
out of five species of Aparavirus have a NPGP 2A motif: Acute bee paralysis virus (ABPV), Israeli 
acute paralysis virus and Kashmir bee virus (KBV). Two species out of nine of Cripavirus have a 2A, 
Drosophila C virus (DCV), and Cricket paralysis virus (CrPV). The 2A for these viruses is located at 
the N-terminus of the replicative ORF1. The glycine- proline of the [NPGP] motif of 2A is found at 
residue 96 in DCV and residue 166 in ABPV and CrPV polyproteins (Luke et al., 2008). The N-
terminal region of the replicative polyprotein encodes an RNA helicase (Govan et al., 2000). RNA 
helicases are a family of proteins involved in a wide range of RNA-processing events such as mRNA 
degradation and RNA editing. The RNA helicases have a core region of 290 to 360 aa homologous to 
initiaton factor 4A, however the amino and carboxy termini are of variable length and sequence (Soto-
Rifo and Ohlman, 2013). 2A is located within the RNA helicase. The sequence upstream of the 2A 
motif is thought to be involved in the modulation of the host immune response by interfering with the 
formation of double-stranded RNA complexes targeting the viral RNA for degradation (Luke et al., 
2008). CrPV 2A was tested to be only 88 % efficient and ABPV 94 % (Luke et al, 2008).  
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Iflavirus is the only genus in the Iflaviridae family. There are seven species currently classified and 
2A was found in the genome of three of these: Infectious flacherie virus (IFV), Peruna nuda picorna-
like virus (PnPV), Ectropis oblique picorna-like virus (EoPV). The iflaviruses are the causative agents 
of flacherie disease for invertebrates such as honey bees and silkworm (Ribiere et al., 2010). 
The iflaviruses have a single ORF encoding the capsid protein from the 5’ genomic region and non-
structural proteins from the 3’ region (Wu et al., 2002).  
Purified EoPV particles were analysed by SDS-PAGE and only two protein masses were detected: 
31.5 kDa and 28.8 kDa. Further bioinformatic analyses of the particle proteins revealed homologies to 
several other ssRNA viruses-virion proteins (Wang et al., 2004). The position of 2A coincides with 
two junctions. In PnPV and EoPV, 2A is found between VP4 and VP1 (at residues 572- 575) and 
between the last capsid protein and the helicase of the non-replicative precursor (at residues 1189- 
1192). Both 2A sequences were highly efficient in vitro (Luke et al., 2008). It is highly likely that the 
two virion particles detected correspond to processing events induced by the 2A sequences. The 28.8 
kDa protein was detected in twice greater amounts than the 31.5 kDa (Wang et al., 2004). The 
phylogenetic study published by Wang and colleagues indicates that EoPV, PnPV are closely related 
to IFV. These three virus species share a common organisation and some sequence similarities. There 
are several strains of IFV reported and potential new members for the Iflavirus genus, however only 
one sequence is available to date (GenBank accession number AB000906 (Isawa et al., 1998). IFV 
has one 2A element at position 1081 to 1084 aa segregating the capsid precursors from non-structural 
proteins precursor.  
 
The Tetraviridae family taxonomy has been reassessed extensively. The current classification 
(http://www.ictvonline.org) recognises three genera: Cormotetravirus, Permutotetravirus and 
Alphatetravirus. Permutotetravirus consists of two species Europrosterna elaeasa virus (EeV) and 
Thosea asigna virus (TaV), both containing a 2A sequence. Cormotetravirus has a single species, 
Providence virus (PrV) known to have three 2A sequences.  
Tetraviruses have been isolated from lepidopterans such as moths and butterflies (Gordon and 
Waterhouse, 2010). The permutotetraviruses have two ORFs in a linear genome. The first ORF 
encodes the polymerase while the second ORF encodes the capsid proteins (Zeddam et al., 2010). The 
second ORF was derived by bioinformaric analyses from the aa and corresponding nucleotides 
sequences of the viral particle. ORF2 overlaps by 520 nts the first ORF. Translation from the second 
ORF AUG codon requires a +1 frameshift (Pringle et al., 2001). The 2A motif in EeV and TaV is 
found on the second ORF. TaV particles were isolated from Setothosea asigna larvae from Sumatra 
(Pringle et al., 2001). Analysis on SDS-PAGE of the particle shows that the virion is assembled from 
proteins of 58.3 kDa (L protein) and 6.8 kDa (S protein). The expression of these two proteins on 
separate vectors failed to replicate any virus. Pringle and colleagues (2001) concluded that the L and S 
proteins are joined and cleaved after translation during virion synthesis; the L and S aa sequences 
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correspond to the C-terminal segment of the capsid precursor encoded by the ORF2. The N-terminus 
encodes for a third protein of 17 kDa (p17) of unknown function and not incorporated in the virion. In 
TaV and EeV, the 2A sequence is found between p17 and the capsid precursor (Zeddam et al., 2010). 
Providence virus has a monopartite genome but encodes three ORFs (Walter et al., 2010). The first 
ORF encodes for a protein of 130 kDa (p130) of unknown function. The second ORF encodes for a 40 
kDa protein (p104 and in figure 1.2 the replicase polyprotein) in a +1 frame relative to p130. The third 
ORF begins 4 nts after p104 stop codon. ORF3 encodes for the capsid polyprotein p81 from a read-
through event at the second ORF stop codon. PrV has three 2A elements. PrV-2A1 is at the N-
terminus of p130 and produces fragments of 17 and 113 kDa. PrV-2A2 and PrV-2A3 are at the N-
terminus of p81. The two 2A elements process p81precursors into fragments of 7, 8 and 68 kDa. The 
capsid precursor is the 68 kDa which undergoes auto-proteolysis to yield the peptides of 60 and 7.4 
kDa composing the virion (Walter et al., 2010). The 7 and 8 kDa segments resulting from PrV-2A2 
and 2A3 processing have not been studied. 
 
 
 
Figure 1.2: Location of 2A coding sequences in the genomes of other ssRNA (+) viruses  
The 2A is marked in red. The key features of the genomes are provided. The proteins sequences associated with virion 
formation (VP or CP) are coloured in shades of green, the grey boxes represent the replicative domains, blue and pink 
represent other coded proteins. (Graphics are reproduced and adapted from http://www.viralzone.expasy.org, using 
information from Luke et al., 2008). 
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In addition two families of double-stranded RNA viruses, Reoviridae and Totiviridae, have members 
coding for a 2A sequence.  
 
Reoviruses have segmented genomes. Figure1.3 gives an illustration of the position of the 2A motif in 
the relevant genomic segment. Reoviruses are organised in two subfamilies: Sedoreovirinae and 
Spinareovirinae.  
 
Sedoreovirinae consists of six genera. It includes the genus Rotavirus further organised in five 
species: Rotavirus A, B, C, D, and E. Rotaviruses have eleven segments encoding six virion forming 
proteins and five replicative proteins (James et al., 1999). Species of the genus Rotavirus C: Bovine 
rotavirus C (BoRV), Porcine rotavirus C (PoRV) and Human rotavirus C (HuRV) encode a 2A 
sequence in their segment 6 (NSp3). In addition, 2A was identified in segment 5 (NSp1) of the 
rotavirus type non -A,B, C novel adult diarrhea virus (ADRV) (Luke et al., 2008).  
Rotaviruses mRNAs lack 3’ poly(A) endings. NSp3 protein enhances rotavirus translation by its 
ability to circularise the viral mRNAs (Jayaram et al., 2004). When the NSp3 segment of porcine 
rotavirus C was expressed in COS-1 cells, three products were observed by SDS-PAGE analysis a 45 
kDa full-length product, a 38 kDa and a 8kDa product (Langland et al., 1994). Further analysis of the 
NSp3 aa sequences for type C rotaviruses revealed three regions: a ssRNA binding protein region at 
the N-terminus, a initiation factor 4G binding region in the mid region, the 2A motif followed by a 
dsRNA binding protein region (Luke et al., 2008). In other types of rotaviruses, the NSp3 protein is 
shorter and lacks the 2A-dsRNA binding domain of type C rotavirus (James et al., 1999).  
NSp1 is the most variable protein in rotaviruses and targets the host interferon response (Arnold and 
Patton, 2011). Although NSp1 of ADRV is unrelated to NSp3 of type C rotaviruses, both of these 
segments contain downstream of 2A a dsRNA binding protein. 
 
The subfamily Spinareovirinae is organised in nine genera and includes the genus Cypovirus, which is 
further categorised in sixteen species, Cypovirus 1 to 16. Four viruses Bombyx mori cypovirus 1 
(BmCPV-1), Lymantria dispar cypovirus 1 (LdCPV-1), Dendrolimus punctatus cypovirus 
1(DcpCPV-1) and Operophtera brumata cypovirus 18 (OpbuCPV-18), encode a 2A in their segment 
5. The segment 5 for BmCPV-1 is 881 aa long and was analysed in vitro (Hagiwara et al., 2001). 
Three bands were detected by SDS-PAGE analysis corresponding to proteins of 107 kDa (p107), 80 
kDa (p80) and 23 kDa (p23). The fragments of lesser molecular weight constitute the processed 
products of p107. Hagiwara and colleagues (2001) identified a 2A motif between residues 219 and 
235 but failed to identify any other domains in p80 and p23. 
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The family of Totiviridae comprises five genera, amongst these in the genus Giardavirus, the virus 
Penaeid shrimp infectious myonecrosis virus (IMNV) has two 2A sequences at the N-terminus of 
ORF1(Luke et al., 2008). Totiviruses have non segmented dsRNA genomes, with two ORFs that 
overlap (Nibert, 2007). ORF1 encodes the capsid protein and ORF2 the polymerase. The polyprotein 
processing of ORF1 results in the production of three products of different sizes, 93, 284 and 1228 
amino acids (Poulos et al., 2006). The extreme 93 aa N-terminal fragment is a dsRNA binding protein 
terminated with a 2A sequence (Nibert, 2007). Totiviruses were originally isolated from fungi but in 
2006 IMNV was isolated in aquacultures of shrimps in Brazil and Indonesia (Poulos et al., 2006). In 
IMNV, the capsid protein starts half-way through the ORF1 and is preceded by the dsRNA binding 
protein, which is an unusual feature for totiviruses. New totiviruses were isolated from drosophila 
cultures and mosquitoes. These new isolates retain the dsRNA binding protein-2A feature previously 
observed in IMNV (Isawa et al., 2010). 
 
 
Figure 1.3: Location of the 2A coding sequence in the genome of dsRNA viruses 
2A is marked in red, the rotaviruses, and cypoviruses genomes are segmented and only the relevant segment is shown. The 
capsid protein is represented in green, the replicative protein in grey and other proteins in pink, the ORF in boxes. 
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Sequence alignments proved that the only conserved part was the 2A motif used for identification, as 
the upstream context is very diverse. Previous analyses of the residues by positions ruled out any 
regularity or patterns (Luke et al., 2008). The table 1.2 was created with a representative 2A-like 
sequence for each virus previously identified with a 2A motif in their genome and provides the 2A 
sequences tested to date and their efficiencies. 
 
The evolutionary analyses performed by Luke an co-workers (2008) suggested that 2A could have 
emerged independently or could have been acquired vertically. Luke and co-workers (2008) used the 
polymerase domain to construct a phylogenetic tree relating the various viruses which were identified 
with a 2A sequence (figure 1.4). They included in their analysis the sequence of closely related 
viruses. The analysis showed that for cypoviruses, rotaviruses and totiviruses, 2A was probably 
acquired independently. The authors argued that given the short length of the motif, and high 
mutational rate of the viruses, multiple acquisition of 2A is likely to occur. Members of the 
cardioviruses and aphthoviruses genera however may have acquired their 2A from a common 
ancestor. 
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Figure 1.4: Phylogenetic tree showing occurrence of 2A in diverse virus groups 
(provided by Prof. Ryan as published in Luke et al., 2008.) 
The analysis was based on alignment of the RNA-dependent RNA polymerase domain. The viruses with a 2A 
element in their genome are indicated in boxes and the virus group to which they belong highlighted in grey. 
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Table 1.3: The stalling efficiency of the viral 2A motifs tested to date 
The table features the reported efficiency for viral 2A-sequences previously tested in the in vitro expression system 
(Compiled from Luke et al., 2008 and Donnelly et al., 2001b). 
 
 
virus sequence tested proportion 
(%) of  
processed 
proteins 
 
reference 
Positive stranded RNA viruses 
Picornaviruses 
FMDV  
FMDV  NFDLLKLAGDVESNPG/P 75 Ryan and Drew, 
1994 
Other picornaviruses 
TMEV  FREFFKAVRGYHADYYKQRLIHDVEMNPG/P 98 Donnelly et al., 
1997 
EMCV VFGLYRIFNAHYAGYFADLLIHDIETNPG/P 99 Donnelly et al., 
2001b ERAV QCTNYALLKLAGDVESNPG/P 99 
PTV ATNFSLLKQAGDVEENPG/P 94 
SAF-V FTDFFKAVRDYHASYYKQRLQHDVETNPG/P  
99 
 
Luke et al., 2008 
ERBV EATLSTILSEGATNFSLLKLAGDVELNPG/P 
LV YFNIMHSDEMDFAGGKFLNQCGDVETNPG/P 
Other viruses 
Iflaviruses 
IFV TRAEIEDELIRAGIESNPG/P 63 Donnelly et al., 
2001b 
Longer version of 
IFV 
PSIGNVARTLTRAEIEDELIRAGIESNPG/P 99 Luke et al., 2008 
EoPV-2A1 GQRTTEQIVTAQGWAPDLTQDGDVESNPG/P 
PnPV-2A1 GQRTTEQIVTAQGWVPDLTVDGDVESNPG/P 
EoPV-2A2 TRGGLQRQNIIGGGQRDLTQDGDIESNPG/P 
PnPV-2A2 TRGGLRRQNIIGGGQKDLTQDGDIESNPG/P 
Tetraviruses 
TaV RAEGRGSLLTCGDVEENPG/P 99 Donnelly et al., 
2001b 
EeV RRLPESAQLPQGAGRGSLVTCGDVEENPG/P 99 Luke et al., 2008 
PrV-2A1 LEMKESNSGYVVGGRGSLLTCGDVESNPG/P 
PrV-2A2 NSDDEEPEYPRGDPIEDLTDDGDIEKNPG/P 94 
PrV-2A3 TIMGNIMTLAGSGGRGSLLTAGDVEKNPG/P 99 
Dicistroviruses 
CrPV LVSSNDECRAFLRKRTQLLMSGDVESNPG/P 88 Luke et al., 2008 
ABPV TGFLNKLYHCGSWTDILLLLSGDVETNPG/P 94 
Double stranded RNA viruses 
Animals rotaviruses 
PoRV AKFQIDKILISGDVELNPG/P 31 Donnelly et al., 
2001b 
BoRV-C GIGNPLIVANSKFQIDRILISGDIELNPG/P 89 Luke et al., 2008 
HuRV-C GAGYPLIVANSKFQIDKILISGDIELNPG/P 82 
ADRV-N FFDSVWVYHLANSSWVRDLTRECIESNPG/P 97 
Insect cypoviruses 
BmCPV-1 RTAFDFQQDVFRSNYDLLKLCGDIESNPG/P 99 Luke et al., 2008 
OpbuCPV-18 IHANDYQMAVFKSNYDLLKLCGDVESNPG/P 
Totiviruses 
IMNV-2A1 WDPTYIEISDCMLPPPDLTSCGDVESNPG/P 99 Luke et al., 2008 
IMNV-2A2 RDVRYIEKPEDKEEHTDILLSGDVESNPG/P 
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1.3 Discovery of the 2A NPGP sequence 
 
The ribosome-stalling hypothesis was derived by a process of elimination. The 2A gene product for 
poliovirus (belonging to the genus Enterovirus) is 2A
pro
, an enzyme of 142 residues (Toyoda et al., 
1986), distantly related to 3C
pro
 and which performs a cleavage at its N-terminus. Nicklin and co-
workers (1987) constructed various plasmids to demonstrate the proteolytic activity of poliovirus 
2A
pro
. They showed that the cleavage site consisted of a tyrosine-glycine pair. 2A
pro
 catalytic triad was 
later determined by mutational and structural studies (Hellen et al., 1992, Sommergruber et al., 1997) 
and consists of Cys106, His18 and Asp35. Compounds such as iodoacetamide and N-ethylmaleimide, 
inhibitors of thiol proteases, were active against 2A
pro
 (Konig and Rosenwirth, 1988).  
 
The mature 2A protein of Hepatovirus escapes detailed molecular analyses as it so far failed to be 
purified, suggesting that the protein is either unstable or simply not released. The predicted translated 
2A presents no similarities to Aphthovirus, Cardiovirus or Enterovirus counterparts and deletion of 60 
% of the C-terminal 2A sequence did not impair replication. For Hepatovirus, cleavage at the 2A/2B 
junction is carried out by 3C
pro
 (Martin et al., 1995) whereas the cleavage between VP1/2A occurs in 
the course of virion formation and is likely mediated by a cellular protease (Martin et al., 1999, Cohen 
et al., 2002). 
 
 
Figure 1.5: Picornavirus organisation and schematic representation of the three possible types 
of activity at the 2A region                                                                                                                                       
3Cpro carries out most of the proteolytic processing. At the 2A/2B junction, 2Apro cleaves at its own N-terminus (example of 
Enterovirus, where the processing is mediated by two virally encoded enzymes, 2APro and 3CPro ). 2A NPGP results in 
segregation of capsid and replicative precursors (example Aphthovirus genus characterised by the NPGP 2A and the leader 
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protease (Lpro)). 2A is flanked by cleavage sites (example of Hepatovirus) (Derived from information available at 
http://www.picornaviridae.com). 
 
Theiler’s murine encephalomyelitis virus (TMEV) transcripts lacking 3Cpro sequence retained the 
ability to operate the separation at the 2A/2B junction (Roos et al., 1989). Inhibition studies involving 
encephalomyocarditis virus (EMCV) showed that the 2A/2B processing occurred very quickly and 
was not influenced by all the inhibitors used (Jackson, 1986). Sequence alignment showed no possible 
correlation to rhinoviruses and poliovirus 2A. No protease domains were found in the 2A sequences 
of cardioviruses EMCV and TMEV (Palmenberg, 1990). In a separate study, EMCV 2A could 
tolerate large deletions (60 %) at the N-terminal half and still result in the 2A/2B separation. Deletions 
to the C-terminal of 2B produced a similar result. A sequence alignment showed that the C-terminus 
of 2A is absolutely conserved amongst all cardioviruses. Subsequent directed mutagenesis identified 
the cleavage site. For cardioviruses, the cleavage occurred between the last glycine of 2A and the next 
proline of 2B of the absolutely conserved four amino acid sequence [NPGP] (Palmenberg et al., 
1992).  
 
L
pro
 or 3C
pro
 do not cleave the 2A/2B junction of FMDV (Ryan et al., 1989, Belsham et al., 1990). 
Alignment of the 2A regions between FMDV and cardioviruses EMCV and TMEV showed that the 
C-terminal [NPGP] motif was also conserved. FMDV 2A was later introduced internally in a 
synthetic reporter system flanked by virally unrelated sequences and translated in rabbit reticulocyte 
lysates and showed to retain activity. The processing event at the 2A [NPGP] motif did not rely on 
any other viral elements (Ryan et al., 1991). 
 
This synthetic in vitro approach (Ryan et al., 1991) has been adopted since and consists of two genes 
encoding for different molecular weight proteins which could then easily be visualised on an 
acrylamide gel. The 2A sequence is inserted in-frame between these two genes creating one single 
ORF on a plasmid harbouring a T7 promoter. The plasmid is then introduced in cell-free systems such 
as rabbit reticulocyte lysates or wheat germ assays supplemented with [
35
S]-methionine.  
In the current expression system (figure 1.6), 2A is inserted between green fluorescent protein (GFP) 
and beta-glucuronidase (GUS) coding sequences. Three bands can be visualised. One band 
corresponding to the full-length ‘unprocessed’ polyprotein, and two further bands corresponding to 
the segregated proteins. 
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Figure 1.6: The bicistronic expression system for analysis of 2A activity  
Cloning involves insertion of the 2A sequence in-frame between GFP (27 kDa) and GUS (70 kDa) coding sequences. The 
plasmid is introduced in a cell-free system supplemented with [35S]-methionine and translation is driven by T7 promoter. 
The distribution of de novo radiolabeled translation products are analysed on SDS-PAGE gels. Three translation products 
can be observed: the full-length non-processed polyprotein (100 kDa) and the two segregated products GFP-2A (~30 kDa) 
and GUS (top drawings provided by Prof. Ryan, figure adapted from Donnelly et al., 2001b).  
 
Several common features were reported between FMDV 2A and the cardioviruses TMEV, EMCV 
and mengovirus (mengovirus is a strain of EMCV) 2As, despite their difference in size. The 2A 
peptide is eighteen amino acids long in FMDV and 150 amino acids long in cardioviruses. In addition 
to the common [NPGP] conserved motif at the end of their 2A and at the beginning of 2B, there are 
three other conserved amino acids [D(V/I)E] (figure 1.7). In addition, their processing involves a C-
terminus event between 2A and 2B rather than an N-terminal cleavage between VP1 and 2A as is the 
case for the other proteases in picornaviruses (Donnelly et al., 1997). Donnelly and colleagues (1997) 
therefore proposed that the mechanism of action for these separate members of Picornaviridae were 
exactly the same. The motif [D(V/I)ExNPGP] was proposed as the critical amino acid sequence 
involved in the unusual activity of 2A.  
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Figure 1.7: C-terminal sequences at the 2A/2B region of cardioviruses (EMCV, TMEV and 
mengovirus) and aphthovirus (FMDV)                               
The violet box highlights the conserved residues, the separation between 2A and 2B occurs between the last glycine of 2A 
and the first proline of 2B, shown with a blue arrow (adapted from Donnelly et al., 1997).  
 
It was therefore concluded that the picornavirus 2A region can either encode a proteinase (2A
pro
) as 
for enteroviruses, or the translated 2A can be flanked with protease cleavage sites such as for 
hepatoviruses and parechoviruses, or it can induce a ribosome stalling event characterised by the C-
terminal residues [D(V/I)ExNPGP], as is the case for aphthoviruses and cardioviruses (summarised in 
figure 1.5).  
 
Ryan and Drew (1994) focussed first on understanding how much of the already small peptide 
(eighteen amino acids) was necessary to maintain 2A activity in an artificial context. It seemed that 
the critical threshold was thirteen amino acids, although at that length the amount of polyprotein 
processed was reduced from 75 % to about 65 %. On the other hand adding more amino acids 
upstream of 2A altered that activity favourably to the point where almost all the polyproteins (>99 %) 
were effectively divided into the two expected distinct proteins. Similarly, truncating the EMCV and 
TMEV cardioviruses 2A to only the last N-terminal eighteen amino acids (Donnelly et al., 1997) 
resulted in decrease in the proportion of polyproteins processed. It seemed therefore that the upstream 
context played an important role in increasing 2A efficiency. It was not, however, what explained the 
mechanism of action. 
 
A noted feature of FMDV 2A activity was a molar excess of the upstream versus the downstream 
translated proteins in vitro. These suggested a differential synthesis of the coding mRNA such as the 
first part of the mRNA up to 2A was more translated than the second part (Donnelly et al., 1997). 
Similar translation profiles were observed with shorter periods of translation, meaning that the odd 
ratio was not attributed to proteolytic degradation of the downstream product (Donnelly et al., 2001a). 
There was no post-translational proteolytic degradation of the full-length product observed (Ryan and 
Drew, 1994).  
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Based on these observations and inspired by the early work published about Escherichia coli (E. coli) 
SecM sequence, Ryan and co-workers (1999) proposed that NPGP 2A influences the translating 
ribosome and affects its ability to perform the formation of a peptide bond between the C-terminal  
glycine and proline. In E. coli, SecM and SecA form an operon. SecA protein is essential to E. coli 
and is a translocase (Sarker and Oliver, 2002). SecM has a C-terminal motif FxxxxWIxxxxGIRAGP 
able to stall the prokaryotic ribosome (Nakatogawa and Ito, 2002). The intergenic area between SecM 
and SecA contains a Shine-Dalgarno motif, normally inaccessible, and which becomes available to a 
ribosome only if the mRNA is re-structured. This change in secondary structure is introduced by the 
presence nearby of a stalled ribosome on the SecM motif (Butkus et al., 2003). SecM is translated 
normally in E. coli. When the bacterial cell has an abundance of SecA, SecA interacts with the SecM 
N-terminal sequence which extends outside the ribosome tunnel. SecA translocase activity acts like a 
pull and thus un-stalls the ribosome. There is a stop codon following the SecM stalling motif where 
the ribosome is able to terminate translation. In these conditions the stalled ribosome does not have 
the time to re-organise the intergenic mRNA structure. When the cellular level of SecA decreases, 
SecM stalled- ribosomes can re-structure the mRNA, allowing a new ribosome to start translation of 
SecA downstream of SecM (Yap and Bernstein, 2011).  
 
 
1.4 Model for 2A Activity  
 
 
The first model to explain 2A activity was published by Ryan and co-workers (1999) and suggested 
that translation of the ORF started and progressed normally from a start codon up to the 2A [NPGP] 
stalling motif. The glycyl-prolyl peptide bond was not being made, the ribosome thus could terminate 
translation and the imbalance in products suggested that a proportion of the ribosomes stopped while 
others could carry translation further into the downstream sequence. In this study, computer generated 
modelling of several C-terminal 2A peptides revealed a tight turn at the [NPG] while the short 
eighteen amino acids FMDV 2A was predicted to adopt an α-helix.  
 
Ryan and co-workers (1999) mentioned that proline is structurally different from other amino acids. 
The nitrogen is engaged within a ring and is sterically constrained. The nitrogen of proline is a poor 
nucleophile. There are two prolines in the [NPG/P] motif therefore presumably allowing very little 
flexibility in the structural organisation of the 2A peptide into the ribosome exit tunnel. The glycine is 
also an unfavorable amino acid as its nitrogen is considered the second poorest nucleophile (Ryan et 
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al., 1999). These features are thought to play a critical role in 2A activity. At the peptidyl transferase 
centre (PTC) within the ribosome, the 2A nascent peptide linked to glycyl-tRNA is located in the P 
site. When prolyl-tRNA occupies the ribosome A site, the conformation of 2A in the ribosomal exit 
tunnel prevents peptide bond formation. 
 
Toeprint analyses confirmed that 2A acted upon translating ribosomes, and mapped the activity to be 
at the Gly-Pro pair (Doronina et al., 2008). Toeprint analysis also confirmed the hypothesis of a pause 
in translation. In this study, yeasts (strain sup45-2) with reduced release factor 1 (eRF1) activity at 34 
o
C, led to an increase in full-length products. In yeasts and yeast extracts with impaired release factor 
3 (eRF3) activity, there was a large reduction in the production of downstream and full-length 
product. This implied a rescue function for factors eRF1 and eRF3 (Doronina et al., 2008).  
 
Doronina and co workers (2008) proposed that the pause in elongation observed is related to 
dissociation of prolyl-tRNA from the A site. They argued that the unusual dissociation of prolyl-
tRNA from the A site following failure to generate the peptide bond, would leave a structural 
conformation, similar to a natural stop codon,  that can be a substrate for binding of the termination 
factors. 
 
Following the release of the nascent peptide, eRF1/3 would exit the A site, prolyl-tRNA re-enters the 
A site and the ribosome ingresses assisted by eEF2. One possible outcome is the dissociation of the 
ribosomal subunits which could also explain the imbalance in ratio between the product upstream of 
2A and the product downstream of 2A (the model is summarised in figure 1.8). 
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Figure 1.8: Model of the mechanism of 2A-induced ribosome stalling 
The assembled ribosome large and small subunits are represented containing the aminoacyl site (A), peptidyl site (P) and 
exit site (E), fitted with tRNA deacylated (-OH) or aminoacylated with Pro or Gly. The cartoon shows the possible step by 
step scenario for when a eukaryotic ribosome encounters the last Gly-Pro residues of the NPGP stalling motif of 2A.  
(Step a) peptidyl-tRNA is in A site and  
(step b) is translocated to the P site, prolyl-tRNA occupies A site. Interaction of the 2A structure within the ribosome exit 
tunnel and the tight turn at the last NPG residues, precludes peptide bond formation.  
(Step c) the prolyl-tRNA exits the ribosomal unit and  
(step d) the eRF1/3 complex enters the A sites and hydrolyses the ester bond linking the nascent peptide to tRNA in P site.  
(Step f) eRF1/3 leaves the A site. The nascent peptide is released.  
(Step g) prolyl-tRNA re-enters A site and  
(step h) is translocated to P site by eEF2.  
(step i) the next aa-tRNA enters the A site, peptide bond is formed and the mRNA sequence downstream of 2A is translated. 
(Figure provided by Prof. Ryan) 
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1.5 The translating ribosome, implications for 2A activity  
 
1.5.1 Elongation and peptide bond formation  
1.5.1.1 The ribosome 
 
The ribosome is a cellular organelle assembled from three (prokaryotes) or four (eukaryotes) 
molecules of RNA and proteins for the process of translating mRNAs into proteins (summary 
provided in table 1.4 and the structure of the assembled complex is provided in figure 1.9). It is 
assembled from two subunits: a large and a small. The number of proteins associated with the 
ribosome varies. However, the core of the ribosome where peptide bond formation occurs is 
conserved across all life and is composed of rRNA only (Nissen et al., 2000). It is thought that peptide 
bond formation is a conserved mechanism. The reactive centre or the peptidyl transferase centre 
(PTC) has been located in a deep cleft in domain V, the central loop (and equivalent in eukaryotes) of 
23S rRNA (Nissen et al., 2000).  
 
Table 1.4: Summative table of relevant prokaryotic and eukaryotic ribosome and translational 
features. 
(Adapted from Taylor et al., 2009, Harish and Caetano-Anollés, 2012 and Dever and Green, 2012). 
 Ribosomal element prokaryotic Eukaryotic 
homolog No homologies 
to prokaryotes 
Large 
subunit 
rRNA 23 S (2900 nts) 28 S (4800 nts)  
5 S (120 nts) 5 S (120nts)  
  5.8 S (160nts) 
Number of 
ribosomal proteins 
31 50 
Proteins associated 
with exit tunnel 
L22 L17  
L4 L4  
L23 L25  
L16 L10e  
  L38e 
Size 50 S 60 S 
Small 
subunit 
rRNA 16 S (1540 nts) 18 S (1900 nts)  
Number of 
ribosomal proteins 
21 33  
size 30 S 40 S  
Assembled ribosome size 70 S 80 S  
Elongation proteins EF-Tu EF1A  
 EF-G eEF2  
Termination factors 
Class I 
RF1 and 2  eRF1 
Termination factors 
Class II 
RF3  eRF3 
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Figure 1.9: Crystal structure of Thermus thermophilus 70S ribosome 
The 30S subunit is on the left, the 50S subunit is on the right. Peptidyl-tRNA is in orange and the mRNA is in green-yellow-
red, and is shown wrapped around the neck of the 30S subunit. The cross section also depicts an α-helical nascent peptide 
chain (green) in the exit tunnel. 23S is in grey and 16S in cyan (sourced from Noller, 2012 based on his early work Yusupov 
et al., 2001). 
 
 
 
The ribosome has three sites where the tRNA substrates can bind: the amino-acyl site at the decoding 
centre (A site) where new amino-acyl-tRNA (aa-tRNA) are fitted based upon their matching sequence 
to the mRNA codon triplet; the peptidyl site (P site) where the tRNA moves to after peptide bond 
formation has occured, thus leaving an empty A site ready to accommodate the next aa-tRNA; and the 
exit site (E site) where the deacylated tRNA is moved to before being ejected from the ribosome-
mRNA complex (Noller, 2012). The figure 1.10 shows tRNA features relevant to this project: the 
anticodon arm that interacts with specific mRNA codons and at the 3’ end The C74C75A76 arm (the 
CCA acceptor arm) which is the site of aminoacylation. 
 
 
35 
 
Figure 1.10: Schematic representation of features of the tRNA molecule 
Nucleotides are represented in dots. Of special interest for this study are: the anticodon arm that interacts with specific 
mRNA codons and the 3’ end, characterised by the CCA tri-nucleotides (the acceptor arm). The C74C75A76 arm is the site of 
aminoacylation by dedicated cellular tRNA synthesases and also plays a critical role in positioning amino acids for peptide 
bond formation (taken from Kazantsev and Pace, 2006). 
 
The elongation step on the ribosome involves a series of induced fit re-arrangements. Much of the 
elucidation of molecular mechanism comes from structural, cross-linking, antibiotics and mutational 
studies of the prokaryotic 70S ribosome. The movements have been characterised as ‘classical and 
hybrid states’ based upon the configurations of the tRNA species during elongation (figure 1.12).  
Upon entry in the A site the incoming aa-tRNA associated with EF-Tu adopts the A/T state where the 
CCA arm faces away from the PTC. After release of EF-Tu, the CCA arm swings towards the PTC. 
The aa-tRNA as well as the P site tRNA are then fully positioned in the ‘classical’ A/A, P/P and E/E 
state. After peptide bond formation, the tRNAs adopt the ‘hybrid’ state where their anticodon arms are 
still positioned in the A or P sites but their CCA arm has moved to the P or E sites (Noller, 2012). 
 
 
 
 
 
 
 
36 
1.5.1.2 Accommodation and selection of incoming aa-tRNA on the A site. 
 
Based on data from crystallography and FRET analyses, Rodnina and co-workers (2005) proposed a 
model for the aa-tRNA selection on the A site. The process involves two steps: the initial selection 
step and the proofreading step separated by GTP hydrolysis of EF-Tu (in bacteria) or EF1A (in 
eukaryotes).  
 
 
 
Figure 1.11:  Summary cartoon depicting activity at the ribosomal PTC  
(A)- The A site is selecting for a cognate aa-tRNA specified by an mRNA codon. The nascent peptide (in green) attached to 
the P site tRNA is protected (represented by spikes) from hydrolysis by water (orange dot) by a specific configuration of the 
PTC. 
(B)- When the cognate aa-tRNA is accommodated in the A site, the PTC is re-organised to allow peptide bond formation. 
The A and P sites tRNAs are represented in blue, the incoming amino acid in pink. (Created using information from 
Schmeing et al., 2005b). 
 
 
Aa-tRNAs are transferred to the ribosome A site in complex with the GTPase EF-Tu or EF1A. Single 
molecule FRET was used in a study to monitor the incorporation of amino acids from tRNA. The 
study provided evidence that the charged tRNA was at first labile in the A site (Blanchard et al., 
2004). Crystal structures provided complementary details. Discrimination of matching codon anti-
codon pairing is based on recognition of structural features. A suitable match triggers 30S subunit 
closure (Ogle et al., 2002) and a closed conformation activates EF-Tu for GTP hydrolysis (Ogle et al., 
2003). The GDP- bound factor looses affinity for its tRNA, dissociates and this in turn allows the aa-
tRNA to be fully accommodated in the A site and the PTC. At proofreading step, a mismatch can still 
be detected. The incorrect tRNA dissociates from the ribosome due to low stability or low rate of 
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accommodation whereas a correct charged-tRNA will be accommodated to the PTC (Rodnina et al., 
2005). 
 
From entering the ribosome coupled to EF-Tu, to adopting the right position for peptide bond 
formation, requires that the aa-tRNA CCA arm moves 70Å towards the PTC (Blanchard et al., 2004). 
A simulated study, aimed at retracing movements of aa-tRNA adaptation to the PTC from the A/T 
state to the A/A state suggested that the tRNA moved through a corridor made of twenty conserved 
nucleotides of the 23S rRNA. The authors also argue that a ‘gate’ of 23S rRNA nucleotides: 
U2492/C2556/C2573 configures the aa-tRNA CCA arm to facilitate bonding of the tRNA C75 to the 
23S rRNA base G2553 (Sanbonmatsu et al., 2005) (depicted in figure 1.10). The accommodation 
stage of the elongation step is considered the rate limiting step (Rodnina et al., 2005). 
 
Before peptidyl transfer, the A and P sites tRNAs are held in place by 23S rRNA. The CCA arms 
form interactions with the ribosome. In the P site, C74 is paired to G2251 and C75 to G2252 and the 
3’ A76 of P site tRNA interacts with the base-pair A2450-C2501 of 23S rRNA. The C75 of the CCA 
arm of A site tRNA is fixed by G2253 while the 3’ A76 form interactions with G2583 (Nissen et al., 
2000, Bashan et al., 2003, Schmeing et al., 2005). The core of the peptidyl centre (PTC) contains the 
following highly conserved nucleotides: A2451, U2506, U2585, C2452 and A2602 (Bashan et al., 
2003, Schmeing et al., 2005).  
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Figure 1.12: Overview of the elongation step on the 70S ribosome, the central role of peptidyl 
transfer in translocation 
The positions of the tRNAs on the ribosome are characterised by the position of their anticodon arms (paired to mRNA 
codon on the small subunit) in relation to their acceptor arms located within the large ribosomal subunit). The ribosome large 
subunit is in turquoise and the small subunit in gold.  
Before peptide bond formation, (I) the ribosome is in the classical state characterised by peptidyl tRNA (in green) in P/P and 
exit tRNA (in yellow) in E/E configuration. (II) New aa-tRNAs (in pink) delivered by EF-Tu (in red) are probed on the A 
site. The tRNA adopts the A/T state on the A site. Following accommodation, (III) EF-Tu GTPase activity is activated EF-
Tu departs. (IV) The tRNAs adopt the classical A/A and P/P configuration and (V) the peptide is transferred to A site tRNA. 
The peptide transfer to the A site tRNA is the essential step to trigger the ratcheting motion of the ribosome (VI), where the 
small subunit moves counter-clockwise to the large subunit. The tRNAs enter the hybrid A/P and P/E state. (VII) EF-G-GTP 
(in brown) binds the complex and is thought to stabilize and facilitate translocation. (VIII) Translocation is accompanied by 
the clockwise motion of the 30S subunit. After GTP hydrolysis, EF-G dissociates and the ribosome re-enters the classical 
P/P and E/E state. 
(Images sourced from Voorhees and Ramakrishnan, 2013) 
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1.5.1.3 Peptide bond formation and elongation 
 
 
Once the aa-tRNA is positioned in the PTC, peptide bond formation between NH2 group of the A site 
amino acid and the COOH group of the P site amino acid, occurs rapidly (Sievers et al., 2004). The 
elongation and peptidyl transfer steps are summarised in figure 1.12 and 1.13.  
 
The creation of the peptide bond between the amino group and the carboxy group of the last amino 
acid depends exclusively on the proximity of the groups. Many theories were put forward to explain 
the ribosome function. It was thought that the peptide bond formation could be attributed to a 
chemical reaction involving the ribosome nucleotides in domain V of 23S rRNA. Mutations of the 
nucleotides of the PTC A2451, U2506, U2585 and A2602 retained reaction to puromycin, a tRNA 
analogue (Polacek et al., 2001, Thompson et al., 2001, Hesslein et al., 2004, Youngman et al., 2004, 
Beringer et al., 2005). It was thought that ribosome proteins could participate in peptide bond 
formation, but mutagenesis, as well deproteination proved this theory wrong, also the theory of an 
acid base reaction involving a proton relay across the ribosome could not be demonstrated (Polacek et 
al., 2001, Beringer et al., 2003). It was however important that the interaction between C75 of the A 
site tRNA and G2553 in 23S rRNA stayed intact (Youngman et al., 2004, Brunelle et al., 2006).  
 
Based on crystallographic results, Schmeing and co-workers (2005) discovered that binding of a 
suitable substrate to the A site rearranges residues G2583, U2506 and U2585 such that the carbonyl 
carbon of the peptidyl-tRNA is oriented favourably for attack by an incoming nucleophile in the A 
site. The PTC structural re-arrangement is supported by X-ray data collected using analogues of tRNA 
acceptor arm in 50S subunits (Schmeing et al., 2005, Voorhees et al., 2009). 
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Figure 1.13: Activity at the catalytic pocket of the PTC 
In (a), the diagram shows the stabilising interactions between the CCA arm of aa-tRNA in the A site (shown in green) and 
23S rRNA (in blue). In (b), the interaction of the aa of A site tRNA to the 23S rRNA (in blue) and to the peptidyl-tRNA (in 
violet) is shown. In (c), the empty (in grey) and pre-peptidyl transfer (in blue) movements of the A sites nucleotides are 
characterised by shifts of A2584, U2585, U2506 and A2602. In (d), upon binding of the A site tRNA, the residue U2585 
exposes the P site tRNA ester for nucleophilic attack. (Images reproduced from Voorhees et al., 2009). 
 
Peptide bond formation proceeds through a nucleophilic attack of the A site aa-tRNA on the carbonyl 
carbon of the peptidyl-tRNA (figure 1.13 and 1.14). The reaction involves two intermediary steps: a 
tetrahedral intermediate (T+/-) and (T-) (figure 1.14).  
 
Figure 1.14: Peptide bond formation 
Attack of the amino group of the aa-tRNA at the A site to the carbonyl carbon of the peptidyl-tRNA at the P site, which 
results in formation of the intermediate (T+/-) (step 1). The intermediate is deprotonated to yield the (T-) intermediate (step 
2) and (step 3) the intermediate is broken down into the final product leaving a deacetylated tRNA in the P site and the 
peptidyl-tRNA with an additional amino acid in the A site (Picture reproduced from Rodnina, 2013). 
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Peptide bond formation results in the P site tRNA being deacylated. The peptide is transferred to the 
A site tRNA. This pre-translocational complex is the substrate for elongation factor G (or eEF2 in 
eukaryotic systems). EF-G derives energy from GTP hydrolysis and was thought to catalyse the 
translocation of the tRNAs, the mRNA and also promote conformational changes in the ribosome. 
Previous studies showed that the stimulation of the GTP hydrolysis of EF-G is accompanied by the 
clockwise rotation of the 30S and translocation (Zavialov and Ehrenberg, 2003). The exact 
participation of EF-G in translation is being re-assessed currently (Ermolenko and Noller, 2011). 
 
Ribosome subunits undergo a ratchet motion where the two subunits are in a counter-clockwise or 
clockwise rotation relative to each other (Franck and Agrawal, 2000). A recent publication by 
Ermolenko and Noller (2011) using FRET to monitor the rotation of the subunits in E. coli proved 
that the translocation occurs in two steps. First the translocation involves a counter-clockwise rotation 
that favours the hybrid A/P, P/E state for the tRNAs. Previous work also showed that the hybrid state 
adopted by the acceptor arms of the tRNA, the A/P and P/E state, is spontaneous in nature and does 
not require any other element (Moazed and Noller, 1989). Ermolenko and Noller (2011) however 
proved that this first spontaneous step is followed in a second time by the clockwise rotation of the 
subunits, independent of the EF-G and GTP hydrolysis and responsible for the movements of the 
tRNAs and the mRNA. The study does not volunteer much discussion about the actual role of EF-G. 
The body of the article does mention, however, that EF-G may be necessary to stabilise the hybrid 
state (Ermolenko and Noller, 2011). 
The current model for translocation however still retains the theory that the movement one codon 
forward is dictated by the formation of the peptide bond, as the ratcheting (counter-clockwise 
transition) does not occur without deacylated P site (Zavialov and Ehrenberg, 2003, and Valle et al., 
2003).  
 
1.5.2 Nascent peptides that influence the elongating ribosome 
 
Several nascent peptides (leader peptides or stop-peptides) form interactions with the ribosome exit 
tunnel and halt the translating ribosome. The mechanism of translation arrest was discovered to 
involve the regulation of expression of the downstream ORF:  
 for secretion (SecM, Nakatogawa and Ito, 2002) 
 amino acid metabolism (AAP, Gong et al, 2007) 
 antibiotic resistance (ermC, Vasquez-Laslop et al., 2008). 
Translation arrest can be brought about by mRNA secondary structure, co-effectors or not require any 
other elements outside the nascent peptide sequence. This section provides an up to date profile for 
four well studied stop peptides: ermC, SecM, TnaC and AAP. 
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1.5.2.1 Antibiotic resistance 
 
 
ermC, catA-86 and cmlA are resistance genes to macrolide antibiotics in bacteria. A well studied 
example in this category is resistance to erythromycin mediated by the ermCL operon. The ermCL 
cassette has two ORFs: the leading ORF ermL and a downstream regulated ORF ermC. The ErmC 
translation product is a methyltransferase able to dimethylate the amino group of nucleotide A2058, 
and therefore provides resistance. The erythromycin binding site is near ribosomal nucleotides A2058, 
G2057, C2611 (Vasquez-Laslop et al., 2008 ). Interaction of the antibiotic with ribosome translating 
the ermL mRNA causes translation arrest at a C-terminal specific peptide, nine amino acids long in a 
nineteen codon long ORF. Mutational analyses of the nine residues showed that the C-terminal IFVI 
motif was critical for arrest (Ramu et al., 2009). Conservative substitution of the last isoleucine to 
valine eliminated arrest. Erythromycin cannot mediate arrest by itself, but the combined effect 
antibiotic and stalling peptide leads to a retardation of the ribosome on the motif. In the absence of 
antibiotic the mRNA structure between the two ORFs prevents translation of the ORF 60bp 
downstream of ermL (see figure1.15). In the presence of antibiotic, ribosome translating the critical 
nine aa of ermL are stalled. This results in mRNA re-conformation and exposure of the ribosome 
binding site for ermC ORF. The nucleotide A2062 proved to be the key ribosomal element which 
changed from open to closed upon stalling, and mutations of this residue to C or U resulted in no 
induction by erythromycin (Vasquez-Laslop et al., 2008 ). 
 
 
 
Figure 1.15: Expression of ermCL  
In the absence of antibiotic erythromycin (panel A), the ribosome (represented in grey spheres with the exit tunnel in pink) 
translates ermL. The ribosome binding site (red rectangle) for ermC is shielded by mRNA secondary structure. In the 
presence of erythromycin (panel B), stalling leads to the re-arrangement of the mRNA secondary structure; exposing the 
ribosome binding site and allowing translation of ermC. 
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Analogous to ermCL, the catA and cmlA resistance operons are induced by the antibiotic 
chloramphenicol. This antibiotic inhibits translation at random, but the specificity is provided by a 
nascent peptide, five amino acids long (MVKTD) for catA and nine amino acids long for clmA 
(Rogers and Lovett, 1994 and Lovett and Rogers, 1996). Chloramphenicol binds in the vicinity of 23S 
rRNA C2452, A2062, and G2505 part of the PTC and the exit tunnel (Dunkle et al., 2010). 
 
 
1.5.2.2 SecM regulation of SecA expression 
 
 
SecM and SecA form a bicistronic operon. SecA is involved in protein secretion in E. coli. The leader 
region SecM encodes a 170aa protein constitutively expressed. At the N-terminal region SecM has a 
signal peptide recognised by the secretion machinery (by SecA) and at the C-terminal part a nascent 
stalling sequence. The SecA ORF translation is repressed by a secondary structure shielding the 
ribosome binding site. Cellular deficiency of SecA results in retardation of the ribosome on the SecM 
stalling motif resulting in melting of the secondary structure, exposure of the ribosome binding site 
and translation of the SecA ORF (Huber et al., 2011 and Yap and Bernstein, 2011). Mutational 
analysis of SecM showed that the critical residues were F150xxxxWIxxxxGIRAGP166. In this 
sequence x corresponds to residues where substitutions to alanine did not alter the activity of the 
sequence. The exact spacing between these residues is critical. In addition, SecM stalling involves a 
critical prolyl-tRNA in the A site (Nakatogawa and Ito, 2002). The arrest is caused by the ribosome’s 
inability to synthesise the Gly165 to Pro166 peptide bond, with the stalled complex attached to the 
tRNA in the P site (Muto et al., 2006) (summarised in figure 1.16). Using cryoEM, cross-linking and 
FRET studies, Woolhead and colleagues (2006) concluded that the SecM conformation within the 
tunnel is an essential element for stalling. The peptide adopts a compacted conformation, and the 
interaction between the nascent sequence and the tunnel leads to changes in both, that result in altered 
PTC activity. The absence of compaction in the C-terminal sequence results in decreased efficiencies 
to complete abolition of activity. Woolhead and co-workers (2006) concluded that the compaction 
could be regulated by the nature of the residues in the sequence and that the spacial location of key 
residues to face ribosome exit tunnel nucleotides was the essential element for SecM activity. A 
comparison of SecM residues in the genome of different bacteria demonstrated that Arg163 and 
Pro166 were the only absolutely necessary residues; Gly165, Ile 156 and Trp 155 would increase the 
arrest efficiency. Based on a sequence alignment the authors concluded that other variable residues in 
the SecM sequence served to create the conformation that fixes Arg163 to the tunnel (Yap and 
Bernstein, 2009). The ribosomal nucleotides required for SecM stalling are A2058, derived from 
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mutagenesis studies (Ito and Nakatogawa, 2002) A2062 and A2503 derived from cryoEM (Bushan et 
al., 2011).  
 
 
Figure 1.16: SecM regulation of SecA expression  
The ribosome is represented by two spheres and the tunnel appears in red. In (panel A), translation of SecM (green line) 
introduces a pause which normally is alleviated quickly by the pulling force exerted by the translocase secA (represented by 
a violet dot), the ribosome binding site (red rectangle) is shielded and unavailable to a translating ribosome. When the 
cellular level of SecA is limited (in panel (B)), the SecM-paused ribosome melts the mRNA secondary structure and exposes 
the ribosome binding site for SecA. SecA is translated (violet line and arrow). 
 
 
1.5.2.3  Regulation of tryptophanase expression  
 
 
Tryptophan (Trp) is a source of carbon and nitrogen for many bacteria, including E. coli. 
Tryptophanase is the main operating enzyme able to degrade tryptophan. The Trp operon consists of a 
leader sequence TnaC and two genes: TnaA and TnaB. Tryptophanase is the translational product of 
TnaA and its expression is under the regulation of the leader peptide TnaC. In E. coli, transcription 
and translation are coupled. The leading sequence TnaC is twenty-four codons long (translated to 
MNILHICVTSKWFNIDNKIVDHRP, red letters are the critical amino acids). The purpose of the 
stalling function is to mask or expose the rut site downstream of the translating TnaC ribosome. Since 
the rut site is the binding site for Rho termination factor, its availability determines the transcription 
of downstream TnaA and TnaB. There are two essential elements necessary for stalling, free 
tryptophan and the TnaC coding sequence (summarised in figure 1.17). When tryptophan is not 
abundant, TnaC translation stops at the stop codon, the rut site is free and Rho termination factor can 
bind and terminate transcription activity of DNA polymerase.With high levels of intracellular 
tryptophan, the coupled action of free tryptophan binding to the ribosome translating the TnaC motif 
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leads to ribosomal arrest. The rut site is sequestered and DNA polymerase carries transcription in the 
TnaA and TnaB regions of the operon (Yanofsky, 2007).  
 
 
 
Figure 1.17: Expression of the TnaA under regulation of TnaC and free Trp 
In normal levels of Trp in (panel (A)), the ribosome translating the TnaC mRNA terminates translation at the stop codon 
(represented by a red cross). Rho factor terminates transcription of the remaining operon TnaA and B. In panel (B), Trp 
(black dot) binds to the A site at the stop codon (red cross) of ribosome translating TnaC mRNA. The stalling complex hides 
the rut site so Rho termination factor can not bind. Transcription carries into the TnaA downstream region.  
 
The residues Trp12, Lys11 could be covalently cross-linked to nucleotide A750 and Trp12 protected 
against methylation of A788. Mutational analyses showed that ribosomal nucleotides U2609, A752 
and aa K90 of protein L22 were critical for stalling (Cruz-Vera et al., 2005). Puromycin as well as 
sparsomycin could not bind to the A site in the presence of free Trp for ribosome translating TnaC 
(Gong et al, 2007). The authors concluded that free Trp binds to the ribosome A site and induces an 
altered structure in the PTC. Deletions and insertions in the N-terminal region of TnaC have no effect. 
Trp12 is absolutely required, as no induction was observed with substitution of Trp12 for Arg. The 
correct spacing between Trp12 and Pro24 is also critical (Cruz-Vera et al., 2007). CryoEM study of 
the TnaC-ribosome interaction showed that although TnaC is unfolded, the nascent peptide makes 
contacts with the exit tunnel at many places, and Trp12 is located at the constriction point opposite the 
Arg92 of L22 protein and nucleotide A751 of 23S rRNA (Martinez et al., 2011). 
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1.5.2.4 Fungal arginine attenuator peptide (AAP) 
 
 
The stalling mechanism leads to repression of the expression of genes involved in the biosynthesis of 
arginine in Saccharomyces cerevisiae and Neurospora crassa in response to high levels of 
intracellular Arg. The CPA1 gene of S. cerevisiae and arg-2 gene of N. crassa are involved in 
synthesis of Arg. The 5’ end of their mRNA has a conserved ORF of twenty-four codons specifying 
the AAP leader peptide. In normal conditions, the ribosome translates the uORF and terminates at the 
stop codon. In high levels of free Arg, the leader peptide AAP and the binding of free Arg prevent 
termination and further elongation in the main ORF (Wang and Sachs, 1997). The stalling is linked to 
degradation of the mRNA (Gaba et al., 2001). The leader peptide can stall the eukaryotic ribosome in 
response to free Arg when placed into a polypeptide. The binding site for Arg has not yet been 
elucidated, but recent cryoEM studies (without occupied Arg) demonstrated that the C-terminus of 
AAP interacts with the ribosome exit tunnel as well as with the proteins L4 and L22. The PTC 
conformation had an altered geometry, which the authors concluded would be adversely affecting the 
release factor activity (Bhushan et al., 2010).  
The stalling sequence is: MNGRPSVFTSQDYLSDHLWRALNA, (the letters in red represent the 
critical aa and the blue letters aa for which substitution reduces activity) (Delbecq et al., 2000). 
The ribosomal nucleotides in proximity to the important residues are: U2585/A2062, U2609, A2058 
and A751 as well as the residue Arg136 from protein L17 (Bhushan et al., 2010) 
 
1.5.3 Implications for 2A activity 
 
The model for 2A activity predicts that a peptide bond cannot be formed and suggests the formation 
of a α-helix in the tunnel, yet no two 2A sequences are alike and some do not have a predicted helical 
conformation; this is the subject of chapter 4. Why is the peptide bond not formed? In the light of the 
ribosome dynamic nature, and compaction of some of the other stop peptides, the theory of a 
structural pattern adopted to stall the ribosome could be true. 
There are several aspects of translation which could be the ‘target’ for 2A activity: 
 the local organisation of the mRNA at the A site and the abundance of the tRNA specified 
 the conformation of the nascent peptide in the tunnel 
 the presence of elongation and release factors 
 and the identity of the amino acid in the ribosome A and P site. 
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1.6 Outline of this thesis 
 
Nascent peptides able to stall the translating ribosome have been characterised by mutational analysis 
of the stalling peptide (successive alanine substitution, spacing between important residues and 
conservative/ non-conservative mutations), mutational analysis of the ribosome residues, the 
reactivity of the peptidyl-tRNA in the P site to puromycin and structural resolution generally by 
cryoEM of the ribosome bound peptide. In addition other relevant and applicable molecular analyses 
have also been performed. The aim of this project was to carry out some of these characterisations. 
 
Although many studies were focused on identifying new 2A sequences, scanning mutagenesis has 
never been performed. In chapter 4, mutation was carried out on the consensus motif of TaV and the 
upstream context of FMDV, TaV and DHV 2As. This study revealed several features of 2As. The 
upstream context immediately preceeding the consensus motif is critical for stalling. The results 
suggest that 2A likely adopts different stalling mechanisms. One mechanism precludes a helical 
structure and favours the hypothesis of interactive partnership with the tunnel, whereas for the second 
mechanism a compaction or helical structure may be part of the mechanism.  
Chapter 5 presents other in vitro characterisations of 2A-induced ribosome stalling. The main 
characteristic of 2A is an altered PTC leading to a restrictive A site. 
It was previously shown that eRF1 and 3 were somehow linked to the re-initiation step after 2A-
mediated stalling at the glycine codon. A method employing a visual reporter for cellular stress was 
tested, and was not successful and summarised in chapter 3.The discussion of this chapter focusses on 
the experimental conditions necessary to study the function eRF1 and 3 may have in rescuing the 
stalled ribosome.  
And finally, in chapter 6, evidence is provided for the presence of 2A in two cellular organisms: 
Saccoglossus kowalevskii and Branchiostoma floridae. Notably, the 2A element was identified at the 
N-terminus of two clades of non-LTR retrotransposons in B. floridae.  
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2.1 Solutions, bacterial strains and enzymes 
 
For preparation of media as well as reagents, water was deionised and sterilised. Heat-sensitive 
solutions were filtered using Millex 0.2 μm syringe filters (Millipore, PES membrane). Chemicals 
were purchased from various sources, mainly Sigma-Aldrich and were at least of analytical grade.  
 
2.1.1 Solutions, media and other reagents 
 
Standard molecular stock solutions were prepared following standard protocols (Sambrook et al., 
1989).  
- 50  TAE (2 M Tris-base, 0.05 M EDTA pH 8.0, adjusted to pH 7.8 with glacial acetic acid 
- 10 and 40 %(w/v) glycerol stock filtered sterilised. 
-  DNA gel loading buffer type III (30 %(w/v) glycerol, 0.25 %(w/v) bromophenol blue and 0.25 % 
(w/v) of xylene cyanol, stored at 20
o
C). 
- 100 mg/ml ampicillin stock filtered and stored at 20 
o
C and added to media to a working 
concentration of 1 μg/ml. 
- 0.1 M IPTG, working concentration of 0.1 mM (E. coli blue/white screening), 0.4 mM or 1 mM (for 
bacterial protein expression). 
- 50 mg/ml XGal, dissolved in DMSO, filtered, wrapped in foil and stored at 20 
o
C, added to final 
concentration of 40 μg/ml. 
- 1 %(w/v) agarose gel for routine DNA analysis was sourced from Biogene and for DNA gel 
extraction low melting point Seakem LE agarose from Cambrex was used. 
- 2  SDS loading dye (0.5 M Tris-HCl pH 6.8, 4.4 %(w/v) SDS, 20 %(v/v) glycerol, 2 %(v/v) 2-
mercaptoethanol, and 20 %(w/v) bromophenol blue). 
- 1 M potassium phosphate adjusted to pH 6 (132 ml of 1M K2HPO4 + 868 ml 1M KH2PO4) 
- 20 %(w/v) biotin (made fresh and filtered sterilised). 
- 20 %(w/v) dextrose, filter-sterilised. 
- 13.4 %(w/v) yeast nitrogen base with ammonium sulfate and without amino acids, filter-sterilised. 
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- 1 %(w/v) yeast extract -2 %(w/v) peptone for Pichia pastoris culture was disolved in water and 
autoclaved. Yeast extract and peptone were purchased from Oxoid. 
- Luria Bertani (LB) broth and 1 % (w/v) agar for bacterial culture were purchased from the university 
store. 
- dNTPs were purchased from Promega and aliquoted in 10 μl volume, stored at 20 oC and used 
only once when thawed. Molecular weight markers used were 1 kb marker and 100 bp step ladder 
from Promega. Ethidium bromide at 10 mg/ml for DNA visualisation was also supplied by Promega. 
- DMEM, fetal calf serum (FCS), trypsin and PBS were purchased form the university stores. 
- Optimem was sourced from Gibco. 
- Cell transfection reagent PEI (40 000 Da, from polysciences) was diluted in HEPES pH 7 at 1 mg/ml 
at 20
o
C, and filter-sterilised in sterile environment and stored at 20
o
C. Other transfection reagents 
were lipofectamine 2000 (Invitrogen) and fugene 6 (Promega). 
- CelLytic for cell lysis was purchasd from Sigma. 
- Restore western blot stripping buffer was purchased from Thermo Scientific. 
- Protein marker precision plus protein standard was purchased from Biorad. 
- PBST solution for western blot 0.5 % (v/v) tween 20 dissolved in PBS. 
 
2.1.2 Bacterial strains and cell lines 
 
Escherichia coli strain used for all routine bacterial transformation was JM109, genotype: endA1, 
recA1, gyrA96, thi, hsdR17 (rk
–
, mk
+
), relA1, supE44, Δ( lac-proAB), 
 [F´ traD36, proAB, laqI
qZΔM15]. 
 
DE3 strains for protein expression (from this laboratory stock or kind gift from Prof. Naismith 
laboratory)  
BLl21: F
–
 ompT gal dcm lon hsdSB (rB
-
 mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5].  
BL21*: F
-
ompT hsdSB (rB
-
, mB
-
) gal dcm rne131 (DE3) 
C43: F
-
 ompT hsdSB (rB
-
 mB
-
) gal dcm (DE3) 
Origami: Δ(ara-leu)7697 ΔlacX74 ΔphoA PvuII phoR araD139 ahpC galE galK rpsLF′[lac+ lacIq 
pro] (DE3)gor522::Tn10 trxB (Kan
R
, Str
R
, Tet
R
) 
Rosetta: F
-
 ompT hsdSB(RB
-
 mB
-) gal dcm λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
pLysSRARE (Cam
R
) 
TUNR: F
–
 ompT hsdSB (rB
–
 mB
–
) gal dcm lacY1(DE3) 
BLR: F
-
 ompT hsdSB(rB
-
 mB
-
) gal dcm (DE3) Δ(srl-recA)306::Tn10 pLysS (CamR, TetR) 
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Mammalian cells: fibroblast cells baby hamster kidney cells BHK21, human tumour cells HeLa  
(kindly provided by Prof. Elliott’s group) and human embryonic kidney cells 293T (a kind gift from 
Prof Randall) and bovine lung cell (EBL) from this laboratory stock were revived and maintained 
through continuous passing. 
 
 
2.1.3 Enzymes, antibodies and kits 
 
Routine PCR were performed with GoTaq DNA polymerase (Promega), amplification of fragments 
for cloning purposes were performed with platinum DNA polymerase (Invitrogen) and PCR for 
mutagenesis purposes were carried out using the KOD Hot Start polymerase mix (Novagen). 
 
Enzymes for DNA restriction digests were purchased from Fermentas and New England Biolabs. 
Primers were ordered individually from IDTDNA and resuspended in sterile water to a concentration 
of 100 pM for PCR for cloning purpose, 100 ng/µl for mutagenesis purpose and 32 pM for sequencing 
reactions. The relevant primers for each study are mentioned in the related chapters. Sequencings 
were outsourced from Dundee sequencing services. 
 
For routine DNA extraction, QIAprep Spin miniprep Kit and HiSpeed Qiagen maxi prep. 
For purification of PCR fragments from gel the Wizard SV gel and PCR clean up (Promega) was 
selected. For thymine-adenine cloning, the pGEM-T system was selected (Promega). All other 
ligations were carried out using the T4 DNA ligase kit (Promega). 
 
Cell-free systems for protein expression: T7 quick coupled transcription- translation system was used 
for routine analysis of novel 2A and mutants (Promega). The T7 coupled version of this system was 
used to incorporate analogs of proline. T7 insect cell-free system (Promega) was used to test for the 
viability of constructs for bacterial expression. 
 
The Pichia pastoris PichiaPink expression system (Invitrogen) was selected for expression of 2A. 
 
SDS-PAGE protein analyses were run with the Nu-PAGE 10 % Bis-Tris 1.0 mm, 12 wells Gel and 
MES buffers from Invitrogen or the RunBlue pre-cast 4-20 % , 12 wells and Tris-tricine-SDS buffer 
from Expedeon. ECL solutions kit for chemiluminescence was purchased from Amersham 
Biosciences. BCA (Bicinchoninic acid) protein assay kit for microscale determination of protein 
concentration was purchased from Novagen. 
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Table 2.1: List of antibodies 
 
Antibody  Target protein source 
Anti- His  His tagged expressed proteins Sigma 
Anti V5  V5 tagged expressed proteins Kindly provided by Prof. Randall  
Anti eEF2 Elongation factor 2 Cell signalling 
Anti 2A 2A  This laboratory stock 
Anti βtubulin β tubulin Roche Diagnostic 
Secondary antibodies: 
Anti mouse or rabbit 
HRP  
Mouse or rabbit primary antibody Dako 
 
 
 
Table 2.2: List of equipment  
 
Function Equipment Supplier 
PCR GeneAmpPCR system 9700 Applied biosystems 
DNA gel electrophoresis Horizon 11-14 Life Technologies 
 Allegra 21
R
 centrifuge Beckman Coulter 
Cell/ bacterial cultures Sterile 96 and 6 -well plates Greiner Bio-one 
Sterile flasks 
Sterile Petri dishes 
Incubator: Hera cell 150 Thermo Electron Corporation 
Microscopy Evos fl AMG micro 
 Delta vision  Applied Precision 
Electroporation Gene Pulser Xcell Biorad 
Protein transfer to membrane iBlot transfer Invitrogen 
microplate reader Infinite M200 Pro Tecan 
Protein electrophoresis and gel 
analysis 
XCell SureLock™ Novex Mini-
Cell 
Invitrogen 
Model 583 gel drier Biorad 
Kodak X-OMAT 1000 
processor 
Kodak 
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2.2 Protocols  
 
2.2.1 Polymerase chain reaction (PCR) 
 
PCR was routinely used to amplify small quantities of a segment of DNA, insert restriction sites or 
create novel 2A sequences at the 3’ or 5’ end of a DNA template. The specific pairs of primers are 
detailed in the material and method sections of each of the result chapters. 
 
For cloning purposes, PCR were performed using platinum DNA polymerase, which has 5’3’ 
exonuclease activity, as well terminal transferase activity and uses the following 10  buffer (600 mM 
Tris-SO4 (pH 8.9), 180 mM (NH4)2SO4). The PCR amplified products carrying additional adenosine 
triphosphate residues are suitable for cloning to vectors with thymine-overhangs such as pGEM-T. 
 
For routine analytical procedures, the GoTaq polymerase was used with the proprietary buffer 
supplied.  
 
The annealing temperature was estimated by subtracting 10 
o
C from the melting temperature (supplied 
by the manufacturer) of a primer pair. The reaction mixtures were set in 200 μl eppendorfs in a total 
volume of 50 μl, using 200 ng of plasmid DNA as template. Each reaction contained also, 5 μl of 10  
reaction buffer, 1 μl forward primer at 100 pM, 1μl reverse primer at 100 pM, 1 μl dNTP mix, 1 μl of 
DNA polymerase at 2.0 U/μl, and sterile water to a final volume of 50 μl.  
 
The samples were subjected to the following cycling programme: 94 
o
C for 2 min, 25 cycles of 94 
o
C 
(30 s), annealing temperature (55 to 68 
o
C) (30 s) and 72 
o
C (1 min for 1kb of product size) and a final 
prolonged extension of 7 min at 72
o
C.  
 
For mutagenesis, the reaction mixtures were set in a total volume of 20 μl using 10 ng of plasmid 
DNA as template, 1 μl of 100 ng/μl of forward and reverse primers, and 0.04 U of KOD (10 μl of 
mix). KOD creates blunt end fragments and has high fidelity and high processivity. The PCR 
programme was reduced to 18 cycles and the extension time adjusted to the size of the plasmid on the 
basis of 25 s/Kbp. The template DNA was then digested with restriction enzyme 1 µl of Dpn1 for 1h 
at 37 
o
C, the restriction enzyme was subsequently inactivated at 70 
o
C for 10 min. 
  
The PCR products were then visualised on 1 %(w/v) agarose gel. 
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2.2.2 DNA gel electrophoresis and gel extraction 
 
DNA samples were analysed by gel electrophoresis. Agarose to give a 1 %(w/v) solution was 
dissolved in TAE buffer. Routinely, gels were run at 100 V in horizontal gel tanks. For visualisation 
of DNA under UV light, 7 μl of ethidium bromide was added to 100 ml of agarose solution before 
pouring. 2 μl of 6  DNA gel loading buffer was added to 10 μl of sample before loading onto gel.  
To perform a DNA agarose gel extraction, the same protocol as previously described was followed 
using a low melting point agarose gel instead. The DNA segment of interest was excised using a clean 
disposable scalpel. Gel slices were placed in a previously weighed eppendorf tube and dissolved 
according to the protocol for Wizard, SV gel and PCR clean up. The DNA was resuspended in 50 μl 
of water and stored at 20 
o
C.  
 
 
2.2.3 Enzymatic restriction digestions 
 
Restriction enzymes were employed following the recommendations specified by suppliers, for 
buffers and active temperatures.  
Routinely, 1 μg of DNA was digested with 1 U of enzyme. 5 to 10 μg of DNA were used for 
preparative double digestions (set in 20 μl) and 500 ng for routine analysis (set in 10 μl). The 
reactions were incubated for 2 h at optimum temperature (generally at 37 
o
C), before analysis by gel 
electrophoresis. 
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2.2.4 TA cloning in pGEM-T-easy 
 
pGEM-T vector contains a thymine overhang able to anneal to the adenine overhang added to the 
PCR product by DNA polymerases such as Taq. In addition the pGEM-T vector has T7 and SP6 RNA 
polymerase promoters flanking a multiple cloning region with also the α-peptide coding region for β- 
galactosidase. Insertional inactivation of the α-peptide allows for white/blue selection of 
recombinants. 
 
 
Figure 2.1: Map of pGEM-T vector. (Sourced from http://www.promega.com) 
 
3 μl of the PCR product gel purified was added to a ligation mixture. A positive control (using a 
segment of DNA provided by manufacturer) as well as a negative control (with no insert) was set up 
in parallel. Ligations were set to a final volume of 10 μl. The reactions were incubated o/n at 4 oC to 
maximise ligation yields. 
 
The E. coli JM109 transformation protocol is described in section 2.2.6, when using pGEM-T 
mixtures, LB agar - ampicillin plates were also supplemented with IPTG and X-Gal, before 
incubation at 37 
o
C o/n. The transformed clones, white in colour, were picked and incubated in LB 
broth-ampicillin o/n.  
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2.2.5 T4 DNA Ligation 
 
Vectors and inserts concentrations were estimated visually by gel electrophoresis. A ratio of 1:3, 
vector: insert was used. The ligation mixtures containing vector and insert DNAs, 10 U of T4 DNA 
ligase and 10  ligase buffer were set up in a total volume of 10 μl and incubated o/n at 4 oC.  
 
2.2.6 Transformation by heat shock of competent E. coli strains. 
 
Transformation of competent E. coli strains were carried out by adding plasmid DNA or ligation 
mixtures to 50 μl cells. After 20 min of incubation on ice, cells were heat-shocked at 42 oC for 50 s 
and returned to ice for 2 min before addition of 950 ml LB broth. The cells were incubated at 37 
o
C 
for 90 min. 100 μl of cells were spread onto LB agar plate containing ampicillin and incubated o/n at 
37 
o
C. Several transformed colonies were transferred with disposable loops to 10 ml LB broth-
ampicillin and incubated o/n at 37 
o
C, shaking at 200 rpm. For the purpose of DNA extraction, the 
bacteria were harvested by centrifugation at 3000 rpm for 10 min. 
 
For the purpose of preservation, at 80 
o
C as 20 %(v/v) glycerol stocks, 500 μl of culture was 
aliquoted into a sterile eppendorf containing 500 μl of 50 % (v/v) glycerol. 
 
2.2.7 Plasmid DNA extraction and sequencing 
 
Plasmid DNA was extracted using either Qiagen plasmid mini kit for routine analysis or Qiagen Hi-
speed maxi kit. DNA extractions were carried out following the manufacturers’ protocols.  
Purity and concentration of DNA were assessed spectrophotometrically with absorbencies of samples 
measured at 260 and 280 nm. 
Plasmid DNA were extracted and restricted with appropriate enzymes to identify correct clones. 
Sequencing reactions were outsourced to Dundee sequencing services, using either T7 or SP6 
promoter to initiate the thermal cycling. Sequencing was performed with 600 ng of sample plasmid 
DNA and 3.2 μM primers. Once available the sequence of each clone was aligned against the 
expected construct using DNAMAN software. 
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2.2.8 Protein expression in E. coli.  
 
Several human translation factors: eEF2, elongation factor 2 kinase (eEF2-K), eRF1 and eRF3 were 
previously cloned in TOPO system by previous members of this laboratory. 
The TOPO vector has C-terminal V5 and polyhistidine tags and is suitable for IPTG induction of 
protein expression in DE3 bacterial strains. They were transformed in E. coli following the protocol in 
section 2.2.6.  
 
 
Figure 2.2: Map of TOPO vector. 
T7 promoter, Lac operator (lacO), ribosome binding site (RBS), TOPO cloning sites for directional cloning of PCR products 
with CACC overhang, V5 epitope, polyhistidine (6xHis) region for affinity purification, T7 transcription termination region, 
ampicillin resistance gene. (Vector map sourced from http://www.lifetechnologies.com) 
 
10 ml of LB- ampicillin was inoculated with one colony and cultured o/n at 37 
o
C. 10 ml of LB-
ampicillin was inoculated with 100 µl of the o/n culture and further incubated until the OD600nm 
reached 0.6. Expression was induced with either 0.4 or 1 mM IPTG. Negative controls were preprared 
the same way and run in parallel but not supplemented with IPTG.  
The bacterial suspensions were cultivated further for 4 h and subsequently harvested at 3000 rpm for 
10 min. The supernatants were discarded and the cells resuspended in 1 ml of PBS to which was 
previously added a protease inhibitor tablet (Roche). The cells were sonicated for 10 s twice and 
centrifuged at 16 000 rpm for 10 min at 4 
o
C to separate the cellular debris from the soluble fraction. 
The protocol was repeated for three induction temperatures: 16 
o
C, 24 
o
C and 37 
o
C. 
3 µl of supernatant were analysed for protein expression on Coomassie-stained SDS-PAGE gels and 
western blot analysis.  
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2.2.9 Protein expression in eukaryotic cell-free systems 
 
The rabbit reticulocyte lysate system (Promega) provides an in vitro eukaryotic expression system for 
proteins. The quick coupled transcription translation uses plasmid DNA with a T7 promoter. The 
coupled system version offers the flexibility for modifying the amino acid content. The T7 insect cell-
free (ICE) system (Promega) also provides a simplified eukaryotic system for expression of proteins.  
The reaction mixtures were set up following the manufacturer instructions. For rabbit reticulocytes 
lysates, proteins were radiolabelled using [
35
 S]- methionine (10 μCi/μl). 200 ng of a plasmid 
preparation was added to the TnT reaction mixture to a final volume of 11.5 μl and incubated at 30 oC 
for 60 min. For T7 ICE reactions, 2 µg DNA was added and incubated for 4 h at 30 
o
C, without 
radiolabels to a final reaction volume of 50 µl. 5 μl of the translation reactions were resolved by SDS-
PAGE and western blot (section 2.2.16). 
 
 
2.2.10 2A expression in Pichia pastoris 
 
 
 
The growth media were prepared according to the manufacturer’s protocols, the kit included some of 
the media, and the others were purchased separately from Invitrogen. 
The YPD medium to culture P. pastoris strains and the selection medium PAD (pichia adenine drop-
out) lacking adenine were part of the kit. After dissolution in water and autoclaving, the media were 
supplemented with 100 ml of 20 %(w/v) dextrose.  
1 l of starter medium BMGY was made with 700 ml sterilised 1 %(w/v) yeast extract and 2 %(w/v) 
peptone, 100 ml 1 M potassium phosphate at pH 6, 100 ml 10 %(v/v) glycerol, 20 ml biotin solution 
and 100 ml of YNB without amino acids.  
 
1 l of induction medium was made with 700 ml sterilised 1 %(w/v) yeast extract and 2 %(w/v) 
peptone, 100 ml 1 M potassium phosphate at pH 6, 100 ml 5 %(v/v) methanol (filter-sterilised), 20 ml 
of biotin solution and 100 ml YNB without amino acids.  
 
 
 
58 
 
Figure 2.3: Experimental outline for protein expression in Invitrogen PichiaPink system.  
 
 
Preparing electrocompetent PichiaPink strains, electroporation and selection 
 
YPD agar plates were inoculated with PichiaPink strain 4 and incubated at 30 
o
C for 3 days until 
colonies were formed. 10 ml of YPD media was inoculated with 1 colony and incubated in a shaking 
incubator for 24 h at 300 rpm. The starter culture was transferred to 100 ml of YPD media in a 1 litre 
flask to a OD600nm of 0.2. When the OD reached 1.3- 1.5, the yeasts were harvested at 4500 rpm at 4 
o
C for 5 min, the supernatant was discarded and the cells re-suspended in 250 ml ice-cold sterile 
water.  
The cells were subjected to several centrifugations at 4500 rpm for 5 min and at 4 
o
C. The supernatant 
each time was discarded and cells were resuspended serially in 50 ml of ice-cold sterile water, 10 ml 
ice-cold 1 M sorbitol and finally in ice-cold 1 M sorbitol to a final volume of 500 μl. 
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PichiaPink strains were prepared freshly prior to electroporation. 80 μl of electrocompetent cells were 
mixed with 10 μg Spe1 linearized vector, transferred to a 0.2 cm electroporation cuvette pre-chilled 
and incubated on ice for 5 min. The cuvettes were pulsed in Biorad gene pulser Xcell with the 
following settings: 2 kV, 25 Ω, 200 μF. 1 ml of the pre-chilled YPD was added and the cells were 
further incubated at 30 
oC for 2 h without shaking. 100 and 300 μl were spread onto a PAD selection 
plate and incubated at 30 
o
C for 3 to 7 days until individual colonies started to form. Single white 
colonies were selected and re-plated on fresh PAD agar and cultured under the same conditions.  
 
 
Extraction of DNA and PCR of transformants 
 
Extraction of DNA was performed using the YeaStar Genomic DNA kit, following the instructions 
for protocol 1. Single colonies were cultured in 1 ml YPD medium for 5 h, the cells were collected by 
centrifugation at 4500 rpm for 2 min. The supernatant was discarded. 120 μl of digestion buffer and 8 
μl of R-zymolase were added to the pellet. The mixture was vortexed and incubated for 1 h at 37 oC. 
250 μl of chloroform was added and mixed for 1 min before proceeding further to the routine DNA 
extraction protocol, with the columns provided. The genomic DNA was subjected to a PCR and 
electrophoresis as described in section 2.2.1. 
 
 
Small scale expression of recombinant strains 
 
A single colony was used to inoculate 10 ml of BMGY medium in a 500 ml sterile flask. The cultures 
were grown for 24 h in a 24 
o
C incubator set to 300 rpm. The cells were harvested at 4500 rpm for 5 
min at room temperature, and resuspended in 1 ml of induction media BMMY and cultivated o/n. 100 
μl was removed from the samples and 100 μl of 40 %(v/v) methanol added and let to continue to grow 
for another 16 h. Cells were centrifuged for 10 min at 4500 rpm. The supernatant fractions were 
analysed for protein expression by western blot analysis. 
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2.2.11 Mammalian cell culture  
 
DMEM-10 %(v/v) FCS media, trypsin and PBSA were stored at 4 
o
C, these were then pre-warmed to 
37 
o
C for 1 h before usage. The old media from the cells were aspirated under sterile conditions. The 
cells were then washed with PBSA, trypsin was added (1 ml or 2 ml depending on the size of the 
container) and the flask placed in incubator until cells were seen floating. To ensure that these were 
individually separated, the flasks were tapped against a hard surface. 3 ml for T25 or 8 ml for a T75 of 
DMEM-10 %(v/v) FCS media were added and pipetted up and down a few times. The cells were 
either grown further in a flask or in a sterile 96-well, or 6-well plates.  
1 ml of the cells was used to seed 9 ml of DMEM-10 %(v/v) FCS, and cultured in a new T25 or T75 
sterile flask for maintenance. The culture was incubated for 3 days at 37 
o
C, 5 % CO2, in a humidified 
incubator. The cell maintenance protocol was repeated every 3 days up to 30 times, before new cells 
were thawed from a 80 
o
C stock. 
96-well plates were seeded with 20 10
4
 cells per well, 6-well plates were seeded with 60 10
4
 cells 
for functional assays and were incubated for 24 h before transfection. 
 
2.2.12 Transient transfections of mammalian cells 
 
Transfection enables the introduction of negatively charged molecules such as DNA into cells without 
using a virus. Confluency of cells was assessed visually under microscope. The following protocols 
required cells to be about 50 % confluent. 
 
Using PEI, 5 μg of plasmid DNA of interest was mixed with 600 μl DMEM (serum free) pre-warmed 
for 1 h at 37 
o
C. 15 μl of 1 mg/ml PEI solution (ratio of 1:3 of DNA: PEI) was added and the mixture 
vortexed for 5 s and incubated at room temperature for 30 min to form the miscelleous complex PEI-
DNA. 100 μl of PEI-DNA mix was then added drop-wise to each well to a six-well plate, and swirled 
to gently mix.  
Lipofectamine 2000 required 1.5 μg of DNA per well for a 60 mm petri dish. 200 μl of Opti-MEM 
was mixed with 5 μl of lipofectamine, incubated for 5 min. In parallel 200 μl of Opti-MEM was 
mixed with 1.5 μg of plasmid DNA of interest. The two mixtures were combined and incubated for 15 
min at RT, before being added drop-wise to a 60 mm petri dish. 
Using Fugene 6, 6 μl of Fugene 6 was diluted into 90 μl of serum free DMEM and incubated for 5 
min at RT. 2 μg of plasmid DNA was added and incubated for a further 15 min.  
The plates were returned to the 37 
o
C, 5 % CO2 humidified incubator for 24 h and the outcome of 
transfection assessed by microscopy. Alternatively, the cells were also harvested for western blot 
analysis. 
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2.2.13 Establishing HeLa stable cell lines with lentiviral vectors. 
 
Lentiviruses allow for the long term study of transfected cells as they rapidly and stabily integrate the 
genome of a broad range of cells.  
 
Three vectors were co-transfected in 293T cell, cultured in 75 cm
2
 flask 50 % confluent. The co-
transfection was carried out as described in section 2.2.13. For a 75 cm
2
 flask, 33 μl of Fugene 6 was 
added to 467 μl of serum-free DMEM. 3 μg of the envelop vector (VSV-G), 3 μg of the packaging 
vector (CMV) and 5 μg of the transfer vector (carrying antibiotic selection and the insert of interest) 
were added to the mix. Post-infection, the medium from the cells were collected and another 10 ml of 
DMEM-10 %(v/v) FCS added. After 24 h, the medium was collected. The cellular debris were 
removed by centrifugation for 15 min at 3500 rpm. The supernatant was filter-sterilised and aliquoted 
in 1 ml vials and stored at 80 
o
C. 
 
Infection by lentiviruses was performed on 30 to 50 % confluent HeLa cells. For a 25 cm
2
 flask, 1 ml 
of lentivirus aliquot was added to 1 ml serum-free DMEM, supplemented with polybrene to a working 
concentration of 8 μg/ml. The mixture was pipetted in a pre-emptied flask of HeLa cells and left to 
rock for 2 h at 37 
o
C. 2 ml of 10 %(v/v) FCS DMEM was subsequently added and the cells incubated 
for 2 days before puromycin was added to select for transformants. 
 
 
2.2.14 Fixing cells for microscopy and imaging 
 
Sterile coverslips were placed at the bottom of individual wells of a six-well plate. After 24 h the cells 
were treated or transfected and returned to their experimental conditions. After a further 24 h, the 
media was discarded, the well washed twice with pre-warmed PBS and 3 ml of 5 %(v/v) 
formaldehyde was added to fix the cells to the coverslip. The formaldehyde was aspirated and the well 
washed several times with PBS. With a pair of tweezers, the coverslips were removed and placed onto 
glass slides so that the cell surface was in contact with 15 μl of Mowiol-Dapi mounting solution. The 
coverslips were left in the dark on a flat surface. The fixed cells were visualised with the DeltaVision 
microscope (Applied Precision). This system consists of a light source (X-cite 120Q lamp), an 
inverted microscope, a 100 oil immersion objective and the softWoRx software package for 
capturing and processing high resolution static images. The DeltaVision permits the observation of 
micro-anatomical details and the use of multiple filters. Fluorescences were detected with an 
excitation wavelength of 488 nm for GFP (FITC filter), 587 nm for cherryFP (RFP filter) and 350 nm 
for Dapi (DAPI filter).  
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2.2.15 Mammalian cell lysis for protein analysis 
 
The media were aspirated from the cell cultures and the cells were washed with pre-warmed PBS 3 
times. The cells were scrapped and incubated for 15 min on a rocking shaker with 200 μl (for a six-
well plate) or 400 μl (for 60 mm dish) of celLytic buffer (Sigma) which was supplemented with 
PhosStop and mini-complete tablets inhibitors for phosphatases and proteases (Roche). The cellular 
debris were removed by centrifugation at 7.500 rpm for 15 min at 4 
o
C. The supernatant was stored at 
80 
o
C and analysed by western blot.  
 
2.2.16 Protein analysis 
 
2.2.16.1 SDS-PAGE analysis 
 
5 μl of samples were mixed with an equivalent volume of 2  SDS-loading buffer. The samples were 
further incubated at 94 
o
C for 2 min and returned to room-temperature before being loaded onto the 
SDS-PAGE gel. Cell extracts and bacterial cultures supernatants were loaded onto a NuPage 10 % 
SDS gel (Invitrogen). Rabbit reticulocyte lysates reaction samples were run onto a 4-20 % RunBlue 
SDS-PAGE gel (Expedeon).  
The gels were Coomassie stained with InstantBlue (Expedeon), following the manufacturer’s 
recommendation. Alternatively the gels were dried for 30 min and radioactively labelled proteins 
exposed to a photographic film o/n. 
 
2.2.16.2 Western blot analysis 
 
Proteins resolved by SDS-PAGE electrophoresis were transferred to a nitrocellulose membrane using 
the iBlot transfer system (Invitrogen). Following transfer, the membranes were blocked for 1h with a 
solution of 2.5 %(w/v) skimmed  milk-PBST. The primary antibodies were diluted 1:2000 in 2.5 
%(w/v) skimmed milk- PBST solution. Membranes were then incubated for 4 h with the primary 
antibodies, washed three times in PBST for 5 min. The membranes were then incubated with the 
secondary-HRP bound antibody for 2 h and following three further 5 min washes in PBST, the bound 
antibodies were detected by chemiluminescence using the ECL kit (Amersham Biosciences)  
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2.2.16.3 Total protein quantification by BCA assay 
 
Where required (chapter 3) the total protein concentration was determined by BCA assay (Novagen) 
following the manufacturer’s protocol. The BCA protein assay allows micro-scale determination (in 
the Tecan microplate reader) of total proteins from cell lysates and is based on the reduction of Cu
2+
 
by protein in alkaline conditions. The Bicinchoninic acid (BCA) chelates the reduced copper and 
produces a purple complex absorbing at 562 nm. The protein standard bovine serum albumin was 
diluted to final concentrations of 0, 25, 125, 250, 500 and 1,000 µg/ml. 25 µl of each standard was 
introduced in individual wells of a 96-well plate. 200 µl of the BCA-cupric sulfate reagent was added 
to each well, and incubated in the dark for 2 h before the absorbance at 562 nm was measured. A 
standard curve was generated from the absorbance of the protein standards, and the concentration of 
protein in the samples interpolated from the plot. 
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3.1 Introduction 
 
These experiments were inspired by an early study by Svitkin and Agol (1983). The authors showed 
that eEF2 modulated the translation of the picornavirus EMCV RNA at the 2A/2B junction. They 
used a Krebs cell-free extract which had limited amounts of eEF2 to translate EMCV RNA, and 
supplemented the cell extracts with purified eEF2 and at time intervals withdrew aliquots. The results 
proved that on SDS-PAGE, the radiolabeled polypeptide corresponding to the RNA segment after the 
2A region started to appear after 40 min of translation for the sample, whereas for the negative control 
(without additional eEF2), only a small amount of this polypeptide was apparent after 180 min. The 
synthesis of sequences downstream of the 2A sequence therefore depended on the availability of 
active eEF2. 
 
Additionally, The toeprint analysis performed on yeast extracts translating 2A provided compelling 
but not direct evidence for the involvement of the release factors (eRF1 and 3) in rescuing the 2A-
stalled ribosome (Doronina et al., 2008). Peptide release involves hydrolysis of the nascent chain-
tRNA ester linkage by a conserved [GGQ] motif from the release factor class 1 (Frolova et al., 1999). 
The eRF1 has three domains, the N (amino) domain interacts with mRNA and contains a highly 
conserved [NIKS] motif, and a [YxCxxxF] motif. The M domain (middle) extends in the PTC and 
contains the [GGQ] motif (Song et al., 2000). The C domain (carboxy) interacts with class 2 release 
factor: eRF3 (Salas-Marco and Bedwell, 2004). Although release factors from bacteria and eukaryotes 
are not direct homologues, they both contain the [GGQ] motif, and mutational studies in bacteria 
showed that substitutions of glutamine did not affect peptide release but substitution of the glycine 
residues resulted in losses of catalytic properties (Shaw and Green, 2007). Shaw and Green (2007) 
concluded that mutation of the glycines in the motif results in a change in polypeptide conformation 
that alleviate the catalysis ability and proposed that the combination of glycines and glutamine 
provides enough space and the correct configuration for a water molecule to reach the ribosome PTC 
and hydrolyse the peptidyl-tRNA ester linkage. In the model of translation termination, the [GGQ] 
motif is proposed to create a channel structure for water. The [GGQ] motif enters the PTC, the two 
glycines are thought to provide local flexibility as well as just enough space for a water molecule to 
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reach the PTC. Substitutions of glycine for other amino acids, occludes passage of the water 
molecule, therefore prevents hydrolysis (Shaw and Green, 2007). 
 
The 2A model proposes that following eRF1/3 rescue, the nascent chain would be released and the 
ribosome subunits would dissociate, which the model predicts will be the inevitable outcome in 
conditions where limited amounts of eEF2 are present to support the next translocation step.  
However, in conditions where there is enough active eEF2 available the dynamics will be driven 
towards re-initiation of translation. Potentially the time delay between rescue and re-initiation is 
shortened and more ribosomes can re-initiate translation. The model predicts a linear relationship 
between re-initiation of translation after 2A-stalled ribosome rescue and availability of eEF2 
(Doronina et al., 2008). eEF2 activity is regulated by elongation factor 2 kinase (eEF2K) and protein 
phosphatase 2A (PP2A). The kinase phosphorylates eEF2 and prevents its binding to the ribosome. 
PP2A reverses the eEF2K effect. Both of these enzymes are regulated by various cellular stress-
related signalling pathways. Under conditions of stress, the cell globally inhibits protein synthesis, 
through repression of the initiation process, and through phosphorylation of eEF2 (Redpath et al., 
1993).  
 
There were two aims to this study. 
First, this study aimed to visually demonstrate the link between translation capabilities of the cell and 
re-initiation of translation following the 2A motif, under conditions of stress, where the general 
available pool of active eEF2 is reduced.  
This project and the vector pHE27 were previously developed in this laboratory using cyan 
fluorescent protein (cyanFP) as a fluorescent reporter protein. The experimental system uses a V5-
tagged cyanFP reporter protein upstream of 2A and downstream of 2A the single-chain Fv antibody 
(scFv) which has a strong binding affinity for V5. Immunoprecipitation of pHE27 products translated 
in 293T cells proved that de novo V5 tag and the scFv chain could bind intracellularly. However, the 
cyanFP fluorescence signal was not satisfactory. At the beginning of this thesis, it was therefore 
decided to replace cyanFP with with cherryFP for an improved signal, transfect mammalian cells with 
the modified plasmids and introduce several stresses in an attempt to modulate the concentration of 
active cellular eEF2.  
By augmenting the size of the reporter protein relying on the strong affinity of de novo synthesised V5 
for scFV, the hypothesis is that the accumulation of the reporter would be limited to the cytoplasm 
only. In contrast, the cherryFP control without the V5 tag would localize in both cytoplasm and 
nucleus of transfected cells. In normal conditions of cell culture, a balanced ratio of V5-cherryFP-2A 
and the scFv should be produced. Following the application of a stress, a higher proportion of V5-
cherryFP-2A should be produced and diffuse to the nucleus. 
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The second purpose of this study was to express the translation-regulating factors in bacteria and 
supplement the purified proteins to rabbit reticulocyte lysates translating a bicistronic vector carrying 
a 2A motif. A mutant eRF1 was created where the [GGQ] conserved motif was mutated to [RGQ]. 
eRF1 RGQ is unable to perform hydrolysis of peptidyl-tRNA ester linkage. 
 
The results obtained for this thesis revealed that a visual approach employing cherryFP did not 
provide adequate discrimination to demonstrate the role of eEF2 in re-initiation of translation in HeLa 
cells. Similarly attempts to study the re-initiation of translation after 2A-induced stalling by 
supplementing a cell-free reticulocyte lysate with additional affinity-purified factors were not 
successful. The expression of translation-regulating factors (eEF2, eEF2K, eRF1 and eRF3 and eRF1 
RGQ mutant) failed using various E. coli strains. 
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3.2 Materials and methods 
 
3.2.1 Plasmids and experimental procedures for a visual method  
 
3.2.1.1 Plasmids and cloning 
 
The pHE27 plasmid (from the laboratory collection of clones) was modified to encode cherryFP 
instead of the cyanFP. The resulting plasmid pSTU1 carried the V5-CherryFP-FMDV2A-scFv insert 
and the negative control plasmid pSTU2 was created without the V5 epitope tag. 
 
 
Figure 3.1: Cloning overview for the creation of pSTU1 and lentiviruses A5 for stress study 
The primers are represented in green arrows, the V5 tag is blue, cherryFP in brown, FMDV in red and the scFv in violet. 
cherryFP was amplified from pJC3 with either Nhe1 or Not1 at the 5’ end and Age1 at the 3’ end. The cyanFP or V5cyanFP 
were extracted from pHE27 and replaced with cherryFP. This created the pSTU1and pSTU2 plasmids. The pSTU1 plasmid 
was amplified to add the restriction sites for insertion in the lentivirus A5.  
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Primers annealing to cherryFP 
CherryForNot1 5’-GCGGCCGCGGTGAGCAAGGGCGAGGAGGAT-3’  
CherryFor Nhe1 5’-GCTAGCACCATGGTGAGCAAGGGCGAGGAGGAT- 3’and reverse primer 
Cherry Rev 5’-CACCGGTGCCTTGTACAGCTCGTCCATGCC-3’  
The pSTU1 and pSTU2 plasmids have the resistance gene for selection by Neomycin, G418 
(geneticin) is an analogue and is generally used to select for neomycin resistance. 
To modify the A5 lentivirus vector: pSTU1 plasmid carrying V5-cherryFP-2A-scFV served as 
template.  
forward primers:  
Spe1 V5 pSTU1F 5’-ACTAGTGCTAGCACCATGGGAAAGCC-3’ to create the V5 tagged  
version A5V5,   
Spe1 ATG ChFP pSTU1F 5’-ACTAGTATGGCGGCCGCGGTGAGCAAG -3’ to create the  
non tagged version A5ChFP, 
and reverse primer:  pSTU1 ScFV Nde1Rev  5’- CATATGAAGCTTTTACCGTCTTATTTC-3’ 
 
 
Figure 3.2: Map of A5 lentivirus expression system  
The SFFV promoter (spleen-focus-forming virus) was used to drive expression of the insert cloned in the multiple cloning 
site (MCS’R) between the Spe1 and Nde1 sites. A5 is a bicistronic vector with EMCV IRES (IRES) driving expression of 
puromycin (puro) resistance gene (Map provided by Prof. Randall Laboratory).  
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3.2.1.2 Experimental procedures 
 
Propagation and extraction of plasmid DNA were carried according to the protocol in section 2.2.7. 
The mammalian cells were maintained, transfected and mounted for microscopy following the 
protocols in section 2.2.11, 2.2.12 and 2.2.14. For total protein quantification, a BCA assay was 
carried out following the protocol in section 2.2.16.3. For western blot analyses the cells were 
prepared and analysed following protocol in section 2.2.15 and 2.2.16. Lentiviruses were produced 
and stored as mentioned in section 2.2.13 and used to infect HeLa cells. To determine the selection 
conditions with geneticin and puromycin, untransfected cells were cultured in presence of increasing 
concentration of the antibiotic of interest, from 0 to 1200 mg/ml of geneticin for BHK21 cells. 
BHK21 cells are resistant to puromycin and could not be used with the A5 lentivirus vector. HeLa 
cells were cultured in presence of up to 2.5 mg/ml of puromycin.  
 
 
BHK21 cells were originally transiently transfected with pSTU1 and pSTU2 and assessed by 
fluorescent microscopy as described in section 2.2.14. Stable HeLa cell lines expressing V5-cherryFP-
2A- scFv (A5V5 HeLa) and cherryFP-2A-scFv (A5ChFP HeLa) were created by lentivirus. Stress 
trials: heat-shock at 42 
o
C, nutrient deprivation, ethanol stress and EMCV infection were performed 
on the A5V5 HeLa cell line and the cells were harvested at time intervals.  
 
The cells incubated under mild heat-shock at 42 
o
C were harvested after 15 min, 1, 2, 4 and 6 h but 
were cultured with the normal medium (DMEM-10 %(v/v) FCS). 
 
For the nutrient deprivation experiment, DMEM was supplemented with 0, 1, 2.5, 5, 7.5 or 10 
%(v/v)FCS. After the HeLa cells were seeded and cultured for 24 h in normal conditions, the media 
were aspirated and the wells washed with pre-warmed PBS. The cells were then incubated at 37
o
C 
with nutrient deficient media for 24 h before being harvested.  
 
For the A5V5 HeLa cells subjected to alcohol stress, DMEM-10 %(v/v) FCS was modified with 
increasing amount of ethanol 0 to 5 %(v/v). After the cells were seeded and left to adhere for 24 h in 
the six-well plates, the media were aspirated and the wells washed with pre-warmed PBS. The cells 
were then incubated with the ethanol modified media for 12 h before being harvested. 
 
For EMCV infection experiment, the HeLa cells were cultured for 24 h in the six-well plates in 
normal condition, then infected with EMCV(multiplicity of infection [MOI]= 10
-3
). The cells were 
harvested at 0, 1, 2, 4, 6, and 8 h post-infection.  
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The cells were seeded in six-well plates for western blot analysis or fluorescent microscopy and 
seeded in parallel (five replicates for each condition) in 96-well plates for the MTT protocol for cell 
viability. The water soluble MTT reagent (Sigma) is yellow and is metabolised to formazan (purple in 
colour) by viable cells. Formazan is stable; the conversion is directly dependent on the cells viability 
and can be quantified spectrophotemetrically at 550 nm. MTT was dissolved at 5 mg/ml in PBS and 
filter-sterilised, the media from the wells aspirated and 150 μl of MTT solution added to the well. The 
96-well plate was incubated wrapped in foil on a shaker for 2 h at 37 
o
C.  
 
 
 
 
Figure 3.3: Molecular weight details of A5V5 and A5ChFP lentiviruses inserts. 
 
 
3.2.2 Bacterial expression of translation-regulating factors 
 
 
Six DE3 strains of E. coli suitable for protein expression (genotype in section 2.1.2) were heat-
shocked with TOPO vectors where the coding sequences for eEF2, eEF2K, eRF1 and eRF3 were 
inserted. The TOPO clones were sourced from this laboratory collection of plasmid.  
In addition the eRF1 [GGQ] conserved motif was mutated to [RGQ] following the protocol in section 
2.2.1.  
The mutagenesis primer pair for eRF1 RGQ was 
RGQ eRF1 Fw  5’-GAAACACGGTAGACGAGGTCAGTCAGCCTTGCGTTTTGC-3’ 
RGQ eRF1 Rev 5’- GGCTGACTGACCTCGTCTACCGTGTTTCTTTGGG-3’ 
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The positive control for the protein expression experiment was pEHISGFPTEV (~30 kDa), which 
confers kanamycin resistance and has a T7 promoter driving expression of N-terminally polyhistidine-
tagged green fluorescent protein (kindly provided by the Prof Naismith laboratory). The negative 
control was the empty vector without GFP (Liu and Naismith, 2009).  
 
 
Figure 3.4: Representation of the TOPOpET101/D-TOPO vector and the molecular weight of 
the translated proteins 
The TOPO vector has a T7 promoter, lac operator (lacO), ribosome binding site (RBS) and the C-terminal V5 epitope and 
poly-histidine (6xHis). 
 
After initial failures at expressing all five proteins in BL21*, further optimisations were performed 
with eEF2, eRF1 and eRF1 RGQ mutant. BL21, BL21*, BLR, Origami, TUNR and Rosetta and C43 
were cultured, induced and analysed as described in section 2.1.2 and 2.2.8, induced with 0.4 as well 
as 1mM IPTG and incubated at 16 
o
C, 24 
o
C and 37 
o
C. After sonication, the soluble fractions (the 
supernatants) were retained for further analyses. The expression was determined by Coomassie-
stained gels and western blots using an anti-his primary antibody.  
   
The TOPO vectors were also translated in the ICE system (insect cell-free extract from Promega) 
following the protocol described in section 2.2.9. The T7 insect cell-free extract (Promega) is made 
from Spodoptera frugiperda Sf21 cell line and is a pre-mixed all-inclusive extract which contains all 
the required components for protein expression in a single mix. The synthesis is initiated with 2 µg of 
template DNA, and requires a T7 promoter sequence. The pre-mixed extract and the template DNA 
were incubated for 4 h at 30 
o
C without radioactive amino acids. The western blot analysis was carried 
out using V5 primary antibody. 
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3.3 Results 
 
3.3.1 Visual method exploiting cellular stress to study re-initiation of 
translation 
 
3.3.1.1 Transient transfection 
 
The first set of experiments involved transiently transfecting BHK21 cells with the constructs pSTU1 
and pSTU2 conferring resistance to geneticin. The rationale was to culture BHK21 cells with 
geneticin to select for transfected cells and obtain a homogenous population, before applying a 
cellular stress.  
The expected results were that under normal growth conditions, where no stress was applied, 
cherryFP expression would be localised to the cytoplasm only for cells transfected with pSTU1. For 
the control plasmid pSTU2, cherryFP however should be diffused throughout the cell. Under 
conditions of stress, the only difference to the above was that cherryFP should also diffuse to nuclei 
for cells transfected with pSTU1. 
To estimate the concentration of geneticin necessary to select for transformants, 60 10
4
 BHK21 cells 
were seeded in six-well plates and transfected with pSTU1 and incubated for 24 h. In parallel, control 
BHK21 (not transfected) were cultured under the same conditions. Geneticin was introduced at 
increasing concentrations (0 to 1200 μg/ml) to both cultures and the percentage of alive cells was 
assessed under light microscopy 24, 48 and 72 h after addition of geneticin (table 3.1). At suitable 
selective concentration of antibiotic, there should be few to no alive cells for non-transfected cells 
versus a higher proportion of alive cells for transfected BHK21.  
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Table 3.1: Visual determination of the suitable concentration of geneticin for selection of 
BHK21 transiently transfected with pSTU1  
Geneticin was introduced at different working concentrations to six-well plates and the result visually assessed under light 
microscopy at 24, 48 and 72 h. the results represent an estimation of the average alive cells for non-transfected versus  
transfected cells.  
 
Concentration 
geneticin 
(G418) (μg/ml) 
Transfected with pSTU1 
(neomycin Resistant) 
Normal BHK21 
time 72h 48h 24h 72h 48h 24h 
0 All alive All alive 
150 All alive All alive 
300 All alive ~ 60% alive 
600 All alive None alive ~20% alive 
900 ~30%alive None alive ~10% alive ~20% alive 
1200 <10% alive ~20% alive ~20% alive None alive 
 
Based on the results presented in table 3.1, the selection conditions established were 600 µg/ml of 
geneticin for three days and 900 µg/ml afterwards. 
After defining the selective concentrations necessary, the next step was to determine a suitable stress 
required to produce a decreasing concentration of eEF2. Transient transfection and geneticin selection 
were discarded because of two major limitations. The selection process using geneticin required three 
weeks but BHK21 cells transiently transfected lost the expression of the fluorescent marker within 
several days post-transfection. The second problem encountered was that fluorescent microscopy 
results (figure 3.5) for pSTU1 cells, to which no stress was applied, were not as expected. In figure 
3.5, a population of BHK21 transfected with pSTU1 shows cherryFP expression throughout the 
cytoplasm and nuclei, while for others fluorescence is limited to the cytoplasm. To demonstrate that 
the plasmids used to transfect BHK21 were correct, a test translation in rabbit reticulocyte lysates, 
analysed by SDS-PAGE (figure 3.6) was carried out. The figure 3.6 shows the translation profile 
expected for these two vectors and demonstrates that the 2A sequences for pSTU1 and pSTU2 were 
functional. 
 
Because transient transfection may act as a cellular stress and limit the expression of the transgene in 
time, it was decided that a lentiviral system might be more adequate. Modified lentiviruses for the 
purpose of cloning retain the sequences necessary for insertion of the transgene in the host genome, 
thus allowing long term expression. The lentivirus A5 plasmid (provided by Prof Randall laboratory) 
contains a suitable multiple cloning site for the inserts of pSTU1 and pSTU2 and was therefore 
selected. 
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Figure 3.5: Results showing localisation of cherryFP expression by fluorescent microscopy of 
BHK21 cells transfected with plasmids pSTU1 (A) and pSTU2 (B) 
As expected, cherryFP expression was detected throughout nucleus and cytoplasm for pSTU2 (no V5 tag, (B)). 
Unexpectedly, a population of cells ((A), cell 1) showed cherryFP expression throughout cytoplasm and nucleus for pSTU1 
transformants. The panels consist of the red fluorescence image contrasted to the nucleus only picture stained with DAPI 
(bottom right for each cell) and the merged version (top right for each cell). 
 
 
Figure 3.6: Cell-free control translation of pSTU1 and pSTU2 plasmids  
Plasmids were translated in rabbit reticulocytes with [35S]-Methionine. This was carried out as a control to demonstrate that 
the plasmids used to generate figure 3.7 were functional. The positive control lane 1 was pJC3. 
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3.3.1.2 Stable transfection 
 
The coding sequences of pSTU1 and pSTU2 were inserted into the A5 plasmid for lentiviral 
transfection (figure 3.2). The A5 plasmid confers resistance to puromycin, it is not suitable to BHK21 
cells which are puromycin resistant, but adequate for mammalian cells such as HeLa cells.  
The lentiviral particles were generated in 293T cells and used to infect HeLa cells. The resulting cell 
lines are referred to as A5V5 HeLa for cells expressing the pSTU1 coding sequence and A5ChFP 
HeLa for cells expressing the control pSTU2 coding sequence.  
A titration of puromycin using non-transfected HeLa cells was conducted, it was found that after 
addition of 1.5 µg/ml of puromycin ~ 20 % of cells survived but with a concentration of 2 µg/ml no 
cells survived. After lentivirus infection, cells were selected for two weeks with 2 µg/ml of puromycin 
before any cellular stress was applied.  
The defining parameter for this assay was that the cellular stress would decrease the level of active 
eEF2 within the cells. Preliminary stresses were applied to A5V5 HeLa cell line to determine a stress 
that would correspond to a drop in active eEF2. Western blot analyses were performed with anti-eEF2 
antibody and the phosphorylated anti-eEF2 antibody. After introduction of stresses, the cells were 
lysed with CelLytic buffer (Sigma) and their total protein content quantified using the BCA assay 
(Pierce) against the calibration standards (bovine serum albumin) in micro-plates. 20 µg of total 
protein was loaded in each well of the SDS-PAGE gel for western blot analysis.  
The four stresses introduced were: addition of ethanol (0 to 5%) to the culture for 12 h, nutrient 
deprivation (0 to 10 % FCS) over 24 h, temperature rise to 42 
o
C over 6 h and viral infection (EMCV) 
over 8 h. A5V5 HeLa cells were seeded in six-well plates and allowed to adhere for 24 h before the 
media or the culture conditions were altered. In parallel, for nutrient deprivation and addition of 
ethanol, a cell viability test (MTT) carried out in 96-well plates (using 20 10
4
 cells per well) was also 
performed to assess the relative survival of cells compared to control cells. The tetrazolium in the 
MTT reagent is intracellularly reduced to the purple formazan by oxidoreductase enzymes of 
metabolically active mitochondria. The more formazan is formed the more viable the cells are, and 
inversely, a drop in the conversion of formazan from the MTT reagent indicates loss of viability.This 
assay was not suitable for 42 
o
C temperature rise, because of the incubation step at 37 
o
C in the MTT 
protocol. The cell viability test was also not performed for EMCV infection of HeLa cells because the 
96-well plate result would not necessarily correlate to the experiment in the six-well plate. The figure 
3.7 shows the western blot analyses and relevant cell viability assays for A5V5 HeLa cells subjected 
to heat-shock at 42 
o
C (A), viral infection (B), serum deprivation (C) and ethanol stress (D). 
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Figure 3.7: Effect of different stresses on the viability and cellular concentration of eEF2 in 
A5V5 HeLa 
A5V5 HeLa cell lysates were examined by western blot analysis probing for eEF2 (panels (A), (B), (C) and (D)) and β-
tubulin (panel D- lower gel). The legend above the gels corresponds to the experimental condition tested. (A) Cells were 
grown at 42 oC and lysed at various times and compared to cells cultured at 37 oC. (B) Cells were infected with EMCV over 
8 h and analysed at different time points. (C) Cells were cultured with decreasing concentration of serum. (D) Cells were 
cultured with increasing levels of ethanol.  
MTT cell viability assays measuring the formation of formazan by live cells, at the wavelength of 550 nm were performed 
for starvation (panel C) and ethanol stress (panel D) experiments. The same experimental conditions as for western blot were 
respected and are indicated on the x-axis of the graphs. The data are presented as the average value +/- the standard deviation 
for five replicates.  
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Western blot analyses using the phosphorylated form of eEF2 were not successful. The antibody is 
designed for immunofluorescence and most likely not suitable for western blot analysis where the 
protein is denatured.  
In figure 3.7 (A), the western blot analysis with anti-eEF2 antibody shows that the concentration of 
eEF2 remains constant when the HeLa cells were incubated at 42 
o
C between 15 min to 6 h. In (B), 
during viral infection, the concentration of eEF2 does not decline over time and the variations 
observed reflect the individual cellular deviations in the susceptibility to viral infection. In (C), A5V5 
HeLa cells did not appear to be stressed when starved; in the graph, there is no decline in formation of 
formazan after 24 h without nutrients. This result correlates with the western blot showing no decline 
in the level of eEF2 when cells were cultivated with 0 to 10 % (v/v) FCS.  
There is however a decrease in the amount of eEF2 when the cells were stressed with increasing 
levels of ethanol (figure 3.7 (D)). The stress status is confirmed by the cell viability assay, showing a 
regular decline in formation of formazan with increasing levels of alcohol (from an initial OD550nm of 
0.6 to 0.2 at 5 %(v/v) ethanol). The nitrocellulose membrane was stripped with the Restore western 
blot stripping buffer (Thermo scientific) and re-probed for β-tubulin which is constitutively expressed. 
This confirmed that the decline in eEF2 observed in the western blot is not due to a difference in the 
amount of samples loaded onto the wells. The experimental condition selected for this experiment was 
therefore an increasing level of ethanol applied for 12 h before mounting cells for fluorescent 
microscopy. 
A5V5 and A5ChFP cell lines were seeded in six-well plates with a sterile coverslip and left to adhere 
for 24 h. The medium was aspirated and the cells were incubated for 12 h with different 
concentrations of ethanol: 0, 2, 4 and 5 %(v/v). The cells were then prepared and mounted for electron 
microscopy. The result for this experiment is provided in figure 3.8, where the A5V5 and A5ChFP 
expression is shown side by side. 
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Figure 3.8: CherryFP-2A with (left) or without V5 (right) did not enter the nucleus                   
HeLa stable cell lines expressing A5V5 or A5CherryFP were subjected to ethanol stress and viewed by electron 
microscopy. Results are provided for two cells for each condition tested: 0, 2, 4 and 5% ethanol. The panel shows 
red fluorescence, nucleus stained with DAPI (blue) and merged image. 
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In figure 3.8, for each condition tested, without ethanol or with increasing level of ethanol, cherryFP 
was localised only in the cytoplasm of cells for both A5V5 and A5ChFP cell lines. The expected 
result was that cherryFP 2A should be found in the cell cytoplasm and nuclei for A5ChFP. This is 
however, not the case. With increasing levels of stress and therefore less available eEF2, more 
cherryFP should be diffusing to the nuclei for the A5V5 cell line. This is also not the observed result. 
To demonstrate that the result observed is not due to a ‘faulty’ sequence, the sequencing results for 
the A5V5 and A5ChFP vectors are provided in figure 3.10. These vectors were used for the viral 
packaging step in 293T cells, figure 3.10 shows integrity of the V5 epitope for A5V5 and its absence 
for the A5ChFP. The 2A sequences were not mutated for both of these vectors.  
To provide a reference for cherryFP expression, the plasmid pJC3 which has a GFP-TaV 2A-cherryFP 
insert, was transiently expressed in HeLa cells, prepared and mounted for microscopy. In this 
construct, cherryFP is expressed as a discrete protein and not fused to the 2A peptide. The image in 
figure 3.9 shows that cherryFP is diffused throughout the HeLa cell.  
 
 
Figure 3.9: CherryFP expression in transiently transfected HeLa cell   
The panel consists of red fluorescence image (left) and nucleus stained with DAPI in blue (bottom right) and merged figure 
(upper right). In pJC3, the cherryFP-coding sequence is downstream of 2A and therefore translation of this plasmid should 
give rise to discrete cherryFP.  
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(A) lentivirus A5V5 ChFP 
V5 epitope        beginning of CherryFP 
1     ATGGGAAAGCCGATCCCAAACCCTCTATTAGGTCTGGACTCCACCGCGGC… 
      |||||||||||||||||||||||||||||||||||||||||||||||||| 
98    ATGGGAAAGCCGATCCCAAACCCTCTATTAGGTCTGGACTCCACCGCGGC 
 
2A sequence for A5V5 ChFP clone 
 1     GACGTCGAGTCCAACCCTGGGCCCGGATCCGCCGA 
       ||||||||||||||||||||||||||||||||||| 
 905   GACGTCGAGTCCAACCCTGGGCCCGGATCCGCCGA 
 
(B) lentivirus A5ChFP 
Aligned against A5V5 sequence  
27    ATTAGGTCTGGACTCCACCGCGGCCGCGGTGAGCAAGGGCGAGGAGGATAACATGGCCAT 
      ||   |          |  ||||||||||||||||||||||||||||||||||||||||| 
71    ATACCGGTGCACTAGTATGGCGGCCGCGGTGAGCAAGGGCGAGGAGGATAACATGGCCAT 
           Beginning of ChFP 
 
2A sequence for A5ChFP 
1     GACGTCGAGTCCAACCCTGGGCCCGGATCCGCCGA 
      ||||||||||||||||||||||||||||||||||| 
852   GACGTCGAGTCCAACCCTGGGCCCGGATCCGCCGA 
 
 
Figure 3.10: Alignment of lentivirus inserts (bottom line) against expected sequences (top line) 
CherryFP beginning is edited in blue text, 2A in pink text. The chromatograph for the area of interest is presented 
underneath the sequence alignments. The lack of result in the previous figure was not due to a lack of V5 in A5V5 construct 
or a mutation in the 2A sequence. 
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3.3.2 Bacterial expression of translation-regulating factors 
 
The translation-regulating factors eRF1, eRF1 RGQ, eRF3, eEF2 and eEF2K in TOPO plasmids were 
expressed in six bacterial strains, at three temperatures and with two concentrations of IPTG. The 
bacterial expression was not successful for all conditions tested. An example of a western blot is 
shown in figure 3.12 (A) for expression in BL21 where 5 µl of the supernatant fractions were probed 
with anti-His antibody. The TOPO plasmids were compatible with the T7 insect cell-free system 
(Promega). A test expression in 50 µl of extract was carried out for all translation factors, aiming at 
testing the viability of the plasmid sequences. 5 μl of the translation reactions, figure 3.12 (B) were 
analysed by western blot using ScFv antibody which probes for the V5 tag.  
 
 
 
Figure 3.11: Western blot analyses of expression of translation-regulating factors in BL21 (A) 
and in Insect cell-free system (B) 
In (A), BL21 cels were cultivated at 37 oC and induced with 1mM IPTG, western blotting was performed with anti-His 
antibody, the positive control (PC)  pEHISGFPTEV (lane2) expresses a tagged GFP at the expected size (30kDa), eRF1 and 
mutant (lanes 3 and 5) did not show expression. eEF2 expression (lane 4) resulted in an unspecific binding to the anti-His 
antibody. Control test of the plasmids performed with T7 insect cell-free system (B) shows successful expression of all the 
proteins. In (B) the western was carried out with anti-V5 antibody. 
 
The above result showed that the protocol (developed in section 2.2.8) is functional and that the lack 
of expression is not a loss of the reading frame, since the V5 tag would not have been recognised by 
anti-V5 antibody. The T7 promoter was therefore also intact and functional. The induction phase of 
the protocol may have failed for the TOPO plasmids or the His-tag is not exposed to the antibody, the 
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latter is however unlikely since the denaturating step before SDS-PAGE resolution should overcome 
this problem. The IPTG used was also functional since the positive control in (A) did show 
expression. The proteins may also have been insoluble. It was decided that for future experiments re-
cloning of the genes of interest in another vector could be the remedy to the expression problems. 
Alternatively, adopting an insect-cell system may prove more successful (figure 3.12 (B)). 
 
3.4 Discussion 
 
Results for transient transfection of cells with the constructs pSTU1 and pSTU2 in BHK21 were not 
reproducible, while stable integration of the inserts in HeLa cells failed to produce conclusive results. 
 
Lentiviruses integrate heterologous DNA into the host genome (Buchschacher and Wrong-Staal, 
2000). The transcript is capped and the regulation of its translation is subjected to cellular status. 
Translation shut off for capped mRNA during conditions of stress (Holick and Sonenberg, 2005) 
would explain the little difference observed in cherryFP localization between the controls and samples 
for increasing stress levels. Translation of the insert depends largely upon the site of integration of the 
heterologous DNA in the host genome and the promoter driving the expression (Buchschacher and 
Wrong-Staal, 2000). It is unlikely for the site of integration to be located after a promoter up-
regulated under conditions of stress. Transient transfection has several drawbacks including that 
heterologous DNA is not integrated in the genome and not stably expressed (Geisse and Voedish, 
2009). Therefore the reporter protein is not expressed long enough for selection and stress to be 
applied. 
 
Surprisingly when transfected with pSTU1 (figure 3.7), for some cells cherryFP was localised 
throughout the cytoplasm and nucleus, for others cherryFP seemed limited to the cytoplasm. A recent 
short communication by David and colleagues (2013) brought doubts to the feasibility of the assay 
developed here. The authors showed that in HeLa cells ribosome translation also occurs in the 
nucleus. Coupling puromycin, the antibiotic emetine and a fluorescent anti-puromycin antibody, they 
showed nuclear localisation of actively translating ribosomes. In another experiment still involving 
HeLa cells, Iborra and colleagues (2001) permeabilised the cells in a physiological buffer and allowed 
translation to proceed for 15 residues in presence of BODIPY-lysine-tRNA
lys
. While most of the 
products were detected in the cytoplasm, 14 % of the signal originated from the nuclei and was 
reduced by cycloheximide (a ribosome inhibitor). One possibility is that the result presented here is 
not only representative of the diffusing ability of cherryFP but also of its localised expression. The 
result may also be related to the brightness of the reporter protein. In addition, the assay does not at 
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the moment provide a true representation of the cellular status at a given time, cherryFP is photostable 
compared to other fluorescent proteins and especially developed for long term imaging (Shaner at al., 
2005). Since the marker accumulates, the visualisations do not reflect de novo synthesis of translation 
products, which for this assay is a particularly sensitive point since the aim is to differentiate at 
different stress levels, the amount of proteins produced after 2A. The destabilisation domain (DD 
domain)/ shield ligand supplied by Clontech might be a solution, as it allows to reversibly destabilise 
in a dose dependent manner a protein tagged with the DD domain.  
 
These results highlight the experimental considerations necessary to achieve the challenging task of 
proving directly the role release factors play in rescuing 2A-induced ribosome stalling. For the 
bacterial expression of translation-regulating factors; the straightforward conclusion is that the coding 
sequences should be cloned into another vector. Purifying eEF2 from cellular cultures may be a more 
successful approach since there is no commercial test readily available to assert the functionality of 
the recombinant eEF2. In the literature for the purpose of reconstituting a translation assay, eEF2 was 
not over-expressed but purified while eRF1 has routinely been expressed from BL21 cultures 
(Alkalaeva et al., 2006 and Pisareva et al., 2011). The experimental rationale here was to modify a 
rabbit reticulocyte by over-riding the translating factors present in the system with additional mutant 
eRF1 or other translation-regulating factors. Since the reticulocyte system has been optimised for 
efficient translation, modulating its content requires either depletion of the factors or addition of 
drastic amounts of additional proteins. Pisarev and colleagues (2011), in an effort to study release 
factors activity, have developed a eukaryotic system fully reconstituted from a mixture of purified and 
overexpressed proteins and ribosome subunits. The system has been used extensively to introduce 
relevant mutations to eRF1 and eRF3 and adopting such a system will provide clear and direct 
evidence for the involvement of eRF1/3 in rescuing 2A- paused ribosome. Moreover, it will enable 
the introduction of multiple mutations so as to test what allows the factor this previously 
uncharacterised ability. 
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‘What saves a man is to take a step. Then another step. It is always the same step, but you have to take it.’ 
- Antoine de Saint-Exupery 
 
4.1 Introduction 
 
This chapter summarises the successive mutagenesis performed on hybrids and truncated constructs 
made for selected model 2A sequences in an effort to identify the important residues leading to 
ribosome stalling. Another aim was to gather evidence to answer the questions: Is the 2A-induced 
ribosomal stalling likely the result of an interaction with the ribosome exit tunnel? Or is it the result of 
the nascent 2A adopting a conformation unfavourable for peptide bond formation?   
Viral 2A sequences tested in vitro and shown to be active, display an intriguing non-conserved 
upstream context preceding the general consensus motif [D(V/I)ExNPGP]. The lack of conservation 
would imply the conclusion that the upstream context to the consensus motif is auxiliary. However, 
previous studies with FMDV 2A showed that the upstream context leading to the signature motif is 
essential. The IFV sequence [TRAEIEDELIRAGIESNPG/P] is 63 % efficient, but a single point 
mutation [TRAEIEDELIRADIESNPG/P] renders it inactive (Donnelly et al., 2001b). For FMDV 2A, 
an extended sequence leads to higher levels of stalling. A FMDV 2A with seventeen amino acids 
[NFDLLKLAGDVESNPG/P] is 75 % efficient, the efficiency decreases with shorter sequences. 
FMDV2A efficiency drops to 65 % when only thirteen amino acids [LKLAGDVESNPG/P] of the 
sequence were included in the insert (Ryan and Drew, 1994). Adding thirty-nine amino acids of the 
1D region of FMDV at the N-terminus of FMDV 2A, increased the efficiency to nearly 100 % 
(Donnelly et al., 1997). In the context of FMDV, these results led to the conclusion that efficient 2A 
stalling required a minimum of thirty amino acids. TaV2A which is naturally only twenty amino acids 
long (Donnelly et al., 2001b ) and shown to be highly efficient at stalling the eukaryotic ribosome is 
not altered by mutations and alteration at the C-terminus of the preceding protein (Minskaia, 
publication in preparation). Systematic mutagenesis of 2A sequences have not previously been carried 
out. 
The reactive centre (PTC) of the ribosome, where peptide bond formation occurs, is situated in a 
cavity deep in the large 60S ribosomal subunit. As residues are added, the nascent peptide enters and 
progresses through an exit tunnel, which originates from the PTC (Yonath et al., 1987). The exit 
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tunnel is 100 Å long in eukaryotes and varies in width, hosting between thirty to forty amino acids of 
an elongating peptide. The first 20 Å from the PTC are considered to be made of rRNA only. The 
tunnel is then constricted by the protruding loops of two ribosomal proteins, L4 and L17 in eukaryotes 
(and L4 and L22 in prokaryotes). Protein contribution to the wall is thought to be limited to these 2 
proteins over a length of 10 Å and to a stretch of residues nearer the exit port from protein L23 or 
L25. The tunnel wall is assembled from domains I, II, III, IV, V of 23S rRNA in prokaryotes or 28S 
rRNA in eukaryotes. Near the PTC the tunnel is 15 Å wide, in the constriction 10 Å wide and further 
in the lower tunnel it enlarges to 25 Å. The L22 protein is involved in the constriction and also at the 
exit port where together with L39 (eukaryotes) or L23 (prokaryotes) frame the exit port (Nissen et al., 
2000 and Voss et al., 2006). 
 
Figure 4.1: The ribosome exit tunnel                                                                                                 
The prokaryotic ribosome exit tunnel is used as a model for this structure in all domains of life. Diagram show the A and P 
site tRNAs in green and khaki, the L4 and L22 ribosomal protein are represented in violet and gold. The blue dot 
corresponds to the entrance to the tunnel (image reproduced from Voss et al., 2006). 
Theosa asigna virus 2A sequence (TaV2A) was selected for the purpose of this study. TaV virus has 
two ORFs, 2A was originally identified preceding the capsid proteins on the second ORF. Luke and 
co-workers (2008) cloned and measured the activity of a twenty aa TaV 2A sequence. TaV 2A is 
considered an optimal 2A since this minimal sequence is sufficient to induce nearly 100 % stalling. In 
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order to answer the question what made TaV 2A so efficient, in the context of this thesis, several 
mutants were created. Other 2A sequences were also employed to provide supplementary data. From 
the picornavirus family: FMDV 2A and Duck Hepatitis virus 2A (DHV 2A) were selected. FMDV 2A 
was included in this experiment since it has been the object of many studies (as detailed in the general 
introduction section) related to the mechanism of action of 2A. DHV 2A was selected because it has a 
deviating consensus motif [EGVENPGP]. Other 2A like elements shown previously to be potent 
ribosomal stalling sequences (Luket et al., 2008) were also selected based on their deviating 
consensus motifs. The adult diarrhoea virus C (ADRV 2A) consensus sequence is [CIESNPGP]. The 
insect iflavirus 2A (IFV 2A) sequence resembled DHV 2A [GIESNPGP]. 
There were several questions driving the mutational studies: 
What part does the consensus motif play in ribosome stalling? To this effect, several hybrid sequences 
were created interchanging the upstream contexts of 2As. The TaV 2A consensus motif was also 
altered to match the ten different other consensus sequences listed to date and finally the residues side 
chains in TaV 2A consensus motif were successively substituted to alanine.  
Since there is much diversity in upstream contexts, is there any residue or type of residue at a 
particular position that is required for efficient stalling? To answer this question, successive alanine 
substitutions were carried out in the upstream context of three model 2As: TaV, FMDV and DHV.  
Is the activity of 2A purely structural as previously proposed (Doronina et al., 2008) or is it the result 
of an interaction with the ribosome exit tunnel or both? An attempt was made to answer this question 
by mutations of TaV residues to glycine. TaV arginine residues were also substituted to isoleucine 
(hydrophobic), lysine (increasing ability to react with RNA), glutamine (no charge) and glutamic acid 
(negative charge). IFV, DHV and ADRV 2As were truncated. Double proline mutations and non-
conservative mutation of leucine residues to asparagine (similar MW, but hydrophilic) were also 
introduced in the FMDV, DHV and TaV 2A sequences. 
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4.2 Materials and methods 
4.2.1 General procedures 
 
The DHV 2A sequence was identified using the basic local alignment algorithm at NCBI online 
server (http://www.blast.ncbi.nlm.nih.gov). Viral 2A sequences were sorted by consensus sequences 
and aligned with ClustalX. The weblogo online server ( http://www.weblogo.berkeley.edu) was used 
for multiple alignments of 2A sequences. Secondary structure was predicted using the Jpred3 online 
server (http://www.compbio.dundee.ac.uk/jpred). 
Plasmid pSTA1 coding for GFP-2A-GUS in one single ORF was used and modified. pSTA1 vectors 
containing 2A sequences for TaV 2A, IFV 2A, FMDV 2A or ADRV 2A were from the laboratory 
collection of clones, DHV was created as part of this body of work. DHV2A (thirty amino acids long) 
was inserted at the 5’ end of GUS coding sequence with two successive PCRs. Primers for PCR1: 
forward 5’-TCTAGAGCATTTGAACTCAATTTGGAAATTGAATCTGACCAAATT 
AGAAACAAGAAAGATCTCACTACTGAAGGAGTCGAGCCAAACCCCGGGCCCCACC-3’ 
and reverse 5'-ACGGGCCTCGAGCGGCCGCACTA GATTGTTT-3'. Primers for PCR2: forward 5’-
TAATACGACTCACTATAGGG-3’ and reverse 
5’_GCTTTGGTGGGGCCCGGGGTTTGGCTCGACTCCTTCAGTAGTGAGATC 
TTTCTTGTTTCTAAT-3’.  
For directional cloning, an Xba1 site was engineered at the 5’ end of all the 2As. The nucleotide 
sequence corresponding to Gly-Pro at the C-terminal motif of the 2A forms a restriction site for Apa1 
(GGGCCC). PCR products were first cloned in pGEM-T via A overhangs and inserted in pSTA1 
preferably digested with Xba1-Xho1 (2A-GUS) or Xba1- Apa1 (insertion of 2A only). The 
experimental procedures summarised underneath are fully detailed in the section 2.2.1-7.  
Primers were designed to introduce a mutation of a specific amino acid (introduced mutation is 
highlighted in blue in the forward primers sequences in this section). PCR were performed using the 
KOD Hot start enzyme from Novagen, following manufacturer’s instructions. The protocol utilised is 
detailed in section 2.2.1. The integrity of the mutants was assessed by big Dye terminator sequencing 
(ABI) outsourced from Dundee sequencing services (sequences in appendix 2). In vitro translation 
was performed in 12.5 µl Rabbit reticulocyte extracts supplemented with [
35
S]-methionine and carried 
out for ninety minutes. The translation products were resolved on 4-20 % tris-bis SDS-PAGE 
denaturing gels (Expedeon). The gels were Coomassie stained and [
35
S]-labelled proteins were 
visualised using photographic film and their size determined against the dual colour marker precision 
standard from Biorad. 
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                                   10        20        30      
                          ....|....|....|....|....|....|. 
Human-C_V508_AY941781           GVGYP-LIVANSKFQIDKILISGDIELNPGP  
Bovine-C_Shintoku_L12390        GIGNP-LIVANSKFQIDRILISGDIELNPGP  
KBVAY275710                     -IGFLNKLYKCGTWESVLNLLAGDIELNPGP  
Clustal Consensus                :*    :   ..::    *::*********  
 
                                  10        20        30      
                         ....|....|....|....|....|....| 
D.punctatusCPV1AY185594          MTAFDFQQAVFRSNYDLLKLCGDVESNPGP  
L.disparCPV1AF389466             MTAFDFQQAVFRSNYDLLKLCGDVESNPGP  
FMDV-194X88861                   RHKEDCAPVKQLLNFDLLKLAGDVESNPGP  
ERAV-393/76L43052                RHKFPTNINKQCTNYSLLKLAGDVESNPGP  
SePV-1EU152976                   SGCFCPLPNVYVPPTHNVLLDGDVESNPGP  
PrV-2A1AF548354                  LEMKESNSGYVVGGRGSLLTCGDVESNPGP  
CrPVAF218039                     LVSSNDECRAFLRKRTQLLMSGDVESNPGP  
EoPV-2A1AY365064                 GQRTTEQIVTAQGWAPDLTQDGDVESNPGP  
PnPV-2A1AF323747                 GQRTTEQIVTAQGWVPDLTVDGDVESNPGP  
IMNV-2A1-BrazilAY570982          WDPTYIEISDCMLPPPDLTSCGDVESNPGP  
Clustal Consensus                                 :   *********  
                                  10        20        30      
                         ....|....|....|....|....|....|. 
TaVAF062037                     -----------RAEGRGSLLTCGDVEENPGP  
EeVAF461742                     RRLPESAQLP-QGAGRGSLVTCGDVEENPGP  
PTV-1-5-D-VIIIAF296106          AMTVMTFQGP-GATNFSLLKQAGDVEENPGP  
IMNV-2A2-BrazilAY570982         -RDVRYIEKPFDKEEHTDILLSGDVEENPGP  
Clustal Consensus                                 :  .*********  
                                         10        20        30      
                                ....|....|....|....|....|....|. 
ABPV_U.K._AF150629              -TGFLNKLYHCGSWTDILLLLSGDVETNPGP  
DCV_EB_AF014388                 -QGIGKKNPKQEAARQMLLLLSGDVETNPGP  
BRV2                            -LRLTGEIVKQGATNFELLQQAGDVETNPGP  
LV_174F_AF327921                YFNIMHS-DEMDFAGGKFLNQCGDVETNPGP  
HumanTheiler-likeVirusYP_00194  FTDFFKAVRDYHASYYKQRLQH-DVETNPGG  
SAF-V_Saffoldvirus_EF165067     FTDFFKAVRDYHASYYKQRLQH-DVETNPGP  
RatTheiler-LikeVirus_NGS910_AB  FSDFFKHVREYHAAYYKQRLMH-DVETNPGP  
Clustal Consensus                   :     .             *******   
                               10        20        30      
                      ....|....|....|....|....|....|.. 
EMCV_Rueckert_M81861           VFGLYRIFNAHYAGYFADLLIH--DIETNPGP  
SVVDQ641257                    --RAWCPSMLPFRSYKQKMLMQSGDIETNPGP  
Clustal Consensus                  :      : .*  .:*::  ********  
                            10        20        30      
                   ....|....|....|....|....|....|... 
B.moriAF433660                ---RTAFDFQQDVFRSNYDLLKLCGDIESNPGP  
HCoSV-A1ACL15185              VLPRPLTRAERDVAR---DLLLIAGDIESNPGP  
EoPV-2A2AY365064              --TRGGLQRQNIIGGGQRDLTQ-DGDIESNPGP  
PnPV-2A2AF323747              --TRGGLRRQNIIGGGQKDLTQ-DGDIESNPGP  
Clustal Consensus                *     :. :     **    *********  
                                         10        20        30      
                                ....|....|....|....|....|....| 
Vilyuiskhumanencephalomyelitis   FGEFFKAVRGYHADYYKQRLIHDVEMNPGP  
TMEV_GDVII_X56019                FREFFKAVRGYHADYYKQRLIHDVEMNPGP  
ERBV-1-P1436/71X96871            EATLSTILSEGATNFSLLKLAGDVELNPGP  
Porcine-C_Cowden_M69115          GNGNPLIVANAKFQIDKILISGDVELNPGP  
Clustal Consensus                       :     :     :  ***:****  
 
Figure 4.2: Representative virus 2A sequences aligned by their consensus motifs                                             
Alignment was performed with ClustalX 
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4.2.2 Primers for mutations and alterations of 2A consensus motifs 
 
4.2.2.1 TaV 2A modified with other viral consensus motifs 
Alignment of the viral 2A were performed with ClustalX, and resulted in seven groups of consensus 
sequences. The TaV 2A consensus motif [DVEENPGP] was swapped for [DVETNPGP], 
[DVEMNPGP], [DVELNPGP], [DVESNPP], [DIELNPGP], [DIETNPGP] and [DIESNPGP] in order 
to test for their efficiencies in ribosomal stalling. The PCRs were performed with T7 (forward) and 
reverse primers underneath with modified sequences. The BamH1-Apa1 segment was re-inserted in 
pSTA1.  
DVETNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTTGTCTCCACGTCC- 3’ 
DVEMNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTCATCTCCACGTCC- 3’ 
DVELNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTAAGCTCCACGTCC- 3’ 
DVESNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTAGACTCCACGTCC- 3’ 
DIELNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTTAGCTCAATGTCC- 3’ 
DIETNPGP, 5’-GGTGGTGGTGGGGCCCGGGATTCGTCTCAATGTCC- 3’ 
DIESNPGP, 5’- GGTGGTGGTGGGGCCCGGGATTCGACTCAATGTCC- 3’ 
 
4.2.2.2 Hybrid 2A sequences type 1 
 
The upstream context sequences of ADRV, DHV and IFV, were replaced with that of TaV. Primers 
annealing at the desired position on these consensus motifs were engineered to create Xba1 and TaV 
upstream context for directional cloning in pSTA1 in conjunction with the reverse primer beginning at 
the end of GUS and creating a Xho1 restriction site. Templates for PCR were pSTA1 ADRV 2A, 
DHV 2A and IFV 2A. 
DHV30 2A, nucleotide and amino acid sequences 
1         GCATTTGAACTCAATTTGGAAATTGAATCTGACCAAATTAGAAACAAGAAAGATCTCACT 
1          A  F  E  L  N  L  E  I  E  S  D  Q  I  R  N  K  K  D  L  T  
 
61        ACTGAAGGAGTCGAGCCAAACCCCGGGCCC 
21         T  E  G  V  E  P  N  P  G  P                                 
 
IFV30 2A, nucleotide and amino acid sequences 
1         CCCTCAATTGGTAATGTCGCGCGGACTCTGACGAGGGCGGAGATTGAGGATGAATTGATT 
1          P  S  I  G  N  V  A  R  T  L  T  R  A  E  I  E  D  E  L  I  
 
61        CGTGCAGGAATTGAATCAAATCCTGGGCCC 
21         R  A  G  I  E  S  N  P  G  P                                 
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ADRV30 2A, nucleotide and amino acid sequences 
1         TTCTTCGATTCGGTTTGGGTGTACCACTTGGCAAACAGCTCTTGGGTTCGAGATTTAACT 
1          F  F  D  S  V  W  V  Y  H  L  A  N  S  S  W  V  R  D  L  T  
 
61        AGAGAATGCATTGAATCTAACCCTGGGCCC 
21         R  E  C  I  E  S  N  P  G  P                                 
 
TaV 2A nucleotide and amino acid sequences 
1         CGCGCCGAGGGCAGGGGAAGTCTTCTAACATGCGGGGACGTGGAGGAAAATCCCGGGCCC 
1          R  A  E  G  R  G  S  L  L  T  C  G  D  V  E  E  N  P  G  P  
 
Forward primers:  
11TaV 9ADRV, 5’-GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACAT 
GCGAATGCATTGAATCTAACCCTGG-3’ 
 
12TaV 8ADRV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAAC 
ATGCGGGTGCATTGAATCTAACCCTGG-3’ 
 
12TaV 9ADRV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACATGCGG 
GGAATGCATTGAATCTAACCCTGG-3’ 
 
12TaV 8IFV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACATGCGGG 
GGAATTGAATCAAATCCTG-3’ 
 
11TaV 9DHV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACA 
TGCGAAGGAGTCGAGCCAAACCCCG-3’ 
 
12TaV 8DHV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACATGCGG 
GGGAGTCGAGCCAAACCCCG-3‘ 
 
12TaV 9DHV, 5’- GGTCTAGACGCGCCGAGGGCAGGGGAAGTCTTCTAACATGC 
GGGGAAGGAGTCGAGCCAAACCCCG-3‘ 
 
Reverse primer for the above 5'-ACGGGCCTCGAGCGGCCGCACTAGATTGTTT-3' 
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4.2.2.3 Hybrid 2A sequences type 2 
 
The second type of hybrid 2As carrying the upstream context of ADRV, DHV or IFV and the 
consensus motif of TaV were created by site-directed mutagenesis of these sequences to match the 
TaV motif [DVEENPGP].  
Modification of the end of DHV, IFV and ADRV 2As with TaV 2A consensus motif 
Mutant Forward primer Reverse primer 
ADRV-
TaV 
5‘GTTCGAGATTTAACTAGAGAAGACGTGGAGGAAAATCCCGGG
CCCCACCACCACCACCACCACTTACG -3‘ 
5‘GGTGGTGGTGGGGCCCGGGATTTTCCTCCACGTCT
TCTCTAGTTAAATCTCGAACCCAAG-3‘ 
IFV-TaV 
5‘-
GATGAATTGATTCGTGCAGACGTGGAGGAAAATCCCGGGCCCC
ACCACCACCACCACCACTTACG -3‘ 
5‘-
GGTGGTGGGGCCCGGGATTTTCCTCCACGTCTGCACG
AATCAATTCATCCTCAATAATCTCCG -3‘ 
DHV-TaV 
5‘-
GAAAGATCTCACTACTGAAGACGTGGAGGAAAATCCCGGGCCC
CACCACCACC -3‘ 
5‘-
GGTGGTGGTGGGGCCCGGGATTTTCCTCCACGTCTTC
AGTAGTGAGATCTTTCTTG -3‘ 
 
11TaV-9 DHV were successively mutated back to TaV 2A 
Mutant Forward primer Reverse primer 
TvDHV G 
5‘-GGAAGTCTTCTAACATGCGGAGGAGTCGAGCCAAACCCC 
GGG -3‘ 
5‘-GTTTGGCTCGACTCCTCCGCATGTTAGAAGACTTC 
CCCTGC -3‘ 
TvDHV D 
5‘-GTCTTCTAACATGCGAAGACGTCGAGCCAAACCCCGGG 
CCCC -3‘ 
5‘-GGTTTGGCTCGACGTCTTCGCATGTTAGAAGACT 
TCCCC -3‘ 
TvDHV E 5‘-GCGAAGGAGTCGAGGAGAACCCCGGGCCCCACCACCACC -3‘ 
5‘-GGTGGGGCCCGGGGTTCTCCTCGACTCCTTCGCA 
TGTTAG -3‘ 
TvDHV 
GD 
5‘-GGAAGTCTTCTAACATGCGGAGACGTCGAGCCAAACCCCG 
GGCCCCAC -3‘ 
5‘-CGGGGTTTGGCTCGACGTCTCCGCATGTTAGAA 
GACTTCCCCTGCC -3‘ 
TvDHV GE 
5‘-GAAGTCTTCTAACATGCGGAGGAGTCGAGGAGAACCCCGG 
GCCCCACCACCACC -3‘ 
5‘-GTGGGGCCCGGGGTTCTCCTCGACTCCTCCGCAT 
GTTAGAAGACTTCCCCTG -3‘ 
TvDHV DE 
5‘-CTTCTAACATGCGAAGACGTCGAGGAGAACCCCGGGCCCC 
ACCACCAC -3‘ 
5‘-GGGGCCCGGGGTTCTCCTCGACGTCTTCGCATGT 
TAGAAGACTTCCCCTG -3‘ 
  
4.2.2.4 TaV 2A distance between the [GDV] and [NPGP] motifs 
 
Mutants were created with 1, 2, 3 or 4 residues between TaV: [DVE] and [NPGP] motifs 
Mutant Forward primer Reverse primer 
1 AA- A 5‘-CGGGGACGTGGCAAATCCCGGGCCCCACC-3‘ 5‘-GGCCCGGGATTTGCCACGTCCCCGCATGTTAG -3‘ 
1AA- E 5‘-GCGGGGACGTGGAAAATCCCGGGCCCCACCAC -3‘ 5‘-GGCCCGGGATTTTCCACGTCCCCGCATGTTAG -3‘ 
3AA- EAE 5‘-GGGACGTGGAGGCAGAAAATCCCGGGCCCC -3‘ 5‘-CGGGATTTTCTGCCTCCACGTCCCCGCATG -3‘ 
4AA- EAAE 5‘-GGGACGTGGAGGCAGCAGAAAATCCCGGGCCCCAC -3‘ 
5‘-GCCCGGGATTTTCTGCTGCCTCCACGTCCCCG 
CATG -3‘ 
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4.2.3 Primers for truncations of 2As and alterations of residues side chains  
 
 
4.2.3.1 N-terminal truncation of ADRV, IFV and DHV 
 
N-terminally truncated 2As were constructed where specific sections in the N-terminal region of 
ADRV, DHV and IFV sequences were deleted. The primer annealing at the desired position on the 
ORF was engineered to create a Xba1 site for directional insertion in pSTA1 and to maintain the 
reading frame. The deletions created 2As of 26, 23, 20 or 17 amino acids. The forward primers are 
detailed underneath; the reverse primer was 5'-ACGGGCCT CGAGCGGCCGCACTA GATTGTTT-
3'. 
 
DHV 2A full-length amino acid and nucleotide sequences and the priming sites (blue arrows) for 
truncated products are shown underneath.  
   DHV26      DHV23       DHV20       DHV17 
1         GCATTTGAACTCAATTTGGAAATTGAATCTGACCAAATTAGAAACAAGAAAGATCTCACT 
1          A  F  E  L  N  L  E  I  E  S  D  Q  I  R  N  K  K  D  L  T  
 
61        ACTGAAGGAGTCGAGCCAAACCCCGGGCCC 
21         T  E  G  V  E  P  N  P  G  P                                 
 
DHV26  forward  5’- TCTAGAAATTTGGAAATTGAATCTGACC-3’ 
DHV23  forward  5’- TCTAGAATTGAATCTGACCAAATTAGAAAC-3’ 
DHV20  forward  5’- TCTAGAGACCAAATTAGAAACAAG-3’ 
DHV17  forward  5’- TCTAGAAGAAACAAGAAAGATCTC-3’ 
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Following is the IFV 2A full-length amino acid and nucleotide sequences with the blue arrows 
showing the priming site to generate truncated sequences. 
               IFV26         IFV23         IFV20         IFV17 
1         CCCTCAATTGGTAATGTCGCGCGGACTCTGACGAGGGCGGAGATTGAGGATGAATTGATT 
1          P  S  I  G  N  V  A  R  T  L  T  R  A  E  I  E  D  E  L  I  
 
61        CGTGCAGGAATTGAATCAAATCCTGGGCCC 
21         R  A  G  I  E  S  N  P  G  P                                 
 
IFV26 forward  5’- TCTAGAAATGTCGCGCGGACTCTGACGAGG -3’ 
IFV23  forward  5’- TCTAGACGGACTCTGACGAGGGCGGAG -3’ 
IFV20 forward  5’- TCTAGAACGAGGGCGGAGATTGAGG -3’ 
IFV17 forward  5’- TCTAGAGAGATTGAGGATGAATTG -3’ 
 
 
Following is the ARDV 2A full-length amino acid and nucleotide sequences with the blue arrows 
showing the priming site for each truncated sequence. 
               ADRV26   ADRV23    ADRV20     ADRV17 
1         TTCTTCGATTCGGTTTGGGTGTACCACTTGGCAAACAGCTCTTGGGTTCGAGATTTAACT 
1          F  F  D  S  V  W  V  Y  H  L  A  N  S  S  W  V  R  D  L  T  
 
61        AGAGAATGCATTGAATCTAACCCTGGGCCC 
21         R  E  C  I  E  S  N  P  G  P                                 
 
ADRV26  forward  5’- TCTAGAGTTTGGGTGTACCACTTGGCAAAC -3’ 
ADRV23 forward   5’- TCTAGATACCACTTGGCAAACAGCTCTTGG -3’ 
ADRV20 forward  5’- TCTAGAGCAAACAGCTCTTGGGTTCGAGATTTAAC -3’ 
ADRV17 forward  5’- TCTAGATCTTGGGTTCGAGATTTAACTAG -3’ 
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4.2.3.2 Site-directed mutations to TaV 2A 
 
Target TaV 2A nucleotides and corresponding amino acid sequences: 
1         CGCGCCGAGGGCAGGGGAAGTCTTCTAACATGCGGGGACGTGGAGGAAAATCCCGGGCCC 
1          R  A  E  G  R  G  S  L  L  T  C  G  D  V  E  E  N  P  G  P  
 
Primers for successive alanine substitutions 
Mutant Forward primer Reverse primer 
R1A 5‘-CCGGGTCTAGAGCGGCCGAGGGCAGGGG-3‘ 5‘-CTGCCCTCGGCCGCTCTAGACCCGGACTT-3‘ 
E3A 5‘-GTCTAGACGCGCCGCGGGCAGGGGAAGTCTT-3‘ 5‘-CTTCCCCTGCCCGCGGCGCGTCTAGACCC-3‘ 
G4A 5‘-GACGCGCCGAGGCGAGGGGAAGTCTTC-3‘ 5‘-GACTTCCCCTCGCCTCGGCGCGTCTAGAC-3‘ 
R5A 5‘-CGCCGAGGGCGCGGGAAGTCTTCTAACATG-3‘ 5‘-GAAGACTTCCCGCGCCCTCGGCGCGTC-3‘ 
G6A 5‘-CGAGGGCAGGGCGAGTCTTCTAACATGC-3‘ 5‘-GTTAGAAGACTCGCCCTGCCCTCGGCG-3‘ 
S7A 5‘-GGGCAGGGGAGCGCTTCTAACATGCGGG-3‘ 5‘-CATGTTAGAAGCGCTCCCCTGCCCTCGGC-3‘ 
L8A 5‘-CAGGGGAAGTGCGCTAACATGCGGGGAC-3‘ 5‘-CGCATGTTAGCGCACTTCCCCTGCCCTC-3‘ 
L9A 5‘-GGGAAGTCTTGCGACATGCGGGGACGTG-3‘ 5‘-CCCCGCATGTCGCAAGACTTCCCCTGCC-3‘ 
T10A 5‘-GAAGTCTTCTAGCGTGCGGGGACGTGGAG-3‘ 5‘-CGTCCCCGCACGCTAGAAGACTTCCCC-3‘ 
C11A 5‘-GAAGTCTTCTAACAGCGGGGGACGTGGAGGAAAATC-3‘ 5‘-CCACGTCCCCCGCTGTTAGAAGA CTTCCCCTG-3‘ 
G12A  5‘-CTTCTAACATGCGCGGACGTGGAGGAAAATCC-3‘ 5‘-CCTCCACGTCCGCGCATGTTAGAAGACTTCC-3‘ 
D13A 5‘-CTAACATGCGGGGCCGTGGAGGAAAATCCCG-3‘ 5‘-GATTTTCCTCCACGGCCCCGCATGTTAGAAG-3‘ 
V14A 5‘-CATGCGGGGACGCGGAGGAAAATCCCGGGCC-3‘ 5‘-GGATTTTCCTCCGCGTCCCCGCATGTTAGAAG-3‘ 
E15A 5‘-CGGGGACGTGGCGGAAAATCCCGGGCCCCAC-3‘ 5‘-CGGGATTTTCCGCCACGTCCCCGCATGTTAG-3‘ 
E16A 5‘-GGGGACGTGGAGGCAAATCCCGGGCCCCACCACCAC-3‘ 5‘-GCCCGGGATTTGCCTCCACGTCCCCGCATGT   TAG-3‘ 
N17A 5‘-GACGTGGAGGAAGCTCCCGGGCCCCACCACCACC-3‘ 5‘-GTGGGGCCCGGGAGCTTCCTCCACGTCCCCGCA TG-3‘ 
P18A 5‘-GGAGGAAAATGCCGGGCCCCACCACCACCACCAC-3‘ 5‘-GTGGTGGGGCCCGGCATTTTCCTCCACGTCC   CCG-3‘ 
G19A 5‘-GAGGAAAATCCCGCGCCCCACCACCACCACCACCAC-3‘ 5‘-GTGGTGGTGGGGCGCGGGATTTTCCTCCAC  GTCC-3‘ 
P20A 5‘-GAAAATCCCGGGGCCCACCACCACCACCACCACTTAC-3‘ 5‘-GGTGGTGGTGGTGGGCCCCGGGATTTTCCTCCA CGTC-3‘ 
 
Primers for mutations of TaV 2A arginine 1 and 5 
Mutant Forward primer Reverse primer 
R1E 
5‘-GAACTATACAAGTCCGGGTCTAGAGAAGCCGAGGGCAG 
GGGAAGTCTTCTAACATG -3‘ 
5‘-GACTTCCCCTGCCCTCGGCTTCTCTAGACCCGGAC 
TTGTATAGTTCG -3‘ 
R5E 5‘-GGTCTAGACGCGCCGAGGGCGAAGGAAGTCTTCTAACATG CGG -3‘ 
5‘-GCATGTTAGAAGACTTCCTTCGCCCTCGGCGCGT 
CTAGACCCG -3‘ 
R(1+5)E 
5‘-GAACTATACAAGTCCGGGTCTAGAGAAGCCGAGGG 
CGAAGGAAGTCTTCTAACATGCGGGG -3‘ 
5‘-GCATGTTAGAAGACTTCCTTCGCCCTCGG 
CTTCTCTAGACCCGGACTTGTATAGTTCG -3‘ 
R1I 
5‘-CTATACAAGTCCGGGTCTAGAATAGCCGAGGGCAGGGGAA GTCTTC 
-3‘ 
5‘-GACTTCCCCTGCCCTCGGCTATTCTAGACCCGGA 
CTTGTATAGTTCG -3‘ 
R5I 5‘-GTCTAGACGCGCCGAGGGCATAGGAAGTCTTCTAACATG CGG -3‘ 
5‘-GCATGTTAGAAGACTTCCTATGCCCTCGGCGCG 
TCTAGACCCG -3‘ 
R(1+5)E 
5‘-GAACTATACAAGTCCGGGTCTAGAATAGCCGAGGGCATAG 
GAAGTCTTCTAACATGCGG -3‘ 
5‘-GTCCCCGCATGTTAGAAGACTTCCTATGCCCTCG 
GCTATTCTAGACCCGGACTTGTATAG -3‘ 
R1K 
5‘-GAACTATACAAGTCCGGGTCTAGAAAAGCCGAGGGCAGG 
GGAAGTCTTCTAACATG -3‘ 
5‘-GACTTCCCCTGCCCTCGGCTTTTCTAGACCCGGAC 
TTGTATAGTTCGTCCATG -3‘ 
R5K 
5‘-GTCTAGACGCGCCGAGGGCAAAGGAAGTCTTCTAACATGC 
GGGGACG -3‘ 
5‘-GCATGTTAGAAGACTTCCTTTGCCCTCGGCGCGT 
CTAGACCCGGACTTG -3‘ 
R(1+5)K 
5‘-GAACTATACAAGTCCGGGTCTAGAAAAGCCGAGGGCAAAG 
GAAGTCTTCTAACATGCGGG -3‘ 
5‘-GTCCCCGCATGTTAGAAGACTTCCTTTGCCCTCGG 
CTTTTCTAGACCCGGACTTGTATAGTTCGTCCATG -3‘ 
R1Q 
5‘-GAACTATACAAGTCCGGGTCTAGACAAGCCGAGGGCAGG 
GGAAGTCTTCTAACATG-3‘ 
5‘-GACTTCCCCTGCCCTCGGCTTGTCTAGACCCGGA 
CTTGTATAGTTCG -3‘ 
R5Q 
 5‘-GTCTAGACGCGCCGAGGGCCAAGGAAGTCTTCTAACATGC 
GGGGAC -3‘ 
5‘-GCATGTTAGAAGACTTCCTTGGCCCTCGGCGCGT 
CTAGACCCG -3‘ 
R(1+5)Q 
5‘-GAACTATACAAGTCCGGGTCTAGACAAGCCGAGGGCCAAG 
GAAGTCTTCTAACATGCGGGGACG -3‘ 
5‘-GTCCCCGCATGTTAGAAGACTTCCTTGGCCCTCG 
GCTTGTCTAGACCCGGACTTGTATAGTTCG -3‘ 
Q rescue 
5‘-GACGAACTATACAAGTCCGGGTCTAGACAAAGGGAGGGCC 
AAGGAAGTCTTCTAACATGCGGGGACGTG -3‘ 
5‘-GTCCCCGCATGTTAGAAGACTTCCTTGGCCCTCCC 
TTTGTCTAGACCCGGACTTGTATAGTTCGTCCATG -3‘ 
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4.2.3.3 Other selected mutations on the upstream context  
 
Following are the primers used for mutations performed on the C-terminal region of FMDV, DHV 
and ADRV 2As. 
Target FMDV nucleotides and corresponding amino acid sequences: 
16        CAACTGTTGAATTTTGACCTTCTTAAGCTTGCGGGAGACGTCGAGTCCAACCCCGGGCCC 
6          Q  L  L  N  F  D  L  L  K  L  A  G  D  V  E  S  N  P  G  P  
 
 
FMDV 2A successive Ala substitution from residues 6 to 17 (in grey in above sequence) 
 
Mutant Forward primer Reverse primer 
Q6A 5‘-GGAGCATGCGCACTGTTGAATTTTGACCTTC -3‘ 5‘-GTCAAAATTCAACAGTGCGCATGCTCCTCTAG -3‘ 
L7A 5‘-GGAGCATGCCAGGCCTTGAATTTTGACCTTC-3‘ 5‘-CAAAATTCAAGGCCTGGCATGCTCCTC -3‘ 
L8A 5‘-CATGCCAGCTGGCCAATTTTGACCTTC-3‘ 5‘-GTCAAAATTGGCCAGCTGGCATGCTCC -3‘ 
N9A 5‘-CCAGCTGTTGGCCTTTGACCTTCTTAAG-3‘ 5‘-GAAGGTCAAAGGCCAACAGCTGGCATGC -3‘ 
F10A 5‘-GCTGTTGAATGCCGACCTTCTTAAGCTTG-3‘ 5‘-CTTAAGAAGGTCGGCATTCAACAGCTGGCATGC -3‘ 
D11A 5‘-GTTGAATTTTGCCCTTCTTAAGCTTGCGG-3‘ 5‘-GCTTAAGAAGGGCAAAATTCAACAGCTGG -3‘ 
L12A 5‘-GAATTTTGACGCCCTTAAGCTTGCGGGAG-3‘ 5‘-CAAGCTTAAGGGCGTCAAAATTCAACAGC -3‘ 
L13A 5‘-GAATTTTGACCTTGCCAAGCTTGCGGGAGACGTCGAG-3‘ 5‘-CGCAAGCTTGGCAAGGTCAAAATTCAAC -3‘ 
K14A 5‘-GACCTTCTTGCCCTTGCGGGAGACGTC-3‘ 5‘-CTCCCGCAAGGGCAAGAAGGTCAAAATTC -3‘ 
L15A 5‘-CCTTCTTAAGGCCGCGGGAGACGTCGAGTC-3‘ 5‘-CGTCTCCCGCGGCCTTAAGAAGGTCAAAATTC -3‘ 
A16S  5‘-CTTCTTAAGCTTTCGGGAGACGTCGAGTCCAACCC -3‘ 5‘-GACCTTCTTAAGCTTTCGGGAGACGTCG -3‘ 
G17A 5‘-CTTAAGCTTGCGGCCGACGTCGAGTCCAACCCCGG-3‘ 5‘-GACTCGACGTCGGCCGCAAGCTTAAGAAGGTC -3‘ 
 
Target DHV20 nucleotides and corresponding amino acid sequences: 
1         GACCAAATTAGAAACAAGAAAGATCTCACTACTGAAGGAGTCGAGCCAAACCCCGGGCCC 
1          D  Q  I  R  N  K  K  D  L  T  T  E  G  V  E  P  N  P  G  P  
 
DHV 2A successive Ala substitution from residues 1 to 12 (in grey in above sequence) 
Mutant Forward primer Reverse primer 
D1A 5‘-GTCCGGGTCTAGAGCCCAAATTAGAAACAAG -3‘ 5‘-GTTTCTAATTTGGGCTCTAGACCCGGACTTG -3‘ 
Q2A 5‘-CGGGTCTAGAGACGCCATTAGAAACAAGAAAG -3‘ 5‘-CTTGTTTCTAATGGCGTCTCTAGACCCGGAC -3‘ 
I3A 5‘-GTCTAGAGACCAAGCCAGAAACAAGAAAGATCTC -3‘ 
5‘-CTTTCTTGTTTCTGGCTTGGTCTCTAGACCCGG 
AC -3‘ 
R4A 5‘-CTAGAGACCAAATTGCCAACAAGAAAGATCTCACTAC -3‘ 
5‘-GATCTTTCTTGTTGGCAATTTGGTCTCTAGACC 
CG -3‘ 
N5A 5‘-GACCAAATTAGAGCCAAGAAAGATCTCACTAC -3‘ 5‘-GAGATCTTTCTTGGCTCTAATTTGGTCTCTAGAC -3‘ 
K6A 5‘-CAAATTAGAAACGCCAAAGATCTCACTACTG-3‘ 
5‘-GTAGTGAGATCTTTGGCGTTTCTAATTTGGTCTC 
TAG -3‘ 
K7A 
5‘-CAAATTAGAAACAAGGCCGATCTCACTACTGAAG 
GAG-3‘ 
5‘-CAGTAGTGAGATCGGCCTTGTTTCTAATTTG 
GTC -3‘ 
D8A 5‘-GAAACAAGAAAGCCCTCACTACTGAAGGAG -3‘ 5‘-CTTCAGTAGTGAGGGCTTTCTTGTTTCTAATTTG -3‘ 
L9A 5‘-GAAACAAGAAAGATGCCACTACTGAAGGAGTC-3‘ 
5‘-CTCCTTCAGTAGTGGCATCTTTCTTGTTTCTAAT 
TTG -3‘ 
T10A 5‘-CAAGAAAGATCTCGCCACTGAAGGAGTCGAGCC -3‘ 5‘-GACTCCTTCAGTGGCGAGATCTTTCTTGTTTC -3‘ 
T11A 
 5‘-GAAAGATCTCACTGCCGAAGGAGTCGAGCCAA 
ACC-3‘ 
5‘-CTCGACTCCTTCGGCAGTGAGATCTTTCTTGT 
TTC -3‘ 
E12A 5‘-GATCTCACTACTGCCGGAGTCGAGCCAAACC -3‘ 5‘-GGCTCGACTCCGGCAGTAGTGAGATCTTTCTTG -3‘ 
 
 
 
96 
Other mutations performed on ADRV 2A and DHV 2A 
Mutant Forward primer Reverse primer 
ADRV 
E22G 
5‘-GTTCGAGATTTAACTAGAGGATGCATTGAATCT 
AACCCTGGG -3‘ 
5‘-GGTTAGATTCAATGCATCCTCTAGTTAA 
ATCTCGAACCCAAG -3‘ 
DHV 
E12D 
5‘-GAAAGATCTCACTACTGATGGAGTCGAGCCAAAC 
CCCGGG -3‘ 
5‘-GCCCGGGGTTTGGCTCGACTCCATCAGT 
AGTGAGATCTTTCTTGTTTCTAATTTG -3‘ 
DHV 
E12G 
5‘-GAAAGATCTCACTACTGGAGGAGTCGAGCCAAAC 
CCCGGG -3‘ 
5‘-GGTTTGGCTCGACTCCTCCAGTAGTGAG 
ATCTTTCTTGTTTCTAATTTGG -3‘ 
DHV 
G13D 
5‘-GAAAGATCTCACTACTGAAGATGTCGAGCCAAAC 
CCCGGG -3‘ 
5‘-GCCCGGGGTTTGGCTCGACATCTTCAGT 
AGTGAGATCTTTCTTG -3‘ 
 
 
 4.2.4 Primers for probing 2A-secondary structure.  
 
Gly and Pro mutants of selected TaV 2A residues 
Mutant Forward primer Reverse primer 
R1G 5‘-CCGGGTCTAGAGGGGCCGAGGGCAGGGG -3‘ 5‘-CTGCCCTCGGCCCCTCTAGACCCGGACTTG -3‘ 
A2G 5‘-GTCCGGGTCTAGAGGGGAGGGCAGGGGAAG -3‘ 5‘-CCCCTGCCCTCCCCTCTAGACCCGGACTTG -3‘ 
E3G 5‘-GTCTAGACGCGCCGGGGGCAGGGGAAGTCTTC -3‘ 5‘-CTTCCCCTGCCCCCGGCGCGTCTAGACCC -3‘ 
R5G 5‘-CGCCGAGGGCGGGGGAAGTCTTCTAACATG -3‘ 5‘-GAAGACTTCCCCCGCCCTCGGCGCGTC -3‘ 
G6P 5‘-CGAGGGCAGGCCCAGTCTTCTAACATGC -3‘ 5‘-GTTAGAAGACTGGGCCTGCCCTCGGCG -3‘ 
S7G 5‘-GGGCAGGGGAGGGCTTCTAACATGCGGG -3‘ 5‘-CATGTTAGAAGCCCTCCCCTGCCCTCGGC -3‘ 
L8G 5‘-CAGGGGAAGTGGGCTAACATGCGGGGAC -3‘ 5‘-CGCATGTTAGCCCACTTCCCCTGCCCTC -3‘ 
L9G 5‘-GGGAAGTCTTGGGACATGCGGGGACGTG -3‘ 5‘-CCCCGCATGTCCCAAGACTTCCCCTGCC -3‘ 
T10G 5‘-GAAGTCTTCTAGGGTGCGGGGACGTGGAG -3‘ 5‘-CGTCCCCGCACCCTAGAAGACTTCCCC -3‘ 
G12P  5‘-CTTCTAACATGCCCCGACGTGGAGGAAAATCC -3‘ 5‘-CCTCCACGTCGGGGCATGTTAGAAGACTTCC -3‘ 
 
Disruption of secondary structure by proline substitutions, mutations performed on TaV, DHV20 and 
FMDV 2As 
 
Mutant Forward primer Reverse primer 
TaV 
R1P+A2P 
5‘-CAAGTCCGGGTCTAGACCACCGGAGGGCAGGGGA 
AGTCTTC -3‘ 
5‘-CTTCCCCTGCCCTCCGGTGGTCTAGACC 
CGGACTTGTATA -3‘ 
TaV T10P 
+C11P 
5‘-GGAAGTCTTCTACCACCCGGGGACGTGGAGGAAA 
ATC -3‘ 
5‘-CTCCACGTCCCCGGGTGGTAGAAGACTTC 
CCCTGCC -3‘ 
FMDV 
A16P 
5‘-CTTAAGCTTCCGGGAGACGTCGAGTCC -3‘ 
5‘-CGACGTCTCCCGGAAGCTTAAGAAGGTC 
-3‘ 
FMDV 
S21P 
5‘-GAGACGTCGAGCCCAACCCCGGGCCCCACCACC -3‘ 5‘-GCCCGGGGTTGGGCTCGACGTCTCCCGCAAG -3‘ 
FMDV 
D11P+ 
L12P 
5‘-CTGTTGAATTTTCCGCCACTTAAGCTTGCGGGAG 
ACGTC -3‘ 
5‘-CCGCAAGCTTAAGTGGCGGAAAATTCAA 
CAGCTGGCATGC -3‘ 
FMDV 
A4P+C5P 
5‘-CCGGGTCTAGACCACCACCCCAGCTGTTGAATTT 
TGACC -3‘ 
5‘-CAACAGCTGGGGTGGTGGTCTAGACCC 
GGACTTGTATAG -3‘ 
DHV20 
P16A 
5‘-GAAGGAGTCGAGGCAAACCCCGGGCCCCACC -3‘ 
5‘-GCCCGGGGTTTGCCTCGACTCCTTCAGT 
AGTG-3‘ 
DHV20 
K6P+ K7P 
5‘-CAAATTAGAAACCCGCCAGATCTCACTACTGAAG 
GAG -3‘ 
5‘-GTAGTGAGATCTGGCGGGTTTCTAATTT 
GGTCTCTAG -3‘ 
DHV20 
T10P 
+T11P 
5‘-GAAAGATCTCCCTCCTGAAGGAGTCGAGCCAA 
ACC -3‘ 
5‘-CTCGACTCCTTCAGGAGGGAGATCTTT 
CTTGTTTCTAATTTG-3‘ 
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Non-conservative mutations of leucine for asparagine 
 
Mutant 
Forward primer Reverse primer 
TaV 
L8N 
5‘-GCAGGGGAAGTAATCTAACATGCGGGGACGTG-3‘ 5‘-CCGCATGTTAGATTACTTCCCCTGCCCTCG-3‘ 
FMDV 
L15N 
5‘-CCTTCTTAAGAATGCGGGAGACGTCGAGTCC-3‘ 5‘-GACGTCTCCCGCATTCTTAAGAAGGTCAAAATTC-3‘ 
FMDV 
L7N+L8N 
5‘-CTAGAGGAGCATGCCAGAATAACAATTTTGACCTTCTTAAGC-3‘ 5‘-GAAGGTCAAAATTGTTATTCTGGCATGCTCCTCTAGACCC-3‘ 
FMDV 
L12N+ 
L13N 
5‘-GAATTTTGACAATAATAAGCTTGCGGGAGACGTCGAG-3‘ 5‘-CTCCCGCAAGCTTATTATTGTCAAAATTCAACAGCTGGC-3‘ 
DHV20 
L9N 
5’-CAAGAAAGATAACACTACTGAAGGAGTCGAG-3’ 5’-CCTTCAGTAGTGTTATCTTTCTTGTTTC-3’ 
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4.3 Results 
 
The ribosome stalls upon encountering the nascent 2A, a peptide bond is not made and this is 
followed by re-initiation of translation. The re-initiation step depends on the ability of 2A to stall the 
ribosome. The results in this section are expressed in terms of arrest or stalling ability/ activity of a 2A 
sequence.  
The standard method previously published to identify the residues responsible for the elongation 
arrest in SecM, AAP and TnaC, consists of non/conservative and scanning mutagenesis and a 
qualitative assessment of each residue (Nakatogawa and Ito, 2002, Cruz-Vera and Yanofski, 2008, 
Spevak et al., 2010). In these publications, each mutated sequence was visually compared to their 
respective wild-type sequence. The authors categorise the residues as essential (mutation alleviate 
stalling), partially required (little to no change in stalling activity) or important (mutation affect 
acitivity but does not result in complete loss of activity). This standard method has been adopted in 
the context of this thesis. 
 
 
 
4.3.1 Mutations of the consensus sequences 
 
 
4.3.1.1 The [DV/IExNPGP] consensus sequences are interchangeable 
 
The experiment aimed at testing the consensus sequences present at the C-terminal of viruses 2A. 
Figure 4.2 shows the alignment of the 2A sequences from representative viruses. Only eight 
consensus motifs were identified and they represent the only conserved region of the 2A sequences 
listed. In the consensus motif most aa are conserved, differences exist at position two (occupied by 
Val or Ile) and at position four. Consensus motifs beginning with DVor DI are followed by Thr, Leu 
or Ser in position four. However, two more aa (Glu and Met) in position four can be identified with 
consensus motif beginning with DV. 
In this experiment, the TaV consensus motif [DVEENPGP] was swapped for [DVETNPGP], 
[DVEMNPGP], [DVELNPGP], [DVESNPGP], [DIESNPGP], [DIELNPGP] and [DIETNPGP]. 
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Figure 4.3: Testing the consensus motif variants 
SDS-PAGE analysis of the in vitro translation of TaV 2A and derivatives. The modified segment of TaV 2A (A) is in blue. 
The residues that characterised each mutant are in blue in (B) and indicated by a black arrow in (A).  
 
 
 
Given the considerable variation and the lack of conservation for the sequences in the upstream 
context, the straightforward conclusion is that the consensus motif contributes much to the stalling 
mechanism. This experiment aimed at comparing the eight consensus motifs identified to determine 
whether the two variable positions are simply plastic or whether these residues are linked to efficiency 
of stalling and fitted to complement a specific upstream context. No difference was observed between 
the translation profiles of the wild-type TaV 2A and consensus motif mutants in figure 4.3, all the 
mutants performed equally efficiently, and therefore not fitted to an upstream context. The conclusion 
is that the 2A consensus motif beginning with Asp [D(V/I)ExNPGP] exhibits some plasticity at 
position two and four in its consensus sequence and a large degree of plasticity in its upstream 
context. 
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4.3.1.2 The consensus motifs have different tolerances 
 
Hybrid 2As were created. ADRV [CIESNPGP], IFV [GIESNPGP] and DHV [GVEPNPGP] have a 
mutation on the first aa of the 2A consensus sequence. The upstream context of ADRV, IFV and 
DHV were joined to the consensus motif of TaV, and the TaV upstream context was placed preceding 
the ADRV, IFV and DHV consensus sequence.  
 
 
Figure 4.4: The translation of hybrids 
The sequences tested are listed in panel (A), and are colour coded. TaV sequence iss represented in pink, DHV in violet, 
ADRV in orange and IFV in green. The indicated mutants were translated in rabbit reticulocytes lysates with [35S]-
methionine and analysed by SDS-PAGE (B).  
 
TaV, DHV and ADRV were highly efficient at stalling the ribosome. DHV-TaV and ADRV-TaV 
hybrids had a canonical consensus motif, and were still able to stall the ribosome although less 
efficiently than their respective wild type (lanes 2 and 4). The IFV-TaV hybrid (lane 3) however lost 
that function. Inverting the sequences and using the TaV upstream context with several consensus 
motifs, compromised stalling in all cases.  
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Figure 4.5: Translation of TaV and DHV hybrids 
The sequences tested are listed in panel (A). TaV sequence is represented in pink and DHV in violet, and mutations 
highlighted in black. The sequences indicated in (A) were translated in rabbit reticulocytes lysates with [35S]-methionine and 
resolved by SDS-PAGE (B).  
 
TaV with an unsual [GGVEPNPGP] motif retained weak stalling abilities 12TaV-8DHV (figure 4.5, 
lane 4). The four residues [CGGV] were able, although very inefficiently, to generate stalling in the 
context of TaV 2A (figure 4.5, lane 6). 
 
These results demonstrate that consensus sequences have different requirements from their upstream 
context. The canonical consensus motif [DV/IExNPGP] could be used with different upstream context 
as it was testified by the range of sequences identified preceding this motif (figure 4.2) and the results 
presented in figures 4.3 to 4.5. Non-canonical consensus motifs such as [GIESNPGP] and 
[CIESNPGP] seemed to have stricter requirements to perform efficiently. 
 
Interestingly, between 11TaV-9DHV (unable to stall the ribosome) and TaV 2A wild type, there were 
only three amino acids difference. Step mutations to reverse this sequence back to TaV 2A showed 
that only a few residues were critical to resume activity. Comparing by pairs: lane 6 [GGVEPNPGP] 
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with 10 [GGVEENPGP], lanes 7 [EDVEPNPGP] with 11 [EDVE ENPGP] and lanes 8 
[EGVEENPGP] and 5 [EGVEENPGP], the results were similar within pairs and consistent with 
previous results (figure 4.2). The identity of the amino acid just preceding [NPGP] did not influence 
2A activity. The varying abilities of the mutants seemed to be attributed to the nature of the two 
residues at the N-terminus of the consensus motif, within the context of this hybrid. The consensus 
sequence in lane 8 [EGVEENPGP] had no activity. The consensus sequence in lane 10 
[GGVEENPGP], had very weak stalling abilities. In lane 11, [EDVEENPGP] 2A could stall the 
ribosome in an estimated 50% of cases. In lane 9, which corresponded to a mutation back to the 
generic motif [GDVEPNPGP], 2A activity was completely recovered. From these results, it was 
concluded that the beginning of the consensus motifs were also to an extent plastic. The other residues 
which could be accommodated were GG, ED and IC instead of GD. The residues found at these 
positions seemed to be somehow involved in the efficiency of stalling. 
 
 
4.3.1.3 A hierarchy of importance in the consensus amino acids. 
 
 
The consensus motif of TaV was subjected to successive alanine substitutions, in order to uncover the 
essential residues. The previous studies proved that the x in [DV/IExNPGP] could be substituted for 
M, L, S, and T without interfering with 2A activity (figure 4.3). The motif [GD(V/I)] could also be 
substituted for [GGV], [EDV] and [ICE], however in the context of TaV 2A these latter resulted in 
loss of efficiency (figures 4.4 and 4.5). Based on these results, further mutations were introduced in 
the consensus motif of TaV 2A to modify the distance between the two segments [GDV] and [NPG] 
(figure 4.6). A single amino acid was inserted; Ala [GDVANPGP], Glu [GDVENPGP], and one and 
two extra Ala residues were inserted to yield [GDVEAENPG] and [GDVEAAENPGP].  
 
In figure 4.6, mutations of the glutamic acid residues to alanine (E15A and E16A, panel (A), lane 4 
and 5) did not alter the stalling capacity of TaV 2A; insertion or deletions of amino acids in this 
segment (panel (B) lanes 2 to 6) completely abolished arrest activity. Therefore the exact spacing of 
[GDV] in relation to [NPG] was critical. Mutations of aspartic acid (D13A in panel (A), lane 2) as 
well as mutations of proline and glycine (P18A, G19A in panel (A), lanes 7 and 8) completely 
abolished 2A activity. Mutations of glycine, valine and asparagine (G12A, V14A and N17A in panel 
(A) lanes 1, 3 and 6) impaired activity. Interestingly, substitution of proline (P20A in panel (A) lane 
9) resulted in only 50 % loss of stalling ability. Proline substitutions at this position were further 
explored in chapter 5. 
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From these results it was concluded that [NPG] was the segment of the 2A required for stalling and its 
exact positioning in relation to the next stretch of important residues was essential. There was a 
hierarchy of importance in residues. [NPG] were considered essential residues, [GDV] important and 
EE partially required. 
 
 
 
 
 
Figure 4.6: Mutations to TaV 2A consensus sequence 
The target sequences are written in blue, the black arrows indicates the residue positions and the underlined sequences are 
the two areas of the consensus motif between which residues were inserted or removed. (A) Translation profile for 
successive alanine substitution of the TaV 2A consensus motif from residues 12 to 20. In (B), results of the activity assay 
with varying spaces between the consensus segments [GDV] and [NPG], the mutations in (B) are indicated in blue.  
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4.3.2 Requirements from the upstream context 
 
4.3.2.1 The sufficient sequence required  
 
It was previously proven that FMDV 2A required thirty amino acids to be optimal (100 % stalling) 
but the minimum length required was thirteen residues (Ryan and Drew, 1994). This was the arbitrary 
reason for cloning a length of thirty residues for each novel 2A. For the purpose of rationalising this 
experiment ADRV, IFV and DHV 2As were subjected to a series of deletions to yield 26, 23, 20 and 
17 aa truncated versions. 
 
 
 
Figure 4.7: N-terminal truncation of ADRV, IFV and DHV 2A 
The sequences tested were above the gel in (panel A) and (panel B). The N-terminal regions were deleted and analysed in 
the In vitro activity assay and resolved by SDS-PAGE gels.  
 
In figure 4.7, comparing ADRV truncated 2As to the wild type, the activity was not affected until the 
sequence was truncated to seventeen aa (comparing lane 5 to lane 1). IFV 2A activity was not affected 
until the sequence was truncated to twenty aa and a further deletion to seventeen aa abolished stalling 
(lanes 9 and 10). Shorter versions of DHV mediated more full-length products with seventeen C-
terminal residues. 
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From this experiment it was concluded that the minimum length sufficient to maintain wild type 2A 
activity was twenty-three aa for IFV and twenty aa for DHV and ADRV. TaV 2A was twenty aa long. 
FMDV 2A was naturally eighteen aa long and defined by the 3C
pro
 cleavage site at the 1D/2A 
junction. It was therefore decided to target the twenty C-terminal residues for the further site directed 
mutageneses on DHV, FMDV and TaV 2As. 
 
4.3.2.2 Mutational tolerance of the upstream context 
 
TaV, FMDV and DHV 2A upstream contexts were subjected to successive alanine mutations. Testing 
the derivatives in vitro allowed visualizing the contribution of each residue to 2A activity. The TaV 
2A residue 2 (alanine) mutant to glycine is included in the glycine scan of TaV 2A in figure 4.14. 
 
 
 
Figure 4.8: Alanine scan of TaV 2A upstream context 
TaV 2A target sequence (residues 1 to 11, in blue) was subjected to alanine scanning mutagenesis, tested in vitro and 
resolved by SDS-PAGE. The residues number and mutations are indicated for each lane. 
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In figure 4.8, altering the side chains of the residues Arg1 (lane 2), Glu3 (lane 3) and Ser7 (lane 7) did 
not compromise the activity of TaV 2A. Any other substitution across the length of the upstream 
contest was arrest impairing. However no substitution completely abolished TaV 2A activity. 
 
 
 
 
 
Figure 4.9: Alanine scan of FMDV 2A upstream context 
The target sequence (residues 6 to 17) is written in blue, with black arrows pointing the residues number. The mutated 2As 
were subjected to the activity assay and resolved by SDS-PAGE. The residue number and the mutation performed are 
indicated at the top of each lane. 
 
In figure 4.9, FMDV 2A could not, or was barely able, to mediate the ribosome stalling when Leu13 
(lane 9), Leu15 (lane 11) side chains were altered. Substitution of Gly17 (lane 13) to alanine had a 
similar affect. Modification of Ala16 to serine (lane 12) resulted in more full-length products 
compared to wild type (lane 1). However, substitutions of any other residues did not alter the 
translation profile as derivatives were as efficient as the wild type 2A. 
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Figure 4.10:  Other mutations of the upstream contexts 
The target sequence (residues 6 to 17) is written in blue, with black arrows pointing the residues number. DHV 2A upstream 
context was subjected to successive Ala mutations (panel (A)). Panel (B) shows non-conservative mutations performed on 
DHV Glu12 and ADRV 2A Glu22. The mutated 2As were subjected to the activity assay and resolved by SDS-PAGE.  
 
 
In figure 4.10, substitutions of DHV20 2A Glu12 (E12) for aspartic acid, alanine or glycine (panel (B) 
lanes 3,2 and 4) resulted in more full-length products but did not abolish the 2A stalling ability, 
adding to the list of residues employable in that region of the consensus motif. Successive alanine 
substitutions was performed on DHV20 2A. Mutations of the first three residues (lanes 2, 3 and 4- 
panel (A)) and of the residues Lys6 (lane 7), Lys7 (lane 8), Thr10 (lane 11) and Thr11 (lane 1 panel 
(B)) did not cause significant alterations in the ratio of full-length versus GFP2A and GUS products. 
Mutations of Arg4 (lane 5), Asn5 (lane 6), Asp8 (lane 9) and Leu9 (lane 10) however impaired 2A 
activity and increased the amount of full-length products.  
 
A comparison of the results in figures 4.8, 4.9 and 4.10 showed that the residues in the upstream 
contexts exhibited different tolerances to substitution. The conclusion from this set of experiments is 
that residues in 2A sequences are partially required, important or essential.The above findings are 
summarised in figure 4.11.  
The alanine-scanning mutagenesis served as the basis upon which the residues were classified in three 
categories. The effect of each susbtitution was assessed against the activity of their respective wild 
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type 2A sequences. The activity of the 2A variants was estimated by the amount of full-length 
products formed. In figure 4.11, residues marked in brown tolerated alanine substitution, and none to 
little alteration to the activity was observed. The residues side chains at these positions may therefore 
not directly be involved in elongation arrest. For the residues attributed the colour orange or red, 
alanine substitution at these positions impaired 2A activity (orange colour) or abolished 2A activity 
(red colour). Residues at these positions may therefore be critical for 2A-induced ribosome stalling. It 
is interesting to note that although the Asp residue of the consensus motif is marked red since 
mutation to Ala completely abolished stalling (figure 4.6 lane 2), its mutation to Gly (figure 4.5, lane 
6) preserved weak stalling abilities.  
 
 
Figure 4.11: Summary showing importance of residues for efficiency of 2A sequences   
The residues marked red were found to alleviate stalling and are judged essential, the residues written in orange, are 
important. The stalling ability was compromised when these residues were substituted. And finally the brown colour is 
attributed to residues that were required but did not seem to play an active role in the stalling mechanism. The first 
consensus motif residue Asp is in bracket as this position is occupied by Gly for DHV 2A.  
 
 
The observation from the figure 4.11 is that for all 2As there is a stretch of important residues (red 
and orange residues) at the C-terminus of the upstream context leading to the consensus motif. This 
section of the 2A sequences is therefore termed the ‘important region’. TaV and DHV 2As ‘important 
region’ encompasses nine residues. FMDV 2A ‘important region’ is shorter and comprises the five 
residues preceding the consensus motif.  
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Next, the sequences deposited in NCBI for FMDV 2A and DHV 2A were aligned using the weblogo 
web server (http://www.weblogo.berkeley.edu) and the result is shown in figure 4.12. A similar 
analysis was not possible for TaV 2A. TaV is not an economically important virus and there are only 
two entries in the public databases for its genome.  
 
 
Figure 4.12: Frequency plot of the residues conservation of FMDV and DHV 2A 
The letter size corresponds to the frequency of occurrence for this residue; the numbering is shown underneath. In (A) the 
plot was generated from 282 available FMDV 2A sequences and in (B) from 68 available DHV 2A sequences. The gold star 
indicated residues in the upstream context for which alanine substitution changed the translation profile for these 2A. 
 
The frequency plots in fugure 4.12 showed that residues that were either important or essential were 
conserved across sequences for each 2A. Surprisingly the conservation extended to the other residues: 
[NFDL] for FMDV 2A and to two stretches of residues [EIESDQ] and [AFEL] for DHV 2A. 
Referring to the frequency plot for FMDV, Pro28 as well as Pro30 of the consensus motif are not 
completely conserved. It was previously assumed that these were sequencing errors. Pro28 is in a 
critical position; it is therefore likely that the deviating sequence Pro28 to Leu is due to a sequencing 
error. In contrast, Pro30 to Ala mutant was viable (figure 4.6). It is therefore likely that FMDV 2A 
sequences containing a C-terminal Ala do exist naturally. 
 
 
110 
4.3.3 Probing interactions with the ribosome exit tunnel 
 
Argine and lysine are residues able to interact with RNA (Lu et al., 2007). An early experiment 
involved a series of non-conservative and conservative mutations performed on TaV 2A. TaV 2A has 
two arginine residues in its upstream context. These were mutated in turn and together to glutamic 
acid, isoleucine, lysine or glutamine. 
 
 
Figure 4.13: Mutations of TaV Arg 1 and/or 5  
The target residues were written in blue and indicated with a black arrow at the top of the figure. The relevant mutations and 
residues number were indicated for each lane. Panel (A) shows mutation of argine residues R1 and/or R5 to glutamic acid, 
isoleucine or lysine. Panel (B), mutation to glutamine. The mutants 2As were subjected to the activity assay and resolved by 
SDS-PAGE.  
 
Mutations of the first residue did not alter the activity of the 2As (figure 4.13). In panel (A) lane 2 
(R1E), lane 5 (R1I) and lane 8 (R1K), in panel (B) lane 2 (R1Q) had the same translation profile as 
TaV 2A wild type (panel (A) lane 1). Comparing pair-wise in panel (A) lane 3 with 4, lane 6 with 7, 
and lane 9 with 10, in panel (B) lane 3 and 4, the double mutations had a similar translation profile to 
the single point mutation of Arg5 only. 
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Mutations of Arg5 to glutamic acid (panel (A) lane 3), or isoleucine (panel (A) lane 6) or glutamine 
(panel (B) lane 3) proved arrest impairing. Mutation of Arg5 to lysine (panel (A) lane 9) enabled 
stalling with reduced efficiency compared to wild type (lane 1). The results suggested that a 
conservation of charge in that position was necessary for TaV 2A.  
 
Proline and glycine residues disrupt the secondary structure of a protein. If the peptide adopted an 
impairing conformation in the ribosome exit tunnel, the hypothesis was that substituting residues 
successively to glycine, and glycine residues to proline would completely abolish 2A activity. 
 
 
Figure 4.14: Glycine and proline mutations of the upstream context of TaV 2A 
The target residues are written in blue and indicated with a black arrow. The relevant mutations and residues number are 
indicated for each lane. The mutants 2As were translated in rabbit reticulocyte lysates with [35S]-methionine and resolved by 
SDS-PAGE.  
 
The results shown in figure 4.14 were similar to those previously obtained for the alanine scan of the 
upstream context of TaV 2A (figure 4.8). Weak stalling ability is retained for Arg5 (lane 6) Gly6 (lane 
7), Leu8 (lane 8), Thr10 (lane 10) and Gly12 (lane 11). The results do not support a model where TaV 
2A would adopt a helical conformation within the tunnel which is disrupted by introduction of glycine 
or proline. The results demonstrate that specific amino acids cannot be altered and strongly suggest a 
model where TaV interacts with the ribosome exit tunnel at these specific residues. 
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Woolhead and colleagues (2006), using FRET found that the seventeen C-terminal aa of SecM adopt 
a compacted conformation in the exit tunnel. They reasoned that proline substitutions should abolish 
the compaction by constraining the polypeptide backbone. They substituted in turn T152, S157, Q158, 
A159 and Q160 to proline and these abolished SecM activity. The resulting FRET analysis revealed 
an extended conformation. Addition of multiple proline residues in 2A would constrain the 
movements of the peptide chain. The conformation and therefore the positioning of the nascent 2A in 
the ribosome exit tunnel should be compromised. The next set of mutations was carried out with 
DHV20, FMDV and TaV 2As. Double proline mutations were introduced to the partially required 
residues of DHV upstream context: Lys6-Lys7 then Thr10-Thr11. Presuming 2A activity relied on its 
conformation; DHV 2A proline mutants would lose activity. If however there was no structural 
pattern and these residues were partially required for providing the correct spacing for example, then 
addition of proline at these residues would not alter DHV 2A activity. Similarly, double mutants were 
introduced in the upstream context of TaV: Arg1-Ala2, which were not necessary to activity, and 
Thr10-Cys11 which were important residues for 2A activity. The same strategy was also applied to 
FMDV. Proline mutations for residues Ala4-Cys5 (outside of the minimal length required) were 
introduced, also partially required residues Asp11-Leu12 were mutated to proline.  
 
Figure 4.15: Proline disruption of  DHV20, FMDV and TaV 2As 
The target residues are written in blue and indicated with a black arrow and numbered. The relevant mutations and residues 
number are indicated for each lane. The mutants 2As ( in panel (A) DHV and panel (B) TaV and FMDV) were translated in 
rabbit reticulocytes lysates with [35S]-methionine and resolved by SDS-PAGE.  
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Introducing multiple proline in the segment of 2A (figure 4.15) outside the ‘important region’, did not 
change the translation profile for TaV and FMDV (panel (B) lanes 2 and 8 respectively). Introducing 
proline within that ‘important region’, completely compromised 2A activity, whether the residues 
were previously shown to be essential (panel (B) lane 5), partially required (panel (A) lanes 3 and 4 
and panel (B) lane 7) or important (panel (B) lane 3). 
 
From this study it was concluded that TaV and DHV 2As would most likely adopt a conformation in 
the tunnel that favoured the partnering of several of its residues with nucleotides of the exit tunnel. 
Since both of these 2As are not predicted to have helical propensity (table 4.1), it is possible these 
would adopt an extended conformation within the exit tunnel.  
 
Referring to figure 4.11, it is noticeable that all the 2As have a leucine residue or sometimes even two 
in the region just upstream of their consensus motif. Leucine and asparagine are of similar size, but 
asparagine is hydrophilic. In the next experiment Leu was substituted with Asn.  
 
 
Figure 4.16: Leucine substitutions in the upstream context of DHV, TaV and FMDV 2As 
The target residues are indicated in blue and indicated with a black arrow and numbered. The relevant mutations and 
residues number are indicated for each lane. The mutants 2As were translated in rabbit reticulocyte extracts with [35S]-
methionine and resolved by SDS-PAGE. 
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Mutations of leucine residues (figure 4.16) in the regions of FMDV 2A partially required (lane 5), did 
not impair 2A activity. But substituting the residues 12 and 13 (lane 6), and 15 (lane 4) for asparagine 
created inactive 2As. Similarly, substitution of leucine residues for a hydrophilic amino acid resulted 
in decrease in the ability of the sequence to stall the ribosome for DHV (lane 8) and TaV 2A (lane 2), 
a result similar to substitution with the hydrophobic residue alanine. These results proved that a 
leucine in that position is critical for 2A activity. 
 
From the mutational analysis and truncation studies carried out so far, the ‘important region’ is critical 
for stalling and precedes the consensus motif. How diverse are the 2A sequences when only the 
‘important region’ is analysed? Figure 4.17 was created by manually sorting the 2A sequences into 
groups based on sequence similarities of the five C-terminal residues. The results show that viruses 
from a family share very similar and sometimes identical ‘important regions’.  
 
Figure 4.17: Subjective grouping of 2A based on sequence similarities of their important region 
For clarity, the consensus motifs were omitted and the residues spanning the important region (preceding the consensus 
motif) were manually grouped by sequence similarity based on the five C-terminal residues. Each family of virus was 
assigned a colour. Tetravirus members are shown in orange, picornavirus in green, cypovirus in red, rotavirus in pink, 
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totivirus in black, cripavirus in blue and iflavirus in violet. This alignment showed high level of conservation of 2A residues 
within a virus family. On the right, a motif was selected to represent a group of 2A. Based on this study, six groups of 2A are 
proposed. This does not account for unclassified 2As, grouped in a category at the bottom of the figure. 
 
By sorting the 2A sequences according to the primary sequence of their important regions, it was 
found that the majority could be aligned and produce six groups (figure 4.17). The group 1 model was 
TaV [GRGSLLTCGDVEENPGP] which has been the object of this body of work.  
The group 2 of 2A could be modelled by FMDV 2A. This group was characterised by threonine or 
serine in position 1, a completely conserved asparagine in position 2, an amino acid with an aromatic 
ring phenylalanine or tyrosine in position 3, a hydrophilic residue aspartic acid, glutamic acid or 
serine followed by completely conserved residues leucine, lysine and leucine position 5, 6 and 7. The 
next residue was either alanine or cysteine and the last residue of the important region of the upstream 
context was glycine.  
The group 3 and 4 shared the key motif from residue 6 to 10: [(I/L)LISG] and was mainly 
hydrophobic. Group 3 can be modelled by PoRV-C [FQIDKILISG] and the group 4 modelled by 
ABPV [WTDILLLLSG].  
The group 5 modelled by TMEV consisting of cardioviruses had a highly conserved upstream 
context: [ADYYKQRLIH] and employed histidine instead of glycine in position 10.  
Iflaviruses 2As were categorised separately in group 6. These sequences had no propensity for helix 
formation. The model selected was EoPV [GGQRDLTQDG].  
 
This categorisation serves the purpose of reducing the population of 2A sequences to several models. 
This could be the starting material to future mutagenesis and a way to compare and measure the 
activity of each variable region and understand the contribution of each amino acid on the efficiency 
of the stalling. The numbers of groups may evolve according to the understanding of the mechanism 
of action.  
 
Ryan and colleagues (1999) proposed that FMDV 2A activity was directly linked to the α-helical 
propensity of the peptide. The author proposed a model of action where the α-helix and the tight turn 
introduced by the [NPG] residues would re-orient the carboxy moiety of P site Gly-tRNA. In this 
model the α-helix is a critical contributing factor to stalling. It has also been suggested that every 2A 
peptide adopts the same mechanism of action (Donnelly et al., 2001).  
The table 4.1 summarises the prediction for α-helix formation in solution for the model 2As. The 
ribosome exit tunnel is not a homogenous environment (this is further elaborated in the discussion 
section). The prediction presented in table 4.1 can not be extrapolated to infer the conformation the 
2A elements would adopt in the ribosome tunnel. It is not known if FMDV 2A is helical in the exit 
tunnel. It is equally not known what conformation nascent peptides adopt in the upper exit tunnel.  
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The prediction in table 4.1 shows that the 2A sequences do not have the same propensities to form α-
helices. FMDV 2A is predicted to be α-helical but DHV and TaV 2As, however are not. If the α-
helical propensity is a critical element of 2A activity, then DHV and TaV 2As may not share a similar 
intra-ribosomal mechanism. This does not rule out the hypothesis that the [NPG] motif contributes to 
the stalling activity, but it implies that the α-helical hypothesis may not explain the activity for every 
2A. 
 
Table 4.1 α-helical propensity of the model 2As                                                                                         
The regions in the 2A sequences predicted by Jpred3 to form α-helix are edited in blue, the Jpred3 score representing the 
reliability of the prediction accuracy is given underneath and ranges from 0 to 9, higher score corresponds to a higher 
confidence in the prediction. The prediction used the thirty amino acids sequences presented in this table.  
Group and model 2A 2A sequence and α-helix propensity 
Group 1 TaV 2A 
 
RGPRPQNLGVRAEGRGSLLTCGDVEENPGP 
No α-helix predicted 
Group 2 FMDV 2A 
 
RHKEDCAPVKQLLNFDLLKLAGDVESNPGP 
        566323899885           
Group 3 PoRV 2A 
 
GNGNPLIVANAKFQIDKILISGDVELNPGP 
No α-helix predicted 
Group 4 ABPV 2A 
 
TGFLNKLYHCGSWTDILLLLSGDVETNPGP 
87367        5777664 
 
Group 5 TMEV 2A 
 
FREFFKAVRGYHADYYKQRLIHDVEMNPGP 
9058999986000699999998 
 
Group 6 EoP V 2A 
 
GQRTTEQIVTAQGWAPDLTQDGDVESNPGP 
    344 
 
Relevant unclassified 2A 
DHV 2A 
 
AFELNLEIESDQIRNKKDLTTEGVEPNPGP 
No α-helix predicted 
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4.4 Discussion 
 
In this section, 2A activity was subjected to site-directed mutagenesis and truncation. The activity of 
2A was assessed by its ability to mediate the production of two proteins from a single ORF. Scanning 
mutagenesis identified a hierarchy of importance for the residues comprising each sequence.  
 
 
All the [D(V/I)E xNPGP] are interchangeable in TaV 2A, in other words, the [DV/IExNPGP] 
consensus motif allows for flexibility in the upstream context. For the [DV/IExNPGP] consensus 
motif, the exact spacing between [NPG] motif (which is an absolute requirement) and the [GDV/I] 
motif is critical. There is flexibility allowed in the [GDV/I] motif, but the resulting consensus 
sequences are not as efficient as [GDV/I] motif in the context of TaV. Other consensus sequences 
[CIExNPGP] and [EGVxNPGP] have stricter requirements from their upstream context to be highly 
efficient. 
 
The minimal length required to maintain wild type activity is twenty amino acid for DHV 2A, twenty-
three for IFV and seventeen aa for TaV 2A. It is however not possible to ascertain the wild type 
efficiency of FMDV 2A. The various 2A sequences tested exhibit different efficiencies. TaV and 
DHV 2As are highly efficient but FMDV 2A is sub-optimal. 
 
The alanine scan mutagenesis identified an ‘important region’. It consists of the C-terminus of the 
upstream context adjacent to the consensus motif and stretches over five residues for FMDV 2A and 
nine residues for TaV and DHV. Alignment for FMDV and DHV sequences prove the residues in this 
region are highly conserved. This finding was extrapolated to other 2A sequences. The region 
preceding the consensus sequence (ten residues in total) was aligned, since this region is highly 
conserved within a family of virus and it was possible to categorise the viral 2A into six subjective 
groups and an unclassified seventh group. Twenty-eight out of thirty-four representative 2A 
sequences could be organised into six models. Some have predicted helical propensities in solution, 
others not, surprisingly the most efficient 2As, TaV and DHV do not. 
 
There are two mutagenesis profiles. DHV and TaV 2A are highly efficient. Any point mutations 
across their variable region alter, but do not result in complete abolition of activity. 
FMDV 2A however tolerates substitutions at all amino acids except for three specific residues Leu13, 
Leu15 and Gly17; for these residues substitution results in completely inactive sequences.  
The results from the double proline mutations imply that in active 2As, the important region has a 
spatial relationship to the exit tunnel and promote a mechanism of action where the residues that 
participate in the activity are positioned to interact with their partnering residue or nucleotide.  
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The mutations performed here are consistent with previously reported point mutations for FMDV 2A.  
[DLLNFLLKLAGDVESHPG/P] is 35% and [DLLNFLLKLAGDVESQPG/P] is only 17% efficient 
compared to the wild type sequence which is 65% efficient (Heras et al., 2006). This is consistent 
with the result presented here: asparagine is an important residue and strongly influences efficiency of 
stalling. [DLLNFLLKLAGDVESNLG/P] is not active (Luke et al., 2008), this result is consistent 
with the Pro18 substitution and suggests that proline is critical.  
 
 
Computer simulations of FMDV 2A structure predicted an α-helix, a tight turn at the [NPG] motif and 
an i-i+4 main-chain main-chain interaction that would stabilise the 2A and create the conformation 
that would reorient peptidyl-tRNA (Ryan et al., 1999). All prediction is created using parameters 
defined for protein in solution and in a uniform environment. The fact that [NPG] substitutions 
abolished 2A activity suggests that the tight turn predicted might be originating the predicted re-
orientation of the peptidyl-tRNA. There is at the moment no available data regarding the 
conformation nascent peptides take in the upper tunnel. How to explain the mechanism of action of 
2A?  
 
There are three main points to discuss: 
 
(i) interaction of 2A with the ribosome 
(ii) for FMDV 2A, the efficiency of stalling increases with the length of the upstream context. Double 
proline mutations proved that residues outside the ‘important region’ may employ an additional 
mechanism. 
(iii) some residues are conserved when they are not necessary 
 
 
Interaction with the exit tunnel 
There are several lines of evidence to prove 2A interacts with the exit tunnel. The most important one 
is that localised substitutions limit activity. The nature of the residue in these positions confers 2A 
efficiency: Arg5, Leu8 for TaV, [GDV] versus [EGV] in the 2A consensus motif, Leu13, Leu15 and 
Gly17 for FMDV 2A and the residues preceding [NPG] are not required. Another proof is that 
introducing double proline in the important region result in no activity, a result that is not observed 
outside this area. Although the hypothesis of no interaction to the tunnel can not be ruled out until 
cryoEM resolution and ribosome mutagenesis are carried out, this hypothesis seems very unlikely. If 
the question is to be asked differently, then it will become, what stabilizes the peptide long enough for 
stalling, rescue and re-initiation to occur if the ribosome is not involved? 
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There could be two options: 2A adopts a stabilised helical structure (or perhaps a compacted 
structure) jamming the tunnel or an extended conformation interacting with partnering residues in the 
tunnel halting translation. Either of these will not be possible without the involvement of the 
ribosome. The rate of integration of amino acids to the growing chain varies with the nature of the 
residue in the A and P site but the ribosome can process lysine at a rate of 100 s
-1
 (Wohlgemuth et al., 
2008). The upper tunnel is not a uniform environment, it has bends (Nissen et al., 2000) and a varying 
electrostatic environment (Lu et al., 2007), and to induce stalling will most likely require stabilisation 
by the ribosome to override the fluctuations. In the translating ribosome, the important region and the 
consensus motif of the 2A sequence would be localised in the upper tunnel, in the area of the exit 
tunnel considered to be flexible. By comparing ribosomes in various states for four bacteria, it was 
discovered that there are flexible areas within the exit tunnel. The most flexible areas are the regions 
adjacent to the PTC and the constriction point where the proteins L22 and L4 protrude in the tunnel 
lumen, in that several nucleotides (especially A2062) or protein residues are seen flat against the 
tunnel wall or protruding in the lumen. The last region of flexibility consists of a small group of 
residues at the exit port (Fulle and Gohlke, 2009).  
 
Could 2A fit in the models elaborated for other stalling peptides? As detailed in the introduction, 
nascent peptides that stall elongation exist both for prokaryotes and eukaryotes. Their primary 
sequence is diverse. Extensive site directed mutagenesis were carried out and uncovered important 
residues at their C-terminus. The length responsible for the stalling activity varies from nine residues 
for ermC (Tenson et al., 2003) to twenty-one residues for fungal arginine attenuator peptide (AAP) 
(Lovett and Rogers, 1996). In every case, the stalling involved an interaction between the important 
residues and the ribosome exit tunnel. For SecM, Yap and Bernstein (2011) concluded that the critical 
residues were facilitated in their placement by neighbouring amino acids. For all nascent stalling 
sequences, mutational analyses of the ribosome exit tunnel coupled with cryoEM analysis uncovered 
nucleotides in the vicinity of the PTC and residues in the protruding loops of protein L17/L22 and L4 
to be involved in stalling. Most importantly cryoEM of the nascent stalling sequences showed 
multiple contacts with the tunnel. TnaC nascent peptide contacts: A751, U2609, U2602, L4 and L17 
(Cruz-Vera et al., 2005). AAP nascent peptide contacts U2585, G2061, A2062, A2058, A2059, and 
U2609 (E. coli numbering) (Bhushan et al., 2010). Nascent SecM interacts with A2062, A2058, L22, 
A2503 and A751 (Nakatogawa and Ito, 2002). ermC contacts A2062, A2503, L4 and A2058 
(Vasquez-Laslop et al., 2008). The authors all agree on a signalling relay between the nascent peptide 
and the ribosomal nucleotides leading to a compromised PTC. Two possible routes of signalling via 
the nucleotide A2058 (Vasquez-Laslop, 2010) or via the nucleotide A751 (Martinez et al., 2012) have 
been proposed. The relay mechanism is at present unknown and SecM is thought to be sensed by the 
ribosome at two locations in the vicinity of the PTC and at the L22 loop (Bhushan et al., 2011).  
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The folding zone of the ribosome exit tunnel (corresponding to Fulle and Gohlke (2009) flexible zone, 
corresponding to the upper tunnel) can accommodate α-helices (Lu and Deutsch, 2010). Lim and 
Spirin (1986) theorised that nascent peptides would adopt an α-helical conformation when growing 
through the exit tunnel. The nascent stalling peptides such as AAP and SecM have a compacted 
formation in the tunnel in the vicinity of the PTC (Woolhead et al., 2006 and Bhushan et al., 2011). 
TnaC however has an extended conformation throughout the tunnel (Seidelt et al., 2009). CryoEM 
studies proved that polypeptides could adopt an extended or a compacted conformation and even a 
helical structure. If a nascent peptide was helical, there would be sixty amino acids protected at any 
time by the ribosome, and if the structure was completely extended, this number will fall to twenty-
five residues only. Very early studies established by proteolysis of nascent chains that thirty to forty 
amino acids are protected by the eukaryotic ribosome (Malkin and Rich, 1967 and Blobel and 
Sabatini, 1970). The logical conclusion was therefore that peptides would adopt partly compacted and 
partly extended conformation in transit. Woolhead and co-workers (2004) used FRET analysis to 
demonstrate that a transmembrane segment (α-helical) as opposed to a control peptide (without that 
propensity) adopted a compact conformation which they localised at the upper tunnel (near the PTC). 
Lu and Deutsch (2010) also demonstrated α-helices in the eukaryotic tunnel. They used blocks of five, 
ten and fifteen alanines at different positions in a growing peptide. The inserted a single cysteine 
residue at the N-terminus of the peptide and measured the ability of this residue to interact with 
maleimide. The reactant chosen for this experiment was too large to enter the tunnel, and the reaction 
could only occur if the cysteine residue was exposed in the solution. They found that α-helices could 
be located in the upper tunnel and the exit port, and failed to observe any helices for control peptides. 
A third study also identified α-helix using cryoEM (Bhushan et al., 2010b). They inserted five times 
the sequence [EAAAK] successively at two locations in a growing peptide. The rationale for their 
choice was that the alanine motif would form an α-helix and the glutamic acid and lysine would 
stabilise the structure with a salt bridge. Their sequence was also known to prefer a helical 
conformation in solution. They found α-helix in the lower tunnel, and in the upper tunnel but not in 
the central region. Collectively, these results prove that α-helix can be accommodated and stabilised 
in the tunnel. But none of these studies report a helical conformation for a peptide that does not have a 
helical propensity. And the result obtained for the stalling sequence TnaC prove that stalling does not 
necessarily require a helical conformation. The literature tends to suggest that a peptide with helical 
propensity may well adopt it as early as the upper tunnel, and for that reason the hypothesis that 
FMDV 2A helical propensity plays a part in its activity, can not be ruled out.  
 
What would explain the activity of TaV and DHV? The results prove TaV 2A adopts a localised 
conformation, involving interactions with the tunnel elements. From the mutagenesis, Leu8 side 
chains and Arg5 are important for TaV 2A. DHV 2A has a hydrophilic context, and outside the 
important leucine residue, has especially an arginine and also two lysines in its important region. A 
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possibility is that DHV 2A positively charged context contribute to pausing via electrostatic 
interactions. Several studies demonstrate the ability of positively charged residues to interact and slow 
and even pause the elongating ribosome.  
 
Dimitrova and colleagues (2008) inserted twelve consecutive lysines between two reporter proteins 
and as a control inserted a stem loop instead of the poly-Lysine. Employing a yeast system, they 
found that poly-lysine caused translation arrest, the downstream peptide was not being synthesised. 
The mRNA was also degraded. Insertion of a stem loop did not result in mRNA degradation. They 
concluded that lysine positive charge could interact with the rRNA from the tunnel, a result which 
mimics poly-A tail at the end of eukaryotic mRNA. The poly-A tail (eighty or so adenines) regardless 
of reading frame encodes for poly-lysine and serves the purpose of stalling the ribosome which has 
read through their termination codon (Akimitsu et al., 2007). In a recent study (Charneski ad Hurst, 
2013), it was reported that charged amino acids regulate the ribosome velocity and the authors argue 
that in their studies they found no evidence that codon usage and mRNA structure would alter the rate 
of elongation. The study consisted of a re-analysis of experimental data collected using ribosomal 
footprinting of Saccharomyces cerevisiae transcriptome. The data set was generated by obtaining, 
reverse transcribing, sequencing and identifying the sequences of the mRNA protected by the 
ribosome. The analysis repeated at time intervals provides the total occupancy for the ribosomes at 
various times points and therefore allows by derivation to assess the velocity of the ribosome. It was 
found that a single positive charge within thirty amino acids without any other positively charged 
residue could slow the ribosome. This ability was not linked to codon usage, or the structure of the 
mRNA and they established that histidine caused a weaker slowing compared to arginine and lysine. 
The authors concluded that positive charge slowing of the translating ribosome is a normal feature of 
translation. A noteworthy detail is that ribosomal protein L22 residue Lys90 is involved in stalling of 
SecM (Nakatogawa and Ito, 2002). Based on the literature, the logical conclusion is that one 
mechanism involved in DHV and TaV 2A stalling is a slowing of translation induced by positively 
charged residues. TaV2A Arg5 may serve also an additional function. Its substitution for lysine 
resulted in less activity. This amino acid would reside in the area of the tunnel constricted by proteins 
L17 and L4. The hypothesis is that Arg5 may interact with a residue from one of these proteins. 
 
Out of the six identified 2A groups, each have a lysine or an arginine residue except for the ABPV 
model (sequence is: WTDILLLLSG) which is leucine rich. 2A without helical propensity can rely on 
the positive charge forming weak interaction with the rRNA as it egresses through the exit tunnel. 
Leucine residues may orient favourably the sequence in the tunnel. 
 
The following figure (4.18) provides an illustration for the upper tunnel and the table underneath 
provides a hypothetical interpretation for the location of TaV 2A residues in the tunnel.  
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Figure 4.18: Illustration of the ribosome exit tunnel and interpretative table showing TaV 2A 
and other stalling peptides 
(A) an illustration of a bacterial ribosome 50S and 30S subunits and the position of the tunnel in the 50S subunit. (B) 
Amplification of the first part of the exit tunnel. Several nucleotides in the wall of the tunnel and at the PTC are represented 
as well as the proteins L22 (blue) and L4 (green). The PTC nucleotides are represented in orange. Red residues are involved 
in SecM and ermC. Nucleotides in pink and residue K90 from the protein L22 are critical for SecM and TnaC. The white 
arrow indicated the possible relay to the PTC (via the nucleotides represented in cyan) for TnaC. In (C) the table provide an 
interpretative residue by residue alignment showing their approximate locations in the ribosome (top line highlighted in grey, 
ribosomal residues in yellow boxes). The table shows the critical residues for stalling. x represents residues that can be 
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substituted. The residue in lower case and in italic at the A site of ermC is not required for the arrest. * represents the UGA 
stop codon for TnaC. The last line provides the hypothetical organisation of TaV2A in the tunnel the colouring for TaV 
residues shows their importance: in brown partially required, orange important and red essential (Adapted from Martinez et 
al., 2012 and Ito et al., 2010). 
 
The relay that other nascent peptides engaged in is thought to involve the residues communicating 
with the PTC. It is critical for peptide bond formation that the two tRNA substrates are positioned 
correctly (Schmeing et al., 2005), and the suggested way that this activity is impaired is through a 
disturbance of the position of critical elements as subtle as a hydrogen bond which takes part in the 
positioning of the P site tRNA. The folding of the 23/28 S rRNA domain V involves base pairing and 
base stacking (Kim and Green, 1999) and it is reasonable to envisage that a simple disturbance in this 
arrangement might be the cause for altered PTC geometry. 
 
Length and double proline mutations. 
From early work and as already cited numerous times, the length of the FMDV 2A peptide is 
proportional to its efficiency. The longer it is the more efficiently it stalls. Recent work in this 
laboratory proved that modification of the N terminus of TaV, both single point mutations and 
insertion and deletions of six residues in the region preceding TaV 2A does not alter in any way TaV 
2A ability to stall the ribosome. This study was conducted without taking into account that positively 
charged residues can slow the ribosome, as a result it is not possible to rule out the involvement of the 
lower tunnel in TaV 2A activity (Minskaia, manuscript in preparation). Additional deletions to the six 
groups of 2A identified will greatly elucidate what role the lower tunnel plays in the mechanism of 
action. The lower tunnel has a larger diameter (25Å) and allows potentially more freedom of 
movement to the growing peptide. One hypothesis is that the N-terminus in the lower tunnel adds to 
the stability of the structure/ conformation and providing that the sequence supports that 
structure/conformation, the 2A will be efficient. Another hypothesis is that the lower tunnel is also 
imbued with sensing abilities like the upper tunnel and intereacts with the growing peptide. The 
argument in favour of an extra sensing mechanism is that introducing double proline in the region 
preceding the important region for different 2As did not alter the stalling ability. The residues 
involved were located eighteen (for TaV 2A) to twenty amino acids (for FMDV 2A) away from the 
Gly-Pro pair, it is likely that the residues mutated would be at the very least located in the constriction 
area or perhaps even further depending on the structure the 2A adopts. If the lower tunnel only 
stabilised the 2A, double Pro would have decreased the activity of FMDV 2A. 
 
The N-terminal half of FMDV 2A sequence is very variable but it is noticeable (figure 4.12) that 
some positively charged residues are favoured. In position 1 histidine and arginine are preferred, the 
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next amino acid is a completely conserved lysine, and eight amino acids downstream there is also a 
completely conserved lysine (Lys10). 
 
Conservation of residues not necessary to 2A activity.  
What is puzzling is that residues that were believed to be the signature motif for 2A: [DV/IE] are 
shown to be replaceable by other residues. [GGV], [AGV], [DGV] and [ICV]. However, in FMDV 
(sub-optimal) these residues are not mutated, and Glu is completely conserved in all viral sequences 
when it could be replaced by alanine, why? In fact several residues not required for activity are still 
conserved. The [NFD] (residues 14 to 16) motif of FMDV 2A, a large part of the N-terminal region of 
DHV too not necessary for activity (since it could be truncated and not affect stalling efficiency) are 
completely conserved.  
 
Aphthoviruses share the FMDV type of 2A. Similarly, TaV and related viruses PV and EeV share the 
same 2A sequence. The result is consistent with previous analyses (Luke et al, 2008). A virus finds 
itself with a certain type of 2A by phylogenetic relationship. There are no available data correlating 
the level of activity of 2A with the virus strategies and fitness. Considering the high level of 
conservation of the sequences, the viruses most likely have a vital reason for maintaining this precise 
sequence and outside the observation that FMDV optimised its codon usage to adapt to that of its host 
(Zhou et al., 2000), it is very likely that FMDV has utility for a sub-optimal 2A and TaV for an 
optimum 2A. The reason is unknown at present. 
 
 
In summary, the highly efficient 2A makes contacts/ interaction with the ribosome tunnel elements. 
The strength or the stability of this interaction dictates the level of efficiency of the 2A sequence and 
dictates plasticity in the consensus sequence. 2A with less efficacies have limited abilities to either 
interact or stabilise that interaction.  
 
 
In this chapter it was shown that the 2A sequences could be reduced to several models but there is at 
least two mechanisms by which 2A induces the ribosome stalling, to uncover the 2A rule, future steps 
could involve trimming the model sequences to twenty amino acids and measure their activity paying 
particular attention to the role charges could play in their activity and carrying out non-conservative 
mutagenesis. Understanding the 2A-induced ribosome stalling would bring a further insight into the 
interaction between nascent peptides and ribosome exit tunnel. 
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5.1 Introduction 
 
The last chapter explored the possible interaction between the nascent peptide in the exit tunnel and 
2A-induced stalling. In this chapter the question adressed is: why is the peptide bond not made, in 
other words, why is the peptide not transferred to the A site tRNA?   
 
For all other stalling peptides listed to date, the PTC geometry is altered and the most straightforward 
way to test for this is to introduce puromycin in the ribosome A site. Puromycin is a tRNA analogue 
and has been employed and modified extensively in ribosomal studies (Pestka et al., 1973). It is 
particularly useful because it circumvents the need for the accommodation stage and reacts to 
prokaryotic and eukaryotic ribosomes. Puromycin reactivity to the peptide drops when the PTC 
geometry is altered.  
 
The abundance of a tRNA species has been demonstrated to play a role in the rate of elongation. The 
choice of codons may be another contributing factor to 2A-induced stalling. The hypothesis was that 
rarer codons would amplify 2A activity since the ribosome would have to stall longer to accommodate 
a rarer species of tRNA. For example, Woolstenhulme and colleagues (2013) identified stalling motifs 
related to cluster of rare codons in E. coli. For this experiment FMDV 2A coding sequence was 
inserted between luciferase and renilla genes. The C-terminal proline codon (CCC) was mutated to the 
synonymous codons CCG, CCA and CCT. In addition the following controls were included: a stop or 
a sense codon between the two genes. The experiment aimed at measuring the levels of renilla and 
luciferase activity using the Dual-Glo system (Promega) in bovine lung cells transiently transfected. 
 
 
An unexpected result was that the Pro20 mutant to Ala (figure 4.6) of TaV 2A still retained good 
stalling activity. The model for 2A activity explained the stalling with the poor reactivities of glycine 
and proline. The experiment carried out was to substitute theTaV 2A A site proline for glycine, valine, 
serine, threonine and cysteine.  
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The Pichia pastoris system enables the overexpression of milligrammes of heterologous proteins. The 
pPinkα-HC vector has the secretion signal α-mating factor from Saccharomyces cerevisiae that 
enables secretion of the protein of interest in the media. The P. pastoris PichiaPink system from 
Invitrogen is designed for high level production of recombinant proteins. The expression system relies 
on the strong inducible AOX1 promoter in the presence of methanol. For the purpose of this study, it 
was decided to use the PichiaPink strain 4 (genotype: ade2, prb1, pep4). pep4 knockout prevents the 
strain from synthesising proteinase A and prb1 knockout, proteinase B. ade2 auxotroph strains can 
not grow without adenine and purine precursors accumulate in vacuoles, the colonies appear small 
and red. In the pPinkα-HC vector the ADE2 gene is driven by a truncated 13bp ADE2 promoter. 
ADE2 encodes phosphoribosylaminoimidazole carboxylase involved in the de novo synthesis of 
purines. The successful transformation of the pichiaPink strain with a copy of the ADE2 gene allows 
the strain to thrive in adenine-deprived media and appear white. Selection of transformants is based 
on colours. Very white colonies have integrated several copies of the plasmid and potentially indicate 
high level of expression. The strategy was to secrete 2A for future NMR resolution and comparison of 
their structure with inactive 2As. This first attempt at expressing 2A in the P. pastoris system was 
carried out with TaV 2A. 
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5.2 Materials and methods 
 
 
Plasmid pSTA1 (coding for GFP-2A-GUS) and pJC3 (coding for GFP-2A-CherryFP) were modified.  
Primers were designed to introduce a mutation in at a specific residue (induced mutation was 
highlighted in blue in the forward primers sequences in this section). Alternatively blunt-ended DNA 
fragments were created for puromycin experiment. PCR were performed using the KOD Hot start 
enzyme from Novagen, following manufacturer instructions. The protocols utilised were detailed in 
sections 2.2.1 to 7. The DNA were gel purified using Wizard SV gel clean up kit (Promega) and 
vectors were extracted using Qiagen spin miniprep kit. The integrity of the mutants was assessed by 
big Dye terminator sequencing (ABI) outsourced from Dundee sequencing services. In vitro 
translation were performed in 12,5 µl Rabbit reticulocytes supplemented with [
35
S]-Met and incubated 
for ninety minutes. The translation products were resolved on 4-20 % tris-bis SDS-PAGE 
denaturating gels (Expedeon). The gels were Coomassie-stained and [
35
S]-labelled proteins were 
visualised onto photographic film and size determined against the dual colour marker precision 
standard from Biorad. 
   
5.2.1 Puromycin test 
 
To generate the blunt ended PCR fragments, the PCR templates were pSTA1 TaV 2A and pSTA1 
TaV 2A mutant G12A, which is inactive. The PCRs amplified the GFP-2A (samples) and the GFP 
segment terminated before TaV 2A (negative control). The translations were carried out in rabbit 
reticulocyte lysates using 1 μl of purified and sequenced PCR fragments, [35S]-Met, in a total volume 
of 25 μl. The primers were designed so that two alternative translated C-terminus were tested for the 
active TaV 2A : [NPG] and [NPGP]. The inactive TaV mutant fragment tested ended with [NPG].  
Forward primer pSTA1 beg T7 Fw: 5’-CTGGCTTATCGAAATTAATACGAC-3‘ and reverses: 
NPG Rev : 5’-CCCGGGATTTTCCTCCACGTC-3’ 
NPGP rev: 5’-GGGCCCGGGATTTTCCTCCACGTC-3‘ 
GFP Rev2: 5’-CCCGGACTTGTATAGTTCGTC-3’ 
 
After translation for 30 min, puromycin was added, incubated for 1 min, the reactions were stopped 
on ice, a 10 μl aliquot of each samples was treated with 5 U of RNAse A/T1 and incubated at 37 oC 
for 30 min. the samples were then resolved on 4-20 % SDS-PAGE. 
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5.2.2 A site proline mutations 
 
A dual renilla-2A-luciferase insert was created in the backbone of pSTA1 vector. Renilla was 
amplified to create a Hind3 site in the 5’ region of the gene and a Xba 1site at the 3’ end. The 
modified renilla was inserted in pSTA1 instead of GFP.  
Primers: 
Ren Hind3 f: 5’-AAGCTTATGACTTCGAAAGTTTATGATC-3’ 
Ren Xba1 rev2: 5’-TCTAGATTGTTCATTTTTGAGAACTC-3’ 
 
 
 
Figure 5.1: Details of the dual renilla-luciferase insert for expression in bovine cell line 
In (A) the schema shows the cloning sites used to modified pSTA1 FMDV 2A with renilla and luciferase genes. In (B) 
Renilla (in pink) replaced GFP at the 5’ end and luciferase (in yellow) replaced GUS at the 3’ end of FMDV 2A. Two 
controls were also created where 2A was replaced by a stop codon TAA or the sense codon TAC.  
 
 
The firefly luciferase gene was amplified to create a Xho1 site at the 3’ end. The 5’ end contained 
either an Apa1 site (for ligation to 2A sequence in pSTA1) or a Xba1 site (for ligation to the renilla 
sequence in pSTA1). Stop codon was TAA and sense codon was TAC coding for Tyr. 
Forward primers: 
Apa1Fluc F1: GGGCCCATGAAGAGATACGCCCTGGTTC 
Xba1StopFluc F2:TCTAGATAAATGAAGAGATACGCCCTGGTTC 
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Xba1senseFluc F3: TCTAGATACATGAAGAGATACGCCCTGGTTC 
Reverse primer, Fluc xho1 rev: 5’- CTCGAGTTACAATTTGGACTTTCCGCCC-3’ 
 
The A site proline (FMDV 2A Pro) was mutated to the synonymous codons: CCA, CCT and CCG 
using the following primers. The substitutions are in blue in the sequences underneath.  
CCA Fw: 5’-GTCCAACCCCGGGCCAATGAAGAGATACGCCCTGG-3’ 
CCA R:5’-GCGTATCTCTTCATTGGCCCGGGGTTGGACTCGAC-3’ 
CCG Fw: 5’-GTCCAACCCCGGGCCGATGAAGAGATACGCCCTGG-3’ 
CCG R:5’-GCGTATCTCTTCATCGGCCCGGGGTTGGACTCGAC-3’ 
CCT Fw: 5’-GTCCAACCCCGGGCCTATGAAGAGATACGCCCTGG-3’ 
CCT R:5-GCGTATCTCTTCATAGGCCCGGGGTTGGACTCGAC-3’ 
 
Bovine lung cells were cultured and transfected as described in sections 2.2.11 and 12. 
 
TaV 2A A site proline (Pro20) was mutated to glycine, serine, valine, threonine and cysteine. In the 
mutation primers underneath, the mutated nucleotides are written in blue. 
mutant Sequence 5’-3’ Primers names 
TaV P20G Fw: GGAAAATCCCGGGGGACACCACCACCACCACCAC 
R:GGTGGTGGTGGTGTCCCCCGGGATTTTCCTCCACG 
 TaV P20G F 
TaV P20G R 
TaV P20S Fw: GGAAAATCCCGGGAGCCACCACCACCACCACCAC 
R: GGTGGTGGTGGTGGCTCCCGGGATTTTCCTCCACG 
TaV P20S F 
TaV P20S R 
TaV P20V Fw: GGAAAATCCCGGGGTACACCACCACCACCACCAC 
R: GGTGGTGGTGGTGTACCCCGGGATTTTCCTCCACG 
TaV P20V F 
TaV P20V R 
TaV P20T Fw: GGAAAATCCCGGGACCCACCACCACCACCACCAC 
R: GGTGGTGGTGGTGGGTCCCGGGATTTTCCTCCACG 
TaV P20T F 
TaV P20T R 
TaV P20C Fw: GGAAAATCCCGGGTGCCACCACCACCACCACCAC 
R: GGTGGTGGTGGTGGCACCCGGGATTTTCCTCCACG 
TaV P20C F 
TaV P20C R 
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5.2.3 2A expression using the PichiaPink system. 
 
TaV 2A was created from pJC3 plasmid (appendix 1) and inserted in the pPinkα-HC vector.  
 
 
Figure 5.2: Map of pPinkα-HC   
The vector contains the α-mating factor for secretion of the recombinant protein. The AOX1 promoter drives expression 
when induced by high levels of methanol. The vector also expresses the ADE2 gene for selection of transformants. (vector 
map sourced from http://www.lifetechnologies.com) 
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Table 5.1: Details of sequences forming the TaV 2A insert for expression in the PichiaPink 
system 
The histidine tag was inserted for affinity purification; the TeV site for proteolytic cleavage of the purified 2A and 2A was 
inserted at the N-terminus of cherryFP. The insert was cloned in pPinkα vector via Xho1and Kpn1sites.  
 motif Nucleotides and amino acid  sequences 
Beginning 
of ORF 
Xho1 CTCGAG 
α vector 
sequence 
AAAAGGCCT 
Start codon 
and polyHis 
ATGGGCCATCATCATCATCATCATCATCAT 
 M  G  H  H  H  H  H  H  H  H 
TeV cleavage 
sequence 
GAGAATAAATATTTTCAGGGGATGCAT 
 E  N  K  Y  F  Q  G  M  H  
 Xba1+ 
TaV2A 
TCTAGAGGCTCCGGAGAGGGCAGGGGAAGTCTT  
 S  R  G  S  G  E  G  R  G  S  L    
CTAACATGCGGGGACGTGGAGGAAAATCCCGGGCCC 
 L  T  C  G  D  V  E  E  N  P  G  P 
End of 
ORF 
cherryFP          …… GATGAATTGTACAAATAA 
Kpn1 GGTACC 
 
 
 
Figure 5.3: Creation of the TaV 2A insert for pPinkα vector 
Cloning sites for pPinkα-HC, as well as polyhistidine for affinity purification and a protease site were created are the 5’ end 
of the TaV 2A sequence, ligated and sequenced in pGemT-easy and further cloned in the final vector via Xho1 and Knp1 
restriction sites.  
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Primers for cloning were,  
Xho1 Pink αHTaV F : 5’-CTCGAGAAAAGGCCTATGGGCCATCATCATCAT-3’  
TaV linker pich F:  5’-GGATCCATGGGCCATCATCATCATCATCATCATCATGAGAATAAAT 
ATTTTCAGGGGATGCATTCTAGAGGCTCCGGA-3’ 
and reverse Kpn1 chFP R: 5’- GGTACCTTATTTGTACAATTCATC-3’.The insert  was created in 2 
successive PCRs. 
 
Forward primer used for sequencing was                     
pink seq F: 5’-ATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTATCT-3’.  
 
Primers used for PCR analysis of transformants were  
Forward, Pichia 2A ana F: 5’- ATGGGCCATCATCATCATCATC- 3’ and  
Reverse Pichia 2A ana R: 5’-TTATTTGTACAATTCATCCATG-3’ 
Expected proteins sizes after translation: cherryFP total amino acid number is 237, MW=26771 and 
MGHistag-Tev-TaV2A total amino acid number is 41, MW is 4575 Da. 
 
P. pastoris media preparation and culture was carried out as described in section 2.2.10. 
Briefly, competent yeast was electroporated with linearised pPinkα vector. They were then cultured 
on PAD media for several days until white colonies were formed. These were sub-cultured again on 
PAD. The transformants were grown in BMGY media containing glycerol for 24 h, the cells were 
collected by centrifugation and resuspended in the induction media BMMY which contained 
methanol. The cells and supernatant fractions were analysed by PCR, western blot and microscopy. 
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5.3 Results 
 
5.3.1 Puromycin test revealed an altered PTC 
 
The toe print analysis carried out by Doronina and colleagues (2008) showed that in the 2A-stalled 
complex, the peptide bond between the last glycine and the proline does not take place. The glycine 
residue remains the last residue added to the nascent chain before translation arrest. Puromycin is a 
tRNA analogue, is able to form peptide bond indiscriminatingly and is therefore able to release 
nascent peptides. It has been used extensively as an indirect assessment of the PTC geometry in 
studies involving other nascent stalling-peptides (Wei et al., 2012, Woolhead et al., 2006, Cruz-Vera 
et al., 2007). To determine whether 2A-induced ribosome stalling also features and altered PTC, 
several truncated PCR products were prepared and amplified from the GFP-2A-GUS insert of pSTA1, 
as depicted in figure 5.4. The DNA products were terminated after the last glycine (TaV NPG) or after 
the last proline (TaV NPGP). In addition, two controls were included in the experiment: an arrest-
impaired sequence which had the G12A mutation and terminated at the last glycine (inactive TaV 
NPG) as well as an unrelated sequence to TaV 2A amplified from GFP.  
Because the PCR products lacked a stop codon, ribosomes reaching the 3’ end of the truncated mRNA 
should remain complexed to the mRNA with the peptidyl-tRNA in the P site. In the following 
experiment, the PCR products were added to the cell-free system and translated in presence of [
35
 S]-
Met. After translation for 30 min, 1 µg of puromycin (an excess of puromycin) was added. The 
puromycin should then enter the A site and readily release the nascent peptide. However, if the PTC 
geometry is altered, the stalled complex is refractory to a reaction to puromycin. The difference 
between the two is observable by gel electrophoresis, as a refractory stalled complex generates an 
additional ‘heavier’ band corresponding to the nascent chain-tRNA. Treatment of this sample with 
RNAse should degrade the tRNA and release the nascent chain and only one band corresponding to 
the nascent chain molecular weight should then be visible on the gel. The molecular weights for the 
expected translated products are 27 kDa for GFP, 30 kDa for TaV NPG, Tav NPGP and inactive TaV 
NPG. tRNA adds 23 kDa to the nascent chain.  
 
In figure 5.4, the results prove that TaV induces an altered geometry of the PTC. In lane 2 and 4 (TaV 
NPG and TaV NPGP) puromycin does not react with some of the stalled ribosomes, as a result a 
heavier band corresponding to the peptidyl-tRNA is visible. In lane 6 and 8 for the negative controls, 
however that extra band is not apparent; puromycin has reacted to all the stalled ribosomes. In lane 3, 
and 5 the treatment with RNAse resulted in the complete restriction of the tRNAs and release of the 
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nascent chains. TaV therefore alters the PTC such that the peptide bond is not made because one or 
several ribosomal elements in the PTC are not positioned correctly.  
 
 
Figure 5.4: Puromycin test for TaV 2A activity 
SDS-PAGE  showing translation of truncated TaV 2A with 1 μM puromycin in rabbit reticulocyte lysates supplemented with 
[35S]- Met. In lane 1, the translation assay without DNA.  
In lane 2 and 3, TaV sequence was stopped at NPG and in lane 3 digested with RNAseA/T1 for 30 min. 
In lane 4 and 5, TaV sequence was stopped at NPGP and in lane 5 digested with RNAseA/T1 for 30 min. 
Negative controls included: In lane 6 and 7 mutant TaV (mutant inactive) sequence was truncated at NPG and in lane 7 
digested with RNAseA/T1 for 30 min. Truncated GFP in lane 8 and 9, without (lane 8) and with digestion with RNAseA/T1.  
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5.3.2 2A renders the ribosome A site restrictive 
 
 
In the previous chapter it was inadvertently discovered that mutation of Pro20 did not alleviate 
stalling. Previously it was thought that proline at that position was mandatory. TaV2A Pro20 
substitutions with residues with smaller or slightly bigger molecular weight amino acids are 
presented: glycine (75 Da), serine (105 Da), valine (117) threonine (119 Da) and cysteine (121), 
proline (115Da).  
 
 
Figure 5.5: Mutation of Pro20 of pSTA1 TaV 2A 
SDS-PAGE showing translation of TaV 2A and mutants in rabbit reticulocyte lysates supplemented with [35S]-methionine. 
TaV 2A sequence is written above the gel and the black arrow and blue text show the residue mutated. The point mutation 
tested is indicated at the top of each lane, Pro20 is substituted for glycine (lane 2), serine (lane 3), valine (lane 4), threonine 
(lane 5) and cysteine (lane 6). The gel shows more full-length product with increasing amino acid MW. 
 
The 2A sequence was able to mediate the production of discrete products with all the substitutions 
tested (figure 5.5). This resulted in more full-length products as opposed to wild type with increasing 
MW of the A site amino acid. These results demonstrated that the stalling ability of TaV 2A altered 
the geometry at the PTC so that peptide transfer to a range of amino acid is inhibited. It is observable 
however that proline added greatly to the efficiency of the stalling.  
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FMDV 2A coding sequence was inserted between luciferase and renilla genes. C-terminal proline 
codon (CCC) was mutated to the synonymous codons CCG, CCA and CCT, Unfortunately, test 
transfection with pJC3 (GFP-2A-CherryFP) to bovine lung cells using three different carriers: 
lipofectamine 2000, PEI and Fugene 6 were not successful. The results underneath showed the 
translation of the dual renilla-FMDV2A-Luciferase in rabbit reticulocyte lysates. 
 
 
Figure 5.6: Effect of proline synonymous codons on activity of FMDV 2A 
In (A) FMDV 2A last Pro (occupying the A site) was mutated to other synonymous codons, CCA, CCG and CCT (lanes 1 to 
4). Negative controls are shown in lane 5 and 6. The text above gave the MW of the proteins expected and the reference lane 
for the gel underneath. The SDS-PAGE gel (panel (A) bottom) resolved samples translated in rabbit reticulocyte lysates 
supplemented with [35S]-Met. Panel (B) showed poor cherryFP expression (on the right) of bovine lung cells transfected 
with different reagents: lipofectamine, Fugene 6 and PEI. The bright field pictures of confluent cells were provided on the 
left.  
 
The expression in bovine cell lung (figure 5.6) did not allow correlating the level of translation of 
downstream luciferase to abundance of prolyl-tRNA isoforms, perhaps re-cloning the inserts in a 
lentivirus system may overcome the limitations of transient transfection relying on cationic lipids. 
Although, cell-free systems are optimised for efficient translation of any T7 driven inserts, the 
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translation profile would have reflected a problematic structure linked to synonymous codons. For all 
proline synonymous codons tested, the same result was obtained. The conclusion derived was that the 
mRNA structural pattern associated to codon identity did not influence the overall translation profile 
in vitro. 
 
5.3.3 P. pastoris for resolution of 2A structure required further cloning 
 
2A is active only in eukaryotic ribosomes. Because of its small size, 2A can be subjected to NMR 
analysis, however several milligrammes of the purified product may be required and for these reasons 
P. pastoris seemed an ideally suited expression system. TaV 2A was inserted in frame fused to the 
pre-pro α-mating factor. This latter consists of a nineteen amino acids signal sequence (pre- sequence) 
targeting the protein being expressed to the endoplasmic reticulum and of a sixty amino acids pro-
sequence transported to the Golgi (figure 5.7). During translocation the signal peptidase cleaves the 
nineteen amino acid pre-sequence, later at the golgi the Kex2 protease recognises basic residues such 
as Lys-Arg or Arg-Arg and cleaves the pro-sequence from the downstream protein. To address the 
purification needs, a poly-histidine tag was cloned upstream of 2A followed by the commonly used 
protease site for TeV. Integration in the genome occurs via homologous recombination and results in 
multiple integrations. Because clones with multiple integrations express higher levels of proteins, the 
PichiaPink system was ideally suited since it allowed a visual assessment of multiple integrations by 
the colour of the transformants. White colonies thrived on the selection media, four white colonies 
were selected for further molecular analyses. The PCR results (figure 5.8) demonstrated that the 
heterologous DNA was stably integrated in the genome of the yeast. P. pastoris transformants were 
subsequently cultured in BMGY and induced in BMMY. The figures 5.10 and 5.11 show the 
analytical results from the supernatant and cellular fractions for four samples. The western blot 
analyses were performed with anti-2A and anti-cherryFP antibodies. The polyclonal anti-2A antibody 
was not commercially available and acquired from this laboratory stock. Figure 5.9 provides a 
western blot test using this antibody to probe FMDV and TaV 2As. 
In the supernatant fractions (figure 5.10) no 2A was detected but unprocessed TaV 2A- cherryFP 
could be detected using the anti-cherryFP antibody. The cell pellets were probed for cherryFP (figure 
5.11). CherryFP could not be detected. 
 
The marked difference in fluorescence between induced and non-induced transformant, demonstrated 
that the induction was also successful. In addition, the western blot analysis of the supernatant fraction 
identified unprocessed cherryFP in the media, and this corresponds to the fraction of recombinant 
proteins which escaped the Kex2 protease activity and the 2A-stalling mechanism. It is not clear from 
these results if 2A can be processed from CherryFP in this system, or too diluted for a successful 
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analysis or simply too small to be adequately seen on the gel. Inserting a stretch of nucleotides 
corresponding to 10 kDa protein upstream of 2A will address the possible size issue and give 2A more 
traceability, while screening for a large amount of colonies will likely identify one or several suitable 
transformants providing good yields. 
 
The second limitation experienced here and the reason why secretion was selected over intracellular 
accumulation was the difficulty associated with breaking the yeast cell wall. Three methods were 
tested: microwaving, enzymatic digest by zymolase and incubation in a breaking buffer. Out of these 
zymolase proved more successful for DNA extraction, it was subsequently applied to the cell fractions 
for western blot analyses, without success. There are other reported methods to explore: sonication, 
glass beads, other enzymatic preparations and freezing-grinding.  
 
 
Figure 5.7: Diagram of the processing of the TaV-cherryFP insert in P.pastoris 
The expression of the TaV insert fused to α-mating type was driven by AOX1 promoter and induced with methanol. During 
translation (1), the α-factor and the TaV insert should be separated by the stalling mechanism at the 2A [NPGP] motif.  
(2) Subsequently, the signal peptidase cleaves the signal during translocation, and the protease Kex2 that recognises the 
cleavage site [VSLQKR] should cleave the α-mating factor. The TaV 2A insert should then be secreted to the media and 
could be purified by affinity via the poly-His tag. CherryFP should be localised in the cytoplasm of the yeast. 
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Figure 5.8: DNA gel electrophoresis of PCR of P. pastoris transformants 
Lanes 3 to 5 contain examples of three positive samples (TaV 1,2 and 3). Lane 1 the negative control set with un-transfected 
yeast and the lane 2 used pVO2 as a positive control, which contains only the TaV-CherryFP insert. The primers annealed at 
the beginning of TaV and at the end of cherryFP and the resulting PCR showed the expected insert of 834 bp. 
 
 
Figure 5.9: Western blot test of 2A antibody  
The pSTA1 containing TaV 2A and FMDV 2A were translated in rabbit reticulocyte lysates without [35 S]-Methionine and  
analysed by western blot using anti-2A antibody. The lane 1 had contained no DNA and lanes 2 and 3 showed detection of 
GFP2A product for pSTA1 FMDV 2A (lane 2) and pSTA1 TaV 2A (lane 3). The antibody was able to detect GFP2A, but 
not the full-length product (GFP2AGUS). However it also reacted with other constituents of the cell-free extract. 
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Figure 5.10: Western blot analysis of the supernatant fractions for four P. pastoris 
transformants 
The cartoon in (A) indicates the MW of the proteins (underlined blue) constituting the TaV 2A inserts. In (B) the western 
blot analysis was carried out with anti-cherryFP antibody, and in (C) with anti-2A antibody. No TaV 2A could be detected in 
the supernatant (C) but unprocessed CherryFP in (B) could.  
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                              (E) 
 
 
Figure 5.11: Analysis of cell fractions of P. pastoris transformants, western blot and fluorescence 
microscopy  
Bright field pictures are on the left and the corresponding fluorescence showing cherryFP expression on the right. (A) and 
(B) were from the transformant TaV1 after culture in BMGY for 24 h. (C) and (D) demonstrated fluorescence of this sample 
after 24 h of induction by methanol in the BMMY medium. (E) Using zymolase to disrupt the yeast membranes, proteins 
were extracted from cell fractions of all four TaV transformants as well as untransfected yeast and examined by anti-
cherryFP antibody. CherryFP was detected for the positive control (PC in lane 6) plasmid pJC3 translated in rabbit 
reticulocyte lysates without radioactive aa. CherryFP was not detected in the P. pastoris transformants (lane 2-5). 
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5.4 Discussion 
 
 
In summary, the puromycin test proves that 2A induces an altered geometry at the PTC. Most 
importantly, substitutions of the A site proline shows that 2A renders the ribosome A site restrictive. 
The structure of the A site mRNA differs considerably in the Pro20 TaV 2A mutagenesis, yet the 
translation of the downstream protein implies that eRF1/3 performed the rescue activity as for TaV 
wild-type. This study proves that the potential rescue activity of eRF1/3 can accommodate several 
codon on the ribosome A site. The N domain of eRF1 carries the motifs for stop codon recognition 
(NIKS, YxCxxxF and GTx) (Song et al., 2000, Kryushkova et al., 2013). In the current model, eRF1is 
thought to be specific for stop codon decoding, it enters the A site complexed with eRF3 and GTP. 
This introduces a +2 nucleotide forward shift on toe print analysis. eRF1 undergoes a conformational 
change following GTP hydrolysis to accommodate the [GGQ] motif in the PTC. The activity of 
eRF1/3 results in peptide hydrolysis and the dissociation of the ribosome subunits (Alkalaeva et al., 
2006, pisareva et al., 2011). Further studies are required to characterise this activity for eRF1 and 3. 
 
Translation arrest by 2A results in a peptide bond not being formed. There are two scenarios; the 
peptide bond is not created because of an unfavourable chemistry involving proline or by steric 
hindrances. It is known that proline residues both in the P and the A site are poorly reactive. A study 
in E. coli, reported that even an efficient stop codon preceded with proline would recruit the tmRNA 
rescue system and induce tagging of the YbeL protein for degradation. The modification of another 
protein to match the end of YbeL, also induced tmRNA tagging (Hayes et al., 2002). Woolstenhulme 
and colleagues (2013) set out to uncover all possible stalling motifs for E. coli. They engineered the 
tmRNA system to link rescue of stalled ribosome to cell survival. They found that proline before a 
termination codon always arrested ribosome, a strategy which has been exploited by TnaC stalling 
peptide. Muto and Ito (2008) used the first 153 aa of the OmpA protein and modified the last proline 
with glycine or alanine. They translated the construct using the in vitro fully reconstituted translation 
system (PURE system), and reacted the translated products to puromycin. Unsurprisingly, more 
peptidyl-tRNA was formed with proline. After 3 min of incubation, 72 % of peptidyl-tRNA remained 
for the protein ended by proline. In another study, the time of transfer of dipeptide (fMet-xtRNA
x
), to 
puromycin was quantified by quench flow technique (Wohlgemuth et al., 2008), and it was 
established that prolyl-tRNA 
pro
 was poorly reactive when in the P site (0.14 s 
-1
) compared to lysine 
(100 s
-1
). The glycyl-prolyl peptide bond at the C-terminus of secM is also not effected. And it was 
proposed that in that context, prolyl-tRNA played the role of effector of translation arrest 
(Nakatogawa and Ito, 2002). In E. coli, strings of three consecutive prolines, whether naturally present 
or engineered stall the translating ribosome and it is argued that this is likely the consequence of the 
imino nature of the residue. Stalling occurs also independently of proline codon usage and in different 
 
143 
proteins. Two studies revealed that a special elongation factor EF-P is designed to assist with poly-
proline stretches in E. coli (Ude et al., 2013 and Doerfel et al., 2013).  
Although all nascent stalling peptides differ in their upstream context and also in their precise 
mechanisms in the exit tunnel, they contain a proline at their C-terminus. It is therefore not surprising 
that in the context of 2A, a proline in the A site is linked to higher efficiency of stalling. But it is 
surprising to find that 2A renders the A site restrictive. The result implies that the imino nature of the 
proline residue is not the principal factor in stalling, but the steric constraint that its pyrrolidine ring 
imposes on the A site is. There are a multitude of possible targets in modulating the PTC activity, any 
nucleotides or H-bondings maintaining the correct position for the tRNA substrates could affect the 
reactivity.  
 
There are no studies involving a systematic quantification of the A site residue in accepting the 
nascent peptide, but two studies reported a quantification for a peptide transfer to the A site tRNA. 
The first study reacted di-peptide to puromycin in the A site (Wohlgemuth et al., 2008). The quench 
flow technique consists of a pretranslocation ribosome/di-peptide mixed with puromycin or 
Phenylalanyl-tRNA
Phe
, reacted and quenched with KOH before HPLC analysis. The amino acid 
reacted to puromycin at diverse speed. Only eight residues in the P site were tested, and their order of 
reactivity was: lysine (100 s
-1
), arginine (90 s
-1
), alanine (57 s
-1
), serine (44 s
-1
), phenylalanine (16 s
-1
), 
valine (16 s
-1
 ), aspartic acid (8 s
-1
) and proline (0.14 s
-1
). When the authors misacylated tRNAs (in the 
P site) to carry Phe the reactivity to puromycin (in the A site) decreased to match that of 
Phenylalanyl-tRNA
Phe
. When the di-peptides fMet-Arg, fMet-Asp, fMet-Phe and fMet-Pro (in the P 
site) were reacted to Phenylalanyl-tRNA
Phe
 (in the A site) the authors found a uniform velocity of 
synthesis regardless of the nature of the last amino acid. These last data demonstrate that the A site 
tRNA, is an important determinant of the efficiency of peptide transfer to the A site (Wohlgemuth et 
al., 2008). Pavlov and colleagues (2009) compared the formation of di-peptide between fMet and Ala-
tRNA
Phe
, fMet and Phe-tRNA
Phe
 and FMet and prolyl-tRNA
Pro
 or prolyl-tRNA
Phe
. They demonstrated 
that it takes 11 ms to transfer fMet to Phe, and 23 ms to transfer fMet to alanine misacylated to 
tRNA
Phe
. The alanyl-tRNA
Ala
 result was not provided. Surprisingly, the reaction of fMet to proline 
misacylated to tRNA
Phe
 occurred in 555 ms, but that time was decreased to 50 ms when the proline 
cognate tRNA was employed. They interestingly also reported a time difference between the four 
synonymous codons. Proline codon CCG reacted in 50 ms to fMet. Proline codons CCA and CCU, 
reacted in 47 ms and CCC reacted in 66 ms. So the logical conclusion is that tRNA somehow 
compensates for the poor reactivity of the residue. Zhou and colleagues (2011) calculated the codon 
usage for FMDV flanking the cleavages and processing sites along the polyprotein and found that the 
viral choice of codons matched the codon usage for cattle and pigs, suggesting that the virus uses this 
strategy to make efficient use of their host translational machinery. At the 2A/2B junction, the AAU 
(Asn) and UUA (Leu) codons are under-represented. However, at the Gly-Pro pair, the viral codon 
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usage pattern resembles that of the host. It is therefore unlikely that in vivo the codon usage at the 
2A/2B Gly-Pro bond would affect the efficiency of stalling.  
 
Other stalling sequences also render the ribosome A site selective. The ermAL (an example of erm) 
stalling peptide can not be transferred to A site: aspartic acid, glutamic acid, glycine and tryptophan 
(Ramu et al., 2011). Woolstenhulme and colleagues (2013) demonstrated that peptides finishing with 
Pro-Pro motifs could not be transferred to A sites: asparagine, aspartic acid, glutamine, glycine and 
tryptophan. In a breakthrough article, summarising the results from a ribosome profiling study carried 
out on mouse stem cells, it was reported that stalling sequences in the eukaryotic proteome is also 
common. The authors found 1500 pauses in a set of 4994 expressed genes. They reported that the 
majority of the ribosomes carried out their translation following pauses. They did not provide the full 
list of the stalling motifs however mentioned that the PPD and PPE were the strongest pause sites with 
aspartic acid or glutamic acid in the A site (Ingolia et al., 2011). The 2 residue also influenced the 
level of tmRNA tagging for the YbeL protein. Substitution of the 2 residue for glutamic acid, 
proline, valine, aspartic acid and isoleucine led to high levels of tagging, interestingly substitution for 
asparagine led to low levels of tagging (Hayes et al., 2002). Referring back to the example of ermC 
and ermAL, it is interesting to note that two peptides very similar in sequence do not induce the same 
restrictivities. ermC (IFVI) stalls regardless of A site amino acid. But ermAL (IAVV) stalls only when 
the A site is occupied by amino acids that can not accept the nascent peptide: aspartic acid, glutamic 
acid, glycine and tryptophan (Ramu et al., 2011). The interaction of the nascent stalling peptides to 
the exit tunnel influences the activity at the PTC and the reactivity of the tRNA/aa at the P and A site. 
ermC, SecM and AAP interacts with the ribosomal nucleotide A2062. A2062 transitions from an open 
(towards the lumen) to a closed (against the tunnel wall) conformation and interacts with the 2 
amino acid (Phe7) of ermC (Ramu et al., 2011) and the compulsory 2 amino acid Arg163 for SecM 
(Yap and Bernstein, 2009). A2062 is flanked at both sides with nucleotides that participate in the PTC 
activity. Collectively, these examples demonstrate that the penultimates residues preceding the 
stalling residues play a major role in the stalling efficiency. The 2 amino acid for 2A would be 
Asn18. The mutagenesis performed for the previous chapter resulting in no 2A activity with mutated 
[NPG], supports the theory that a ribosome residue within the vicinity of the PTC is responsible for 
the stalling mechanism, and through a relay to PTC residues induces a subtle disturbance of the PTC 
geometry. 
 
In the context of 2A, mutations of the A site residues would therefore be a perfect test to categorise 
the nascent 2As. Any nascent 2A interacting in a similar way to the exit tunnel, would produce the 
same results with A site proline substitutions.If the stalling is induced by a different mechanism it is 
likely that this will result in different restrictivities in the A site amino acid. 
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6.1 Introduction 
 
2A presence has firmly been established as part of the genome of several viruses.The motif has also 
been reported at the N-terminal of non-LTR retrotransposons of Trypanosoma cruzi (L1Tc) and T. 
brucei (igni) (Donnelly et al., 2001a and Heras et al., 2006). In the past three years, more than one 
hundred 2A sequences were predicted to be part of the sea urchin Strongylocentrotus purpuratus 
genome based on a BLAST search using the [DV/IExNPGP] motif and are being analysed at the time 
of writing. 2A in the Sea Urchin was identified at the N-terminus of innate immunity CATERPILLER 
proteins or associated with non-LTR retrotransposons. Several of the sequences were tested in the 
expression system and shown to be active. If these sequences were translated, they would confer the 
stalling mechanism and create discrete products from a single ORF.  
 
 
 
 
Figure 6.1: Summary of 2A –like elements in marine organisms  
The summary shows in A abundance and B the typical localisation of 2A in protein sequences. Images were reproduced 
from various sources online. Amphioxus image is from http://www.gsite.univ-provence.fr, acorn worm image is from 
http://www.hermes.mbl.edu, sea urchin image is from http://www.bio.classes.ucsc.edu, Amphimedon queenslandica image is 
from http://www.blogs.sciencemag.org and Acropora millepora image is from http://www.lemur.amu.edu.pl.  
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This section consists of a listing of newly discovered 2A in the genome of several organisms. 
2A sequences with a deviating motif were observed in the genome of viruses Armigeres subalbatus 
virus (AsTV), Omono river virus (OMRV1 and 2) and Drosophila megalonaster totivirus (DTV) 
(Isawa et al., 2011). Similarly, two sequences were also identified in Bovine rotavirus B and Human 
rotavirus A. 2A motifs were identified in several marine cellular organisms. The analytical task was 
divided between several workers and the results for amphimedon, acropora and S. purpuratus / 
franciscanus will not be presented here as they did not constitute my primary focus of work. This 
chapter summarises the results for Branchiostoma floridae (amphioxus), and Saccoglossus 
kowalevskii (acorn worm). The acorn worm bioinformatics analyses were carried out in majority by 
Dr Sukkhodub in this laboratory, but I carried out part of these and tested four 2A sequences. 
However, all the bioinformatic analyses and subsequent testing for amphioxus 2A sequences were 
exclusively my work.  
 
It is not certain that 2A is part of the transcribed genome for the marine organisms; but its presence as 
part of specific non-LTR retrotransposon clades suggests a horizontal transfer. It is now established 
that 2A is not restricted to the consensus motif previously identified, however searches revealed that 
[DV/IExNPGP] is the most abundant and probably still the only reliable query for identification of 
new sequences. 
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6.2 Materials and methods 
6.2.1 Identification of 2A candidates- search for homologies 
 
BLAST searches used the 2A motif [DV/IExNPGP] and [GVEPNPGP] to identify potential new 2A 
sequences. The consensus motif was entered into the ProtBlast search online facility from NCBI 
(http://www.blast.ncbi.nlm.nih.gov) with a maximum target of 500. Protein sequences were entered 
into the ProDom (http://www.prodom.prabi.fr) online facility to identify domains. Thirty amino acids 
leading to the consensus motifs were considered for the purpose of testing the activity of the potential 
2A, and used to derive the corresponding nucleotide sequence. For non-LTR retrotransposons in 
amphioxus, sequences were identified from clustalX alignments to the collection of non-LTR 
retrotransposon available at girinst (repbase) (http://www.girinst.org). Phylogenetic trees were built 
with FigTree v1.3.1 (http://www.tree.bio.ed.ac.uk/software/figtree). For S. kowalevskii, contigs 
coding for potential 2A sequences were identified using the online blast facility at Baylor college of 
Medicine (http://www.blast.hgsc.bcm.tmc.edu), the GenScan programme 
(http://www.genes.mit.edu/GENSCAN.html) was used to predict coding sequences and fastPCR to 
perform in silico translation.  
6.2.2 Selection and cloning 
 
Representatives 2A for each organism/ non-LTR retrotransposon clade were selected on the basis of 
their deviation to the [DV/IExNPGP] 2A motif. Gene blocks of the sequences spaced with unique 
restriction sites were ordered from Dundee cell products and each 2A sequence was excised, gel 
purified and further restricted with Xba1 and Apa1 and ligated to pSTA1. The modified pSTA1 were 
tested in rabbit reticulocyte lysates following the protocol in section 2.2.9. 
 
 
Figure 6.2: Modification of pSTA1 for the cloning of candidate 2As.  
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Table 6.1: Novel amphioxus and totivirus/rotavirus 2A sequences tested. 
Sequences were identified by local alignment at NCBI, the table features the accession number, the nucleotide and protein 
sequence for all the 2A tested.  
 
Organism and NCBI 
accession number  
Experiment reference+ 
Protein sequence (bottom) and corresponding nucleotide sequences (top) 
Branchiostoma floridae  
(XP_002204853.1) 
  
BF53 
        TGGGCGGAGGCCTCCTGTCTACTTGTGTGGATGGTCATTTCCCAACTCATGCTCAAACTT 
         W  A  E  A  S  C  L  L  V  W  M  V  I  S  Q  L  M  L  K  L  
 
        GCGGGAGACGTCGAGGAGAACCCCGGGCCC 
         A  G  D  V  E  E  N  P  G  P                                 
B. floridae  
(XP_002224141)            
BF41 
      TCTAGATACGTCATGATGTCCTGCCTCCTCGTCTGGTTCATGATGGTTCATAAACTTCTT 
       S  R  Y  V  M  M  S  C  L  L  V  W  F  M  M  V  H  K  L  L  
 
      CTGCAAGCGGGAGACATCGAGCCCAACCCCGGGCCC 
       L  Q  A  G  D  I  E  P  N  P  G  P                           
 
B. floridae  
(XP_002229629)              
BF29 
       CGCGTCTGCTCCCCCGACGCCACAGCCACCAAGAACTGCGCTATGTACATGCTTCTGCTT 
        R  V  C  S  P  D  A  T  A  T  K  N  C  A  M  Y  M  L  L  L  
 
       TCTGGAGACGTCGAGACCAACCCCGGGCCC 
        S  G  D  V  E  T  N  P  G  P 
B. floridae  
(XP_002234262)              
BF62 
       CGCGTCTGCTCCCCCGACGCCACAACCACCAAGAACTGCGCTATGTACATGCTTCTGCTT 
        R  V  C  S  P  D  A  T  T  T  K  N  C  A  M  Y  M  L  L  L  
 
       TGTGGAGACGTCGAGCCCAACCCCGGGCCC 
        C  G  D  V  E  P  N  P  G  P                                 
Armigeres subalbatus 
virus 
(ACH85915) 
AsTV 
       CCTGAGCTTAATGGAGATCAAAGAGCTACTCTTTCCGCATGGACTCGAGATCTCACCAAA 
        P  E  L  N  G  D  Q  R  A  T  L  S  A  W  T  R  D  L  T  K  
 
       GATGGCGATGTAGAATCCAATCCCGGGCCC 
        D  G  D  V  E  S  N  P  G  P   
Omono river virus 
(BAJ21512.1) 
OMRV1 
       TTTGATGAGACCAAGAAGCTCGTCTGTCTCGGCACCTATCCCTTTAAGAAGGATCTCACC 
        F  D  E  T  K  K  L  V  C  L  G  T  Y  P  F  K  K  D  L  T  
 
       CGCGAGGGCGTCGAGTCCAATCCCGGGCCC 
        R  E  G  V  E  S  N  P  G  P                                 
Omono river  virus 
(BAJ21510.1) 
 
OMRV2 
       TTTGATGAGAATGCCAAGATCGTCCTCCTCGGCACCTTTCCCTTTAAGAAGGATCTCACC 
        F  D  E  N  A  K  I  V  L  L  G  T  F  P  F  K  K  D  L  T  
 
       AAGGAGGGCGTCGAGCCCAATCCCGGGCCC 
        K  E  G  V  E  P  N  P  G  P                                 
Drosophila megalonaster 
totivirus 
(YP_003289292.1) 
DTV 
       CTCGCCTATCTCAATAATGATCAGAAGACCACCCTCTCCGCCTGGGTCCGCGGCCTCACC 
        L  A  Y  L  N  N  D  Q  K  T  T  L  S  A  W  V  R  G  L  T  
 
       GTCGAGGGCGTCAAGCCCAATCCCGGGCCC 
        V  E  G  V  K  P  N  P  G  P                                 
Human rotavirus A 
(CAC01682.1) 
 
HuRV A 
       CTCACCAATTCCTATACCGTCGAGCTCTCCGATGAGATCAATACCATCGGCTCCGAGAAG 
        L  T  N  S  Y  T  V  E  L  S  D  E  I  N  T  I  G  S  E  K  
 
       GGCGAGAATGTCACCATCAATCCCGGGCCC 
        G  E  N  V  T  I  N  P  G  P                                 
Bovine rotavirus B 
(AAA79028) 
 
HuRV B 
       CTCGCCAATTCCTATACCTCCGATCTCCAGGATACCATCGATGACATCTCCGCCCAGAAG 
        L  A  N  S  Y  T  S  D  L  Q  D  T  I  D  D  I  S  A  Q  K  
 
       ACCGAGAATGTCACCGTCAATCCCGGGCCC 
        T  E  N  V  T  V  N  P  G  P                                 
 
149 
 
Table 6.2: Proteins and nucleotide sequences tested for 2A elements identified in amphioxus 
non-LTR retrotransposons. 
Sequences were identified in repbase database, through similarities to 2A motif and N-terminal position in the organisation 
of the non-LTR retrotransposon 
 
Non-LTR  Protein sequence (bottom) and corresponding nucleotide sequences (top) 
Crack-15_BF          CACTCAGTACTAGTATGCGACCACTGCGTAACAGTATTCGTAGTAATTCTACTACTACTA 
          H  S  V  L  V  C  D  H  C  V  T  V  F  V  V  I  L  L  L  L  
 
        TGCGGAGACATTCACAACAACCCCGGGCCC 
         C  G  D  I  H  N  N  P  G  P                                 
Crack-17_BF          GCAGTAACATCAACATCAGTAAACTGCGTACACCTATGCTTCCACACACTACTAATTCTA 
          A  V  T  S  T  S  V  N  C  V  H  L  C  F  H  T  L  L  I  L  
 
        TCAGGAGACGTAGCAGTAAACCCAGGGCCC 
         S  G  D  V  A  V  N  P  G  P                                 
CR1-2_BF 
 
        CGAACATCAGACCGACTATTCACATGCCTACTATACCTATGCTCAGTACTAATGTCACAA 
         R  T  S  D  R  L  F  T  C  L  L  Y  L  C  S  V  L  M  S  Q  
 
        GCAGTAGACCTAGAAACAAACCCCGGGCCC 
         A  V  D  L  E  T  N  P  G  P                                 
CR1-10_BF 
 
        GGAACAGACAACGTATCAGCAGAATTCACACAATGGAAACCAGCAATTGACCTAACACAA 
         G  T  D  N  V  S  A  E  F  T  Q  W  K  P  A  I  D  L  T  Q  
 
        CACTACGACGTACACCCAAACCCAGGGCCC 
         H  Y  D  V  H  P  N  P  G  P                                 
CR1-11_BF 
 
        CTAGCACCACACTGCCGACCAAAATTCACACTATTCTCACTAACACTAATTATTCTACTA 
         L  A  P  H  C  R  P  K  F  T  L  F  S  L  T  L  I  I  L  L  
 
        GCAGGAGACGTAGAACTAAACCCCGGGCCC 
         A  G  D  V  E  L  N  P  G  P                                 
CR1-31_BF 
 
         TACCTAATGTCACGACAACGACTAGTACTACTATACCTAACAATGCTACTAATTAGCAAA 
          Y  L  M  S  R  Q  R  L  V  L  L  Y  L  T  M  L  L  I  S  K  
 
        TCATACTCACCAGAACCAAACCCCGGGCCC 
         S  Y  S  P  E  P  N  P  G  P                                 
CR1-53_BF 
 
         CACTTCGACATTTTCCTACTATTCTTCCCACTACCAGTACTAGTAGTACTATCACTAATT 
          H  F  D  I  F  L  L  F  F  P  L  P  V  L  V  V  L  S  L  I  
 
        GCAGGAGACATTCACCCAAACCCAGGGCCC 
         A  G  D  I  H  P  N  P  G  P    
 
. 
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Table 6.3: Protein and nucleotides sequences tested for 2A elements identified in S. kowalevskii 
(SK). 
2A were identified by blast search at Baylor College of Medicine, the resulting nucleotide sequence was tested for the above 
contigs. 
 
Contig number  Experiment reference+ 
Protein sequence (bottom) and corresponding nucleotide sequences (top) 
XP_002731766 
(accession 
number in NCBI) 
SK1 
        ATGTGGTTTCTCGTACTACTAAGCTTTATTCTATCAGGGGATATTGAAGTCAATCCCGGG 
          M  W  F  L  V  L  L  S  F  I  L  S  G  D  I  E  V  N  P  G  
 
        CCC 
         P                                                            
Contig 36012 SK6 
         TGTGACCAACACGGGCGCATTCACGTCAGCCTCTTTATTTTTGGAATCCTACTACTACTA 
          C  D  Q  H  G  R  I  H  V  S  L  F  I  F  G  I  L  L  L  L  
 
        AGCGGGGATATTGAAGTAAATCCCGGGCCC 
         S  G  D  I  E  V  N  P  G  P                                 
contig 76190 SK61 
         ATGTTTTCTATCCAGCCCCTCTGGACTTCTAAACTCATCATCCTCTGTGGGGATGTAGAA 
          M  F  S  I  Q  P  L  W  T  S  K  L  I  I  L  C  G  D  V  E  
 
        TCTAATCCCGGGCCC 
         S  N  P  G  P    
contig 10214 SK47 
         ATGTTTGCACTCTATCTCTATCATTGTCGTATGCGTAGTAACCTCATACTCATACGTGAC 
          M  F  A  L  Y  L  Y  H  C  R  M  R  S  N  L  I  L  I  R  D  
 
        ATCGAAACCAACCCCGGGCCC 
         I  E  T  N  P  G  P                                          
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6.3 Results 
 
Using the [D(V/I)ExNPGP] motif, several databases were screened: the non-LTR retrotransposon 
database, NCBI and the genome sequence of S. kowalevskii at Baylor college of medicine. The 
searches identified potential new 2A encoded by the genomes of the cellular organisms: amphioxus 
and the acorn worm and several totiviruses. Further bioinformatics analyses characterised the type of 
sequences where the 2A motif was discovered.  
 
Table 6.4: Summary table of abundance and type of sequences identified with a 2A motif. 
B. floridae sequences were accessed at NCBI, the genome of the S. kowalevskii was accessed at Baylor College of Medicine. 
These are further detailed in figures 6.4 to 6.9 for B. floridae and figure 6.10 and appendix 4 for S. kowalevskii.  
 
Organism Type of sequence Abundance 
Branchiostoma floridae Predicted protein 3  
Non-LTR retrotransposon 20  
Saccoglossus kowalevskii contigs 64 
 
 
6.3.1 2A in B. floridae 
 
In amphioxus, 2A is part of two types of non-LTR retrotransposon clades: the Crack and the CR1 
clades. The figure 6.5 provides the full amino acid sequences of all the amphioxus non-LTRs with a 
2A and their identity. Several of these were tested in the in vitro bicistronic expression test. The result 
provided in figure 6.3 shows that the non-LTRs are mostly unable or inefficient at performing the 
separation between GFP and GUS, compared to FMDV. It is notable that they have a deviating 
consensus motif [GDIHPNPGP] instead of [GDIExNPGP]. Following the standard analysis 
established by Malik and colleagues (1999), the phylogenetic trees (figure 6.7 and 6.8) were created 
by alignment of the reverse transcriptase domain of the non-LTR retrotransposons. In figure 6.7 the 
phylogenetic tree shows that the Crack elements with a 2A motif cluster, a result which is also 
reproduced in figure 6.8 for CR1 elements with a 2A motif. Thirteen CR1 and seven Crack non-LTR 
retrotransposons were found to have a 2A motif. The repbase database provides the details of the 
domains identified in each non-LTR retrotransposon. CR1 and Crack elements share a common 
organisation (Kapitonov et al., 2009), but clades must share a 40 % homology within their reverse 
transcriptase domain to be grouped (Malik et al., 1999). A canonical CR1 element represented in 
figure 6.6 has two ORFs. ORF1 generally encodes a plant homeodomain (PHD) or an esterase. ORF2 
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encodes a protein with endonuclease and reverse transcriptase properties (kapitonov et al., 2009). An 
examination of the CR1 elements with a 2A sequence (CR1-2A) shows that these CR1 may be 
organised differently (figure 6.6). In one subgroup, the 2A sequence is at the N-terminus of the 
endonuclease (CR1-17, 10, 36, 46, 26 and 53) and therefore potentially in ORF2. In that subgroup, it 
is known that CR1-26 and CR1-53 have two ORFs. In the process of successive retrotranspositions, 
the non-LTR undergoes many deletions at the 5’end, and so it is not known if the ORF1 is simply 
missing for the other non-LTR retrotrnaposons of this subgroup of CR1-2A. However, another 
subgroup of CR1-2A (CR1-1, 2, 3, 11, 12 and 18) corresponding to a cluster in figure 6.8 features the 
2A sequence at the N-terminus of the PHD domain, but the classical ORF1 and ORF2 could not be 
identified.  
In amphioxus, 2A was also identified at the N-terminus of three predicted proteins shown in figure 
6.4. An analysis of the proteins domains showed no homologies between these. Their 2A sequences 
however can operate on eukaryotic ribosomes and cause stalling with varying efficiencies (figure 6.3 
(A)).  
The search for the 2A motif was extended to related amphioxus species. The query for Branchiostoma 
belcheri, B. lancealeatum, B. malayanum and B. japonicum did not return any hits in NCBI or 
repbase. 
 
Figure 6.3: SDS-PAGE analysis of test expression for amphioxus 2As 
In (A), all the amphioxus 2A sequences predicted to precede a protein were tested (sequences in table 6.1). They exhibit the 
typical FMDV 2A (lane 1) expression profile: a full-length product at 100 kDa, and a disproportionate amount of upstream 
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GFP2A (at 32 kDa) compared with GUS. Panel (B) shows the translation profile of 2A identified at the N-terminal of non-
LTR retrotransposons (CR1 and Crack clades) in amphioxus (sequences in table 6.2). The non-LTR retrotransposons 2A are 
mostly unable or inefficient at performing the separation between GFP2A and Gus (lanes 2 to 8) compared to FMDV (lane 
1).  
 
 
 
Figure 6.4: Visual representation of key domains in the 2A-containing amphioxus proteins 
Each domain is assigned a coloured box positioned where it has been identified within the protein of interest, the protein 
domain number (PD) is cited in bracket. This is a summary of search done using the ProDom facility available online. The 
position of 2A is indicated as a red bar. The efficiency of 2A is indicated in bracket. These are hypothetical proteins. 
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Figure 6.5: The non-LTR retrotransposons with 2A in amphioxus 
Amino acid window of all non-LTRs with a 2A element. The activity for those tested was indicated in bracket and the 2A 
consensus motif in bold.  
 
 
Figure 6.6: Visual representation of the non-LTR CR1 organisation in amphioxus 
The canonical CR1 non-LTR retrotransposon has two ORFs, CR1-2As however only possess one ORF and is followed by 
either the canonical endonuclease (CR1-17) or the PHD domain (CR1-1) normally present in ORF1. The canonical CR1 
organisation was reproduced according to the schematic structure in Kapitonov et al., 2009. 
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Figure 6.7: Tree showing clustering of Crack non-LTR retrotransposons containing a 2A motif 
The Crack non-LTR retrotransposons containing a 2A motif are highlighted in red. The alignment includes a representative 
of the other clades of non-LTR retrotransposons present in the genome. The alignment was created based on the reverse 
transcriptase domains.  
 
 
To date, the amphioxus genome is believed to host a total of thirty-two Crack elements (identified 
from repbase). Seven of these contain a 2A sequence at the N-terminus. 
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Figure 6.8: Tree showing clustering of CR1 non-LTR retrotransposons containing a 2A motif      
The branches for the CR1s with a 2A sequence are highlighted in pink. 
 
A total of fifty-six CR1 elements were identified for amphioxus at repbase. Twelve of these have a 2A 
element at their N-terminus detailed in figures 6.5 and 6.6. 
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6.3.2 Recently identified 2A in other organisms and viruses.  
 
DTV, AsTV and OMRV1 and 2 were newly identified totiviruses. Their consensus motif resembled 
DHV 2A and as expected performed equally well (figure 6.9). However, the consensus motif for 
rotavirus A and B, which deviated from the usual motif did not exhibit any stalling ability.  
 
For S. kowalevskii, only four out of the sixty-four contigs were predicted to have an identifiable 
protein domain following the 2A motif. One of them was tested (SK 1). Out of these four contigs, two 
sequences were predicted to precede a transposase and therefore be a transposable element. Searching 
of repbase (transposable elements database) for S. kowalevskii transposable elements failed to identify 
any transposon with a 2A sequence. The in vitro assay demonstrated 2A activity for SK6 and SK61 
which were not predicted to precede any domains at present.  
 
 
Figure 6.9: Activity assay for newly identified 2A in other cellular organisms and viruses 
In (A), S. kowalevskii (SK, lanes 2,3,4,5) are shown. In (B), all the 2A motif ( lanes 2, 4, 7 and 8) resembling DHV 
consensus motif (lane 3) were highly efficient, in contrast candidate motif in the genome of rotavirus A and B (lanes 5 and 6) 
could not perform the ribosome stalling mechanism.  
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Figure 6.10: Details for the selected S. kowalevskii contigs with a 2A sequence tested in vitro 
The 2A sequence is marked in red, and the accession number in blue. SK1 is the only sequence identified in NCBI 
(accession number XP_002731766) and the others were derived from bioinformatic analyses of contig sequences from 
Baylor College of Medicine.  
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6.4 Discussion  
 
Identification of new sequences is based on comparison of an amino acid or nucleotide sequence in a 
search for homologues. This is followed by alignment of homologues and finally by a reconstruction 
of the history by phylogenetic analysis. In this section, the result for search by homologies resulted in 
the discovery of 2A motifs in cellular organisms, B. floridae and S. kowalevskii. For the vast majority 
of S. kowalevskii sequences, no protein domains were predicted following the motif; it is at present 
not known if these sequences are translated. The result relied on an algorithm to reverse transcribe a 
protein motif into the various nucleotides sequences possible and matching these to the genome of 
interest. Therefore the number of 2A really present in the genomes of these two organisms might be 
over estimated. For amphioxus, three hypothetical proteins have 2A at their N-terminus. The 2A 
sequences were authenticated in the activity assay, but it is not known at present if these hypothetical 
proteins are translated. They present no homology, unlike for the sea urchin S. purpuratus where all 
the 2A were attributed to a family of proteins: the CATERPILLER proteins involved in innate 
immunity (Lich and Ting, 2007).  
 
The 2A motif was also identified at the N-terminus of two clades of non-LTR retrotransposons: Crack 
and CR1 in amphioxus. Non-LTR retrotransposons replicate via an RNA intermediate which they 
reverse transcribe and integrate in the host genome at new locations. Non-LTR retrotransposons are 
identified by their reverse transcriptase domains and classified into clades according to the type of 
additional domains they carry and the presence of one or two ORF (Malik et al., 1999). The repbase 
facility online is a repository of transposable elements identified in a multitude of organisms. There 
are currently six groups of non-LTR retrotransposons (R2, Randl, L1, RTE, I, and Jockey), further 
organised as clades. Of relevance to this study is the Jockey group, which consists of the clades 
jockey, rex1, CR1, L2, L2A, L2B, Daphne and Crack (Kapitonov et al., 2009). Although non-LTR 
retrotransposons are found in every eukaryotic genome sequenced so far, the type and number of 
copies vary greatly. Certain clades such as crack are host specific. Crack is found in sea urchin, sea 
squirts and amphioxus. Other clades are widely distributed, such as the CR1 clade (Kapitonov et al., 
2009). It was previously established that in amphioxus the number of non-LTR retrotransposons 
account for less than 1% of the genome (Parmanyer et al., 2006). This study also estimated a low copy 
number (up to forty-two) for all the transposable elements. The 5’ end of the non-LTR 
retrotransposon is often truncated and mutated as the reverse transcriptase often fails the transcription 
process at the 5’ end, resulting in copies of various lengths (Kapitonov and Jurka, 2003). The CR1 
clade however is considered to have two ORFs. ORF2 encodes for a reverse transcriptase and the 
APE domain. Kapitonov and Jurka (2003) analysed a variety of CR1 elements and concluded that the 
ORF1 consisted of a PHD domain (involved in protein-protein interaction) or an esterase (lipolytic 
acetylhydrolase). They did not conclude on the function that these two domains could serve in the 
 
160 
retrotransposition process and data are still lacking in that domain. What is interesting is that the 2A 
segment is found at the N-terminal of the retrotransposons, before the PHD domain. The CR1-2A 
elements have a single ORF.CR1-26 and 53 have two ORFs and the 2A is found between ORF1 and 
ORF2. It is likely that mutations resulted in loss of the two ORFs for the CR1-1 type of 2A non-LTR 
retrotransposon. It is possible that the truncation/ error prone transcription resulted in the loss of the 
ORF1 for the CR1-17 type of 2A non-LTRs and therefore these did not appear on the bio-informatic 
analyses. It is also possible for that last subgroup that the 2A element specifies a distinct type of CR1 
element.  
 
How has B. floridae acquired a 2A non-LTR retrotransposon? Non-LTR retrotransposons are thought 
to be transmitted strictly vertically (Malik et al., 1999). There is very little divergence in the 2A 
sequences, such as the motif and several residues preceding [NPGP] are conserved. The fact that most 
are not active is arguably the result of the error prone reverse transcriptase. The identified 2A 
sequences could be the early copies of a non-LTR retrotransposon which subsequently underwent 
serial deletions/mutations. Alternatively, this could constitute a late acquisition of the 2A sequence 
during the history of this genome. The scenario of an early acquisition which then resulted in loss 
seems less probable than the scenario of a recent acquisition, because CR1-2A would have been more 
widespread and is not present in related amphioxus species. One could also argue that the acquisition 
of the 2A is the result of the error prone reverse transcriptase. Acquisition however, likely involved a 
horizontal transfer, which presumably occurred twice in the history of that species for Crack and for 
CR1. The results presented here proved that these recoding elements were present in two clades of 
non-LTR retrotransposons in B. floridae however any conclusions about the origin and mode of 
transmission of 2A would only be hypothetical; perhaps uncovering 2A in greater number in diverse 
organisms as sequencing projects progress will answer some of these questions.  
 
In terms of consensus sequences, probing databases with deviating sequences such as [EGVENPGP] 
identified only a few extra sequences. Other 2A motfs might exist, but it is very likely the most 
abundant form of 2A would be the consensus sequence [DV/IExNPGP], as previously shown 
deviating sequences have stricter requirements from their upstream context. Searching for 2A in 
transcriptomes alone will under estimate the nature and amount of 2A sequences present in organisms 
and would have not resulted in for instance the discovery of this element in classes of non-LTR 
retrotransposon. Screening genomic databases can result in a large amount of false sequences as is the 
case for S. kowalevskii. Several 2A sequences in the sea urchin CATERPILLER family have at their 
N-terminus a signal sequence, several are being tested and preliminary results showed a localised 
expression of reporter proteins depending on whether the 2A sequence is removed by stalling or 
remains attached. S. purpuratus is, therefore, a perfect model to study the expression of cellular 2As, 
and acquire information about the ribosomal and cellular response to its repeated use. 
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All the stalling peptides that have been referred to throughout this thesis have unique sequences and a 
direct comparison is not possible. They do not necessarily employ the same route of intra-ribosomal 
signalling. There are however several features that are common to all of them. 
 They act in cis 
 They use proline at their C-terminus 
 They disturb the PTC activity by interacting with the exit tunnel 
 They show divergent sequences which thwarted any bioinformatics analyses aimed at 
identifying and predicting novel stalling sequences 
 They have a limited occurence. 
 
To acquire a better understanding of 2A-induced ribosome stalling, TaV 2A was chosen as a model 
for its optimum activity. Several mutations and molecular analyses were carried out and it is 
demonstrated here that following translation of TaV 2A, the organisation of the ribosome PTC is 
disturbed (chapter 5). Proline in the A site which is more constraint in its movement than any other 
amino acid accounts for some of the efficiency of stalling, although the disturbed PTC can not make 
the peptide bond between glycine and several other small amino acids in the context of TaV (chapter 
5). 
The understanding of the mechanism of action of TaV 2A-induced ribosome stalling then becomes 
the understanding of why the PTC is disturbed. Alanine scan (chapter 4) identified an ‘important 
region’ as well as several residues within the consensus motif that are critical for stalling. Beginning 
with the consensus sequence, what transpires is that the penultimate amino acids: [NPG] (figure 4.11) 
are critical. Substitutions can be tolerated at other positions within the consensus motif, for example 
[GDV] can be replaced by [EGV]. Alanine scan of two other 2A sequences FMDV and DHV also 
identified an ‘important region’ just preceding the consensus motif as critical for stalling. The proline 
experiment (figure 4.17) shows that free rotation of the ‘important region’ is an essential element to 
stalling for these three 2As.  
What would be the link between a flexible nascent chain in the upper tunnel and a disturbed PTC? It 
is very reasonable to suggest that 2A will interact with one or several ribosome nucleotides and/or 
residues. The discussion in chapter 4 provides many arguments to support this hypothesis. It is 
especially notable that no other nascent-stalling sequences bring about arrest without several 
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interactions with the ribosome exit tunnel. It is therefore proposed that the flexibility required for 2A 
serves the purpose of bringing in proximity the key elements to their ribosomal counterparts.  
 
The results suggest that TaV may form at least two interactions with the exit tunnel to produce the 
altered PTC.  
- One interaction may involve TaV arginine 5 and the tunnel. In the context of TaV, a positively 
charged residue is required in that position, although substitution for lysine results in a less efficient 
stalling sequence. 
- Another interactions may involve the [GDV] region. The fact that the spacing between the [GDV] 
and [NPG] regions is critical indicates that the positioning of [GDV] in relation to [NPG] is critical. It 
is therefore proposed that [GDV] interacts with an element of the ribosome.  
There are several possible scenarios; one is that the interaction(s) of TaV 2A with the ribosome 
induces a placement of the penultimate residues [NPG] such as to disturb one of the PTC 
neighbouring nucleotides like U2585 or A2062, which are known to be flexible and to influence the 
activity of the PTC. Alternatively, the critical position of TaV 2A in the exit tunnel is triggered by the 
addition of [NPG] residues to the growing peptide, in this case the intra-ribosomal partnering and 
positioning is introduced by the penultimate amino acids.  
Do we have a single 2A mechanism or is it that each 2A induces stalling via a different intra-
ribosomal relay? Because there is little conservation of critical residues between three 2A elements 
(figure 4.11): DHV, FMDV and TaV, one conclusion is that these may adopt a similar structure 
within the exit tunnel and arrive at that structure via different interactions. It may also be that they 
adopt different intra-ribosomal signalling routes and therefore position and partner with different 
ribosomal elements. The data suggest that there are at least two intra-ribosomal mechanisms one 
involving positively charged residues (TaV and DHV) and the other not involving that kind of 
residues but perhaps a α-helix stabilised by the ribosome (FMDV). The work presented here favours 
the hypothesis that each 2A adopts a unique conformation within the tunnel.  
Several components contribute to the 2A-induced ribosome stalling (summarised in final figure). The 
choice of proline in the P site adds efficiency, the key [NPG] motif may directly compromise the PTC 
but requires upstream a sequence which could make interaction to the tunnel wall. When the 
consensus sequence begins with the motif [GDV], much plasticity is tolerated in the upstream context. 
Aside interacting residues, the neighbouring residues may simply provide contextual information to 
promote the appropriate placement of the 2A element within the exit tunnel. 
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Final figure: Dissection of TaV 2A 
The consensus motif is in blue, and the upstream context divided between the important region (in orange) and the residues 
not involved in 2A activity (in grey). The residues in bold are critical for 2A activity. 
 
As previously mentioned an alteration of the PTC geometry means that an element of the PTC is not 
positioned appropriately for peptide transfer to occur. The intra-ribosomal signalling system resulting 
in altered PTC geometry could be compared to a domino effect. The disturbance of a nucleotide from 
the tunnel displaces several residues along the way up to the PTC. For SecM, it has been proposed 
that physical force alleviates stalling. The N-terminus of SecM has a unique signal sequence that 
preferentially binds to SecA. The distance between this region to the stalling motif is critical for SecM 
activity. A shorter length abolished SecM activity and a longer length resulted in more release and 
less stalling (Yap and Bernstein, 2011). The authors concluded that the hydrophobic signal sequence 
acts as a timer. Therefore their theory favours a physical movement of the peptide within the tunnel to 
reset the ribosome function after stalling, it is also notable that the ribosome encounters a stop peptide 
after the Gly-Pro pair. The signal sequence of SecM serves three functions, to recruit preferentially 
SecA, to localize the SecA synthesis (in the ORF2) to the site where it will be needed and to reset the 
ribosome after SecM stalling. The 2A motif is always found at the N-terminus of all the cellular 
sequences listed to date containing it. It is also an interesting finding that some Sea Urchin 2A 
sequences have a signal sequence at their N-terminus (Dr Sukhodub, unpublished). Whether the signal 
sequence also serves other purposes than protein targeting for these 2As has not yet been tested.  
What could reset the ribosome so it can resume its translation past the 2A-stalling? Can eRF1 and 3 
whose duties is to lyse the ester bond be the only factor that enables the correct repositioning of the 
PTC and the disturbed residues in the exit tunnel? All the A site residues tested for TaV 2A retained 
stalling abilities and re-initiation of translation. Therefore eRF1 and 3 succesfully rescued the stalled 
complex with structuraly different A site mRNAs, how can eRF1 and 3 bind to very structurally 
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different sequences? These are two of the many unanswered questions regarding the role eRF1 and 3 
play in relation to 2A-induced ribosome stalling. Because their presumed function in the context of 
2A goes against the well established notion that these factors have evolved to accommodate only stop 
codons, it is critical that this is investigated in a reconstituted translation system.  
 
Two aims were not achieved: the structural resolution of 2A and proof for eRF1 and 3 direct 
interventions in rescuing the 2A-stalled ribosome. The work carried on these two instances served as 
negative results to pave the way to more successful experiments. In the light of the dynamic nature of 
the ribosome, the un-uniform environment within the upper exit tunnel, and the fact that 2A sequences 
may adopt at least two mechanisms to stall the ribosome, it will be more informative to resolve the 
structure of a 2A-bound ribosome by cryoEM than to purify and study these in a uniform solution. To 
dissect the molecular aspects of the 2A mechanism, a synthetic eukaryotic translation system will 
provide the necessary platform to carry out cross-linking studies, mutations, additions and omissions 
of various factors. Mutagenesis of the six proposed model 2As and their comparison will complete 
this study as well as further non conservative mutagenesis of TaV 2A important region. 
 
2A and other stalling sequences prove that translation is also modulated by the sequence of amino 
acid progressing in the ribosome exit tunnel. The stalling sequences can therefore be a primary 
platform to study and map the type of interaction possible between the nascent peptide and the 
ribosome exit tunnel. 
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Guide to appendices 
 
The attached CD contains appendices organised in four folders. 
 
 
 
Appendix 1a- pSTA1 vector 
Appendix 1b- pJC3 vector 
 
Appendix 2- provide the chromotagram results for each 2A mutant featured in chapter 4 
A sub-folder was created for each figure of chapter 4. The mutant identity is indicated first, the second 
line provides the expected nucleotide sequence. The chromatogram for the 2A region was inserted 
underneath. 
For each 2A, the Xba1 site (TCTAGA), the first codon of GUS following 2A (CAC), as well as the 
mutation introduced are highlighted in the nucleotide sequence. The mutations are encased in a black 
rectangle in the chromatograms. 
 
Appendix 3- provides the chromatograms for puromycin experiment, the TaV P20 mutants and 
FMDV codon study. 
 
Appendix 4a- the amphioxus protein sequences with NCBI accession number 
Appendix 4b- the list of contigs where 2A was identified in Saccoglossus kowalevskii. 
 
 
 
